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ABSTRACT

The effects of saturated fatty acids (SF A), cis fatty acids (CF A), and trans fatty
acid (TF A) on blood ethanol clearance were determined in 5-week-old male SpragueDawley rats. In the first phase, it was established that the blood ethanol concentrations
(BEC) of the SFA and CF A groups were higher than those of the TF A group after 2
weeks of dietary treatment. While the concentrations of liver triglyceride were
significantly lower in the TF A group, the levels of plasma triglyceride were not affected
by the types of dietary fatty acids.
Possible mechanisms of dietary fat related changes on BEC were investigated in
these rats. It was found that TF A enhanced blood ethanol clearance in comparison to
SF A or CFA; however, the hepatic alcohol dehydrogenase activity was not affected after
either 2 or 6 weeks of dietary treatment. The activity of camitine palmitoyl transferase-I
was also not affected by the types of dietary fatty acid. The excretion of ethanol in urine
was higher in the TF A group than in the CF A group during the first 4 hours post- ethanol
administration and might partially explain the dietary fatty acids related changes in BEC.
In addition, the concentrations of acylcarnitine were changed parallel with BEC of the
dietary groups. Thus, the reduction in BEC in rats fed the TFA may be at least in part
mediated through parallel changes in carnitine concentrations.
Differences in ethanol uptake and metabolism were examined in small intestines
of rats fed dietary SFA, CF A, or TF A. The uptake and/or metabolism of ethanol was
measured in everted intestinal sacs. Ethanol transport expressed as the ratio of serosal to
mucosal ethanol concentrations and the in vitro absorption rate of ethanol was not
IV

significantly affected by dietary fatty acids. However, when the amount of ethanol
metabolized to CO 2 during the transport process was taken into account, uptake and
metabolism of ethanol by the proximal segments of the small intestine were significantly
higher in the rats fed TF A and CF A than in those fed SF A. Because ethanol oxidation
was not significantly different between the CF A and TF A group, some other mechanism
must be responsible for the differences in BEC of CF A and TF A animals. Nonetheless, it
is noted that ethanol metabolism in extrahepatic tissues can not be ignored for the effects
of SF A and unsaturated fatty acids on ethanol pharmacokinetics.
The fatty acid composition data revealed that the fatty acid profiles of diets were
reflected in the fatty acid content of various tissues. The phospholipids fraction of the
liver and small intestine of rats fed the TF A diet for 6 weeks had a higher percentage of
linoleic acid and lower percentages of palmitic, stearic, and arachidonic acids than those
fed the SF A and CF A diets. Compared with rats fed the CF A diet, the fatty acid
composition in the liver microsomes of those fed the TF A diet was characterized by a
significant decrease in palmitic, stearic, and oleic acids and an increase in linoleic acid.
These fatty acid changes were similar in plasma. The fatty acid composition data
supports the suggestion that elaidic acid interfered with the conversion of linoleic acid to
arachidonic acid which has been shown to protect liver from alcohol-induced injury.
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CHAPTER I
INTRODUCTION

There has been a change in the type and amount of dietary fat consumed in the
U.S. and the world. The leading change in consumption of visible fats is the shift from
animal fats to the fats of vegetable origin (Enig et al. 1990, F AO 1994, Hudgins et al.
1991, Meydani et al. 1991). Elevated intake of the processed vegetable fats and oils has
led to an increased availability of chemically altered fatty acids known as trans isomers.
Trans fatty acids (TFA) are formed during the catalytic partial hydrogenation of vegetable
oils to manufacture margarines, shortenings and cooking oils and also are synthesized by
rumen microorganisms. Approximately 90-95 % of dietary TF A are provided by the
partially hydrogenated vegetable oils and the remaining 5-10 % from ruminant fats in the
average American diet (Emken 1984, Enig 1996). The principal TF A produced by the
catalytic partial hydrogenation and microbial biohydrogenation are elaidic acid and
vaccenic acid, respectively (Kris-Etherton and Nicolosi 1995, Senti 1985, Sommerfeld
1983). The average intake of TFA in the U.S. is estimated to be 8.1 to 13.3 g/day or 34% of total energy intake (Enig et al. 1990, Hunter and Applewhite 1991). Nevertheless,
intake may be much higher in individuals who eat large amounts of foods prepared with
such fats (Enig et al. 1990, Lichtenstein 1995).
The answers concerning the health implications and physiological effects of TFA
are not yet clear (Katan 1998, Willett and Ascherio 1994). The concept that the effect of
dietary TFA is not deleterious should be reevaluated. The least of their effect is to inhibit
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the conversion oflinoleic and cx-linolenic acids to their major metabolites, arachidonic
and docosahexaenoic acids, and thus increase the requirement for these essential fatty
acids (Dupont et al. 1991, Sugano and Ikeda 1996, Zevenbergen et al. 1988).
Ethanol metabolism is profoundly affected by the type and amount of dietary
lipids. Epidemiological and animal studies suggested that saturated fats were relatively
protective against the process of alcoholic liver disease (ALD), whereas unsaturated fats
promoted ALD (French 1993, Nanji and French 1986, Nanji et al. 1989, Nanji et al.
1994a). Rats fed saturated fatty acids (SF A) were found to have lower rates of ethanol
metabolism than those fed unsaturated fatty acids (USFA) (Cha and Sachan 1994).
Dietary fat modifications have been shown to alter the absorption of ingested
nutrients (Thomson and Rajotte 1983, Thomson et al. 1986, Bernard et al. 1987), which
may involve the changes in the fatty acid composition of intestinal membranes.
Information concerning the influences of feeding TFA on the intestinal uptake of
nutrients and xenobiotics, however, is not complete.
Camitine has been shown to ameliorate ethanol-induced fatty livers in rats
(Berger and Sachan 1986;1991, Rhew and Sachan 1986, Sachan 1992) which can be
explained by the competitive inhibition of alcohol dehydrogenase (ADH) by
acetylcamitine (Sachan and Cha 1994). When effects of SFA and USFA on ethanol
metabolism were determined, higher blood ethanol concentrations (BEC) were associated
with higher concentrations of camitine fractions (Cha and Sachan 1994). Therefore, it
was essential to determine the changes in camitine fractions in animals fed cis and trans
fatty acid isomers.
We used ethanol metabolism as a model to explore the physiological effect of
2

TF A. The main objective of these studies was to determine the effects of cis and trans
fatty acids on BEC. Possible mechanisms responsible for the changes in BEC, such as
hepatic ADH activity, plasma camitine concentrations, urinary excretion of ethanol, and
intestinal uptake and metabolism of ethanol, were investigated. Fatty acid composition of
plasma and different tissues was also analyzed to examine the relative changes by the
incorporation of TF A.
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CHAPTER II
LITERATURE REVIEW

ETHANOL

Ethanol, ethyl alcohol or simply alcohol, is a colorless volatile liquid of a pungent
odor which is produced principally by means of sugar or carbohydrate fermentation
through the action of microorganisms such as bacteria and yeasts. It is a liquid of polar
nature and is miscible with water. Because of its small size and weak charge, ethanol is
able to pass freely through biological membranes in the same manner as other low
molecular weight polar molecules such as water (Batt 1989, Kricka and Clark 1979).
In mammals, ethanol is normally present in cells at low concentration, on the
order of 0.1 to 1 mmol/L, and it is derived from the fermentation activity of
gastrointestinal flora and some due to endogenous production in different tissues,
especially liver (Baraona et al. 1986, Krebs and Perkins 1970, McManus et al. 1960).
However, the main source of ethanol in man is not its endogenous production but its
direct consumption. Only in rare cases such as patients with a blind intestinal loop and
those with an overproduction of the intestinal flora including Candida and other yeasts,
can there be observed elevated levels of ethanol in blood. The fermentation of
carbohydrates in intestine of these cases may even produce drunkenness.
Absorption of Ethanol

Once ethanol is ingested, it begins to be absorbed immediately through the
mucous epithelium of the mouth and as vapor in the pulmonary alveoli (Batt 1989);
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however, the amount of ethanol absorbed through these two pathways is practically
negligible. For all practical purposes, the orally ingested alcohol is absorbed in the
stomach by simple diffusion through the epithelium of the stomach and intestines at the
same rate as water (Batt 1989, Watson 1989). Small proportions of ethanol
(approximately 20 to 30%) are absorbed in the bloodstream through the gastric mucosa
and the remaining large amount through the small intestine, principally duodenum and
jejunum (Batt 1989, Cooke and Birchall 1969, Smith et al. 1992). Ethanol is rapidly
carried directly to liver to be metabolized via the portal vein.
Once the ethanol is readily distributed throughout the body fluids, it crosses freely
through the totality of the biological membranes (Watson 1989). Women, who have a
lower percentage of body fluids (53% versus 61.8%) and a higher percentage of body fat
(26.9% versus 14.7%) than men, reach higher levels of ethanol in blood even if both men
and women ingest equivalent amounts of alcohol (Batt 1989, Watson 1989).
The absorption rate of ethanol depends mainly on the velocity with which it
passes from the stomach to the small intestine, which in tum depends principally on the
speed at which gastric emptying is carried out. In general, the presence of solid food
retards gastric emptying and therefore, the speed of ethanol absorption (Horowitz et al.
1989). On the other hand, the concentration of the ingested ethanol also influences its
absorption, so that high concentration of ethanol retard the emptying of food in the
stomach (Horowitz et al. 1989, Raine et al. 1991). Various factors which influence to a
greater or lesser extent the velocity of ethanol absorption are listed in Table 2-1.
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TABLE 2-1

Factors affecting ethanol absorption

1

Stomach emptying

Type of beverage

Food in the stomach

Protein deficiency

Ethanol concentration

Body temperature

Blood flow at the site of absorption

Physical exercise

Irritant properties of ethanol

Menstrual cycle

Rate of ingestion
1

Adapted from Kricka & Clark ( 1979).

Excretion of Ethanol

Small amount of ethanol (5 to 10%) are excreted unchanged in urine (0.2 to
2.0%), expired air (5%), and sweat (0.5%) (Agarwal and Goedde 1992). Urinary
excretion of ethanol is a passive process and ethanol clearances of between 0.9 to 12.7
mL/minute have been reported by this route (Blackmore and Mason 1968). It was
estimated that the total alcohol eliminated by the human body per hour is usually in the
range of 100 to 300 mg/kg/hour, which is equivalent to 6 to 9 g alcohol/hour, for a
healthy subject with an average body weight (Agarwal and Goedde 1992).
Metabolism of Ethanol

Ethanol is absorbed mainly from the small intestine, where it is channeled through
the portal vein directly to liver before passing into the systemic circulation and the rest of
the body (Goldstein 1983). The liver is the principal organ responsible for the oxidation
and elimination of ingested alcohol (Hawkins and Kalant 1972). Hepatic vein
6

catheterization studies have shown that around 75% of a dose of ethanol is eliminated by
hepatic metabolism (Winkler et al. 1969). Maximal hepatic metabolic capacity is
approximately 2 mmol ethanol/minute (Tygstrup et al. 1974) as compared to a total
extrahepatic metabolism which is estimated to be 0.4 mmol/minute.
In liver, there are three metabolic systems capable of carrying out ethanol
oxidation. The first system is made up of a series of specialized enzymes known
generically as alcohol dehydrogenases or ADH, which are found in the cytosol of the
different tissues, principally hepatic of the human body. These enzymes promote the
oxidation of ethanol into acetaldehyde, coupling this oxidation with the reduction of a
nicotinamide adenine dinucleotide (NAD+). The second oxidizing system is called
microsomal ethanol oxidizing system (MEOS), which is located in the microsomes and
requires participation of cytochrome P-450. The cytochromes P-450 couple ethanol and
nicotinamide adenine dinucleotide phosphate oxidation (NADPH) to the reduction of an
oxygen molecule to form hydrogen peroxide. The third system is found in hepatic
peroxisomes, and in this system, the oxidation of a molecule of ethanol into acetaldehyde
is coupled with the simultaneous decomposition of a hydrogen peroxide molecule in a
reaction catalyzed by the enzyme called catalase. These three systems work
simultaneously in the presence of ethanol, although with different activities and affinities.
Besides the three enzymatic systems described previously for ethanol oxidation,
there exists a non-enzymatic ethanol oxidation in the microsomal system (Koop 1989).
The presence of this non-enzymic pathway results from two factors. The first is the
inherent degree of uncoupling of the microsomal electron transport system which results
in the one- and two-electron reduction of oxygen to superoxide and hydrogen peroxide,
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respectively (Black and Coon 1987, White and Coon 1980). The H 20 2 formed in in vitro
incubations can then participate in ethanol oxidation when the second factor is present,
that being a reduced metal chelate (such as Cu, Fe, or Co) which facilitates a classical
metal-dependent reduction of H 20 2 (Fenton reaction) and can be formulated as follows:
M"++HO
2 2

--->- M <n+I)+ + OH - + ·oH

The typical promoters of this reaction in vitro appear to be iron ch elates in a classical iron
catalyzed Haber-Weiss reaction formulated as follows (Halliwell and Gutteridge 1986):
Fe 3++0 2-

~

Fe 2++0 2

F e 2+ + H 2O2

-->--

Fe 3+ + OH - + ·oH

In microsomal reactions, the formation of reduced metal chelates such as iron-EDTA is
facilitated by the ability ofNADPH cytochrome P-450 reductase to reduce the complex
(Feierman et al. 1985, Morehouse et al. 1984). Thus, in a microsomal incubation, if Fe 3+
and EDTA are present, the system is poised to catalyze the iron-dependent oxidation of
ethanol. Since NADPH and 0 2 are required, this reaction would appear on the surface to
be catalyzed by P-450, but in fact it is the microsomal electron transport chain which is
supplying the reducing equivalents to both iron and molecular oxygen. In another word,
the metal chelate catalyzes the oxidation. It was reported that biological iron complexes
such as phosphate, carbohydrate, organic acid , and ferritin complexes can produce
hydroxyl radical in a system containing hydrogen peroxide and superoxide (Halliwell and
Gutteridge 1986). In addition, iron-EDTA was found to stimulate microsomal ethanol
oxidation about threefold (Feierman et al. 1985). Therefore, this nonenzymic system may
have a role in vivo in the metabolism of ethanol.
A non-oxidative metabolic pathway where ethanol forms fatty acid ethyl ester by
8

means of a fatty acyl ester synthetase also exists (Lange et al. 1981, Koop 1989). Even if
its contribution to total ethanol metabolism is not significant (Koop 1989), its
participation in the development of pathological alterations remains to be discussed in
organs that lack high activity ethanol oxidating systems, such as pancreas, heart and
brain, (Laposata and Lange 1986).
Alcohol Dehydrogenase (EC 1.1.1.1)
Alcohol dehydrogenase activity is carried out by three families of enzymes.
Three protein families of different origins, structures and reaction mechanisms which
exhibit this capacity have been described.
The first family is comprised of "short chain" alcohol dehydrogenases, which do
not require a metallic ion as cofactor and which are found characteristically among
insects (Persson et al. 1991). The second group is made up of the "medium and long
chain" alcohol dehydrogenases, and includes the "classic" mammalian alcohol
dehydrogenases. These enzymes require zinc atoms as cofactor, and are divided into
tetramerics and dimerics. The latter conform the most diversified group in mammals and
include about a dozen different isozymes classified into six distinct classes (Amon 1995,
Danielsson et al. 1994). The third family corresponds to the Fe-dependent alcohol
dehydrogenases, which are characteristic of unicellular organisms such as Zymomonas
and Clostridium. This group makes up the smallest and least studied family of alcohol
dehydrogenases (Scopes 1983). In vertebrates, only the first two protein families are
present, and only the "medium and long chain" family exhibits a significant alcohol
dehydrogenase activity in these organisms, which will be referred to as the alcohol
dehydrogenase system.
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The alcohol dehydrogenase system in mammals is divided into six distinct classes
with at least twenty different isozymes coded by more than seven distinct genes (Amon
1995, Danielsson et al. 1994). These enzymes are amply distributed in different human
tissues (Boleda et al. 1989), and all of them are characterized by being dimeric proteins
with subunits of approximately 40kDa. Each subunit is characterized as containing two
atoms of zinc bonded by cysteines that help stabilize the enzyme structure (Jelokova et al
1994), besides the fact that one of them forms part of the active site (Amon 1995). Table

2-2 shows the different classes of alcohol dehydrogenases described above as well as the
distinct genes and subunits that they comprise.
All these enzymes use NAD+ as electron-accepting coenzyme, to catalyze the
oxidation of ethanol to acetaldehyde. This reaction mechanism has been described as bibi ordered type, where the NAD+ and NADH should penetrate the coenzyme union site
before the ethanol or acetaldehyde enters the catalytic domain (Branden et al. 1975). The
reaction shows as follow:
ADH

)r

All ADH isozymes show Michaelis-Menten kinetics with respect to ethanol (Burnell and
Bosron 1989), and only yy isozymes seem to exhibit a negative cooperativity for ethanol.
The dissociation ofNADH is the rate-limiting step in these enzymes (Burnell and Bosron
1989, Fan and Plapp 1995).
"Medium and long chain" alcohol dehydrogenases are grouped into classes based
on their structural differences. Figure 2-1 shows the possible phylogenetic relationships
among different ADH types. Of all the classes described, the first five have already been
found in human tissues (Kedishvili et al. 1995, Seitz and Oneta 1998). The recently
10

TABLE 2-2
Alcohol dehydrogenases (ADH) polymorphisms in mammals
Allelea

Subunit

1

Tissue distribution

Class

Gene Locus

I

ADH-1

ADHJ

a1

Liver

I

ADH-2

ADH2*1

P1

Liver and lung

I

ADH2*2

P2

Liver and lung

I

ADH2*3

p3

Liver and lung

I

ADH-3

ADH3*1

Y1

Liver and stomach

I

ADH-3

ADH3*2

Y2

Liver and stomach

II

ADH-4

ADH4

7t

Liver, cornea, kidney and lung

III

ADH-5

ADH5

X

All tissues

IV

ADH-7

ADHa

a

Liver, stomach, skin and cornea

IV

?

ADHµ

µ

Liver, stomach and skin

V

ADH-6

ADH6

?

Liver and stomach

VI

?

?

Liver

?

1Modified from Amon et al. (1995).
a Each gene locus has one allele, except for ADH-2 and ADH-3 which have 3 and 2
alleles, respectively. Alleles from the same gene locus are indicated with an asterisk.
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Short chain
dehydro genases
(lacking in zinc)

Medium and long chain
dehydrogenases
(zinc-dependent)

/

Ancestral alcohol
dehydro genase
(Class III)

ADH
Class I

a

Sorbitol
dehydrogenase

ADH

ADH

Class II

Class III

l~

Subunit

Subunit

p

Alcohol
dehydrogenases
(iron-dependent)

ADH
Class IV

ADH
Class V

Subunit

y

FIGURE 2-1 Phylogenetic relations among the different types of alcohol
dehydrogenases.
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ADH
Class VI

described class VI has not yet been characterized. The most relevant characteristics of
each class of mammalian alcohol dehydrogenase are briefly described below.
Class I: This is the most studied class in this enzyme family and includes the
"classic" hepatic enzyme. It has three distinct gene loci (ADH-1, ADH-2, and ADH-3)
found in human chromosome four, which encode for three types of subunits (a,

p and y subunits differ among themselves by a few amino acid

The alleles for the
residues

(P P P
1,

2,

p, and y).

3,

and y 1, y 2). These subunits can form homodimers or heterodimers

contributing to the generation of a great polymorphism with many isoforms. Each
isoform presents variants as to their kinetic properties (Table 2-3) which partially
explains the great heterogeneity in the capacity for metabolizing ethanol by the human
populations. For example, ADH-2 locus is commonly known as 'atypical' ADH that
contains a variant

p2 subunit instead of the usual p1 subunit.

While about 5-10% of the

English, 9-14% of the German, and 20% of the Swiss population possess the atypical
ADH. The variant enzyme occurs in about 85% of Chinese, Japanese, and other Orientals
(Agarwal and Goedde 1992).
All isozymes of this class are highly sensitive to pyrazole inhibition and show
substrate inhibition ([ ethanol] > 20 mmol/L) because an ethanol excess decreases the
speed of dissociation of NADH from the enzyme (Danielsson et al. 1994, Kamlay and
Shore 1983).
Class II: This class is made up ofhomodimetric isozyme 1t1t, and is found in
diverse organs such as liver, cornea, kidney and lung. It participates actively in the
degradation of circulating epinephrine and norepinephrine (Mardh et al. 1986). This class
exhibits a high affinity for ethanol, and is only slightly sensitive to pyrazole inhibition
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TABLE 2-3
Kinetic properties of some ADH isozymes, with ethanol as substrate 1
Kinetic constant
Isozyme

Optimal
pH

KmofNAD+
(µmol/L)

Km of ethanol
(mmol/L)

Vmax
(min- 1)

aa

13.0

4.2

27.0

10.5

P1P1

7.4

9.2

10.5

P2P2

180.0

400.0

8.5

p3p3

712.0

36.0

300.0

7.0

Y1Y1

7.9

1.0

87.0

10.5

Y2Y2

8.7

0.63

35.0

10.5

20.0

10.5

14.0

1t1t

xx

0.049
0.94

34.0
~

2000

?

1Modified from Burnell & Bosron (1989).

(Bosron et al. 1979).
Class III: This class is made up of isozyme XX, which is a homodimer encoded by
the ADH-5 gene, and probably corresponds to the ancestral form which gave origin to the
rest of the ADH (Amon 1995, Danielsson et al. 1994). It possesses a great capacity to
metabolize long chain alcohols; however, its capacity to oxidize ethanol is, on the other
hand, very limited (Bosron et al. 1988). Class III ADH is broadly distributed in the
different species and tissues (Amon 1995), but it is the only ADH isozyme found in the
brain (Beisswenger et al. 1985). Due to its poor capacity to oxidize ethanol (Km> 2.5
mol/L), the possibilities that ADH protects the brain against ethanol or its metabolites and
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that the brain can generate energy from ADH-monitored ethanol metabolism for cerebral
function is excluded. Therefore, it has been suggested that this class of enzyme plays
special but as yet unknown physiological and biochemical roles (Beisswenger et al.
1985).
Class IV: this class is expressed preferably in the stomach (Danielsson et al.
1994), although it can be found in lesser quantities in other tissues such as liver, skin and
cornea (Amon 1995). It is made up of isozymes aa andµµ, which are encoded by the
ADHo and ADHµ genes, located in the ADH- 7 locus (Amon 1995). It presents a very
high Km for ethanol, and is thought to participate actively in the first-pass ethanol
metabolism in stomach.
Class V: This class has been found in gastric epithelium, and is made up of a
homodimer encoded by the ADH-6 gene (Amon 1995). It possesses a very high Km for
ethanol and is also thought to participate in the gastric first-pass metabolism of ethanol.
Class VI: This class is the newest of the ADH classes described in mammals
(Zheng et al. 1993). It was identified for the first time in Peromyscus maniculatus (deer
mouse), and is present in ADH-positive genotypes as well as in negative ADH (which
lack the Class I "typical"alcohol dehydrogenase). It is expressed principally in liver and
in minimum quantities in kidney. Its role in ethanol metabolism is still uncertain. No
reports of its existence have been noted in humans, but it has been identified in rats
(Hoog et al. 1995).
Microsomal Ethanol Oxidizing System (MEOS)
The MEOS accounts for the major non-ADH pathway of ethanol oxidation in the
liver. This system was investigated for the first time by Lieber' s group at the late 60s
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(Lieber and DeCarli 1968, Rubin et al. 1968) from an initial report by Orme-Johnson and
Ziegler (1965), in which they described parallel increments in the capacity to metabolize
drugs and ethanol with total activity of cytochrome P-450 in the smooth endoplasmic
reticulum of hepatic cells. From these initial reports, the existence of a new cytochrome
P-450 dependent pathway of ethanol oxidation was rapidly developed.
Currently, the presence of MEOS in the microsomes of different tissues is well
recognized (Gonzalez 1992), and it is now known that this system involves the
participation of various enzymes of the present cytochrome P-450 superfamily. The P450 superfamily is composed of about 230 genes and pseudo genes distributed among
thirty-six distinct families, of which at least ten are present in mammals (Degtyarenko
and Archakov 1993, Gonzalez 1992). These families are defined basically as to their
similarities in terms of amino acid sequences (Gonzalez 1992).
Cytochromes P-450 are divided into two main classes, from the functional point
of view. The first class (which is comprised by mammalian classes CYPl, CYP2, CYP3
and CYP4) is involved in the metabolism ofxenobiotic compounds. The second (the
CYP7, CYP 11, CYP 17, CYP 19, CYP21, and CYP2 7 families) is related to the synthesis
of steroids and bile acids (Gonzalez 1992).
Different types of cytochrome P-450 are capable of catalyzing the ethanol
oxidation, although the most efficient is cytochrome P-450 2E 1 (Koop 1989). According
to the nomenclature recommended by Nebert's group (Nebert et al. 1989, Nelson et al.
1993 ), cytochrome P-450 2E 1 is also termed CYP2E 1 or simply 2E 1. This cytochrome
was originally referred to as "3a" in rabbits and rats, and as 'T' in humans, and these
names are kept only for reference while reading papers published previously to the
16

classification proposed by Nebert et al. ( 1989).
Cytochrome 2El is the basic constituent of the MEOS system (Lieber 1994),
which possesses activity to oxidize ethanol and other alcohols, such as butanol and
pentanol (Morgan et al. 1982). This system holds a low affinity for ethanol, with a Km of
8 to 10 mmol/L (Lieber 1994), therefore, it is important participant in non-alcoholic
individuals only when the concentrations of substrates are high in tissues.
The MEOS system catalyzes the oxidation from ethanol to acetaldehyde, coupling
this reaction to the oxidation of an NADPH molecule and the reduction of an oxygen
molecule to form hydrogen peroxide (Teschke and Gellert 1986).
CH3CH20H + NADPH + H+ + 02

MEOS

::>

CH3CHO + NADP-,- + 2H20

The MEOS system is the only one whose activity is significantly induced (5 to 10
times) by the presence of ethanol or other molecules such as pyridine, acetone, and
pyrazole (Koop and Tierney 1990, Lieber 1994). Although it appears that the enzyme
concentration can be regulated by post-translational mechanisms such as mRNA
stabilization, increased translation of existing mRNA, and inhibition of protein
degradation (Koop and Tieney 1990), the molecular mechanism underlying 2El
induction remains disputed (Lieber 1994).
Catalase (EC 1.11.1.6)
This enzyme is an oligomeric protein with 4 subunits (of 60 kDa each) arranged in
tetrahedric form. Each subunit functions in an independent manner, and possesses as
prosthetic groups a ferric protoporphyrin IX and a NADP+ molecule (Fita and Rudman
1985, Schonbaum and Chance 1976). Catalase was one of the first enzymes that was
isolated in a highly purified form and its crystallization from liver extracts marked a
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milestone in the history of biochemistry (Schonbaum and Chance 1976).
Catalase is localized in the peroxisomes and its main activity is the decomposition
of hydrogen peroxide molecules:

In the particular case of ethanol, its oxidation can be coupled to the decomposition
of a molecule of hydrogen peroxide, or even to the decomposition of organic peroxide,
where:
HOOH + CH 3CH 20H
ROOH + CH3CH20H

>

CH3 CHO + 2H 2 0
CH3CHO + ROH + H 20

R = [H, alkyl, acyl]
The main rate limiting factor in the oxidation of ethanol by catalase is the availability of
hydrogen peroxides. It is generally accepted that under normal conditions, its
contribution in ethanol metabolism is minimal (Lieber 1994).
Acetaldehyde Metabolism
Acetaldehyde, the principal metabolite generated in the first stage of hepatic
ethanol catabolism, is produced mainly in the liver. It is metabolized through three
metabolic pathways. The first of these is made up of an enzymatic system generically
known as aldehyde dehydrogenases or ALDH (EC 1.2.1.3 ), which catalyze the oxidation
of acetaldehyde to acetate in a reaction that requires NAD+ as electron acceptor (Amon
1995), where:

This reaction like ADH-catalyzed ethanol oxidation, has a bi-bi ordered type mechanism,
where the previous union of NAD+ is indispensable for the acetaldehyde to penetrate the
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active site (Farres et al. 1995). The rate limiting step for ALDH is not the dissociation of
NADH but the acyl group dissociation of the enzyme.
The second pathway is made up of aldehyde oxidase (EC 1.2.3.1). This enzyme is
localized in the cytosol of the cell and has a molecular weight of 300 kDa. It catalyzes
acetaldehyde oxidation to acetate in a reaction coupled with oxygen consumption and
hydrogen peroxide formation. This enzyme has a Km for acetaldehyde of 1 mmol/L
(Rajagopalan et al. 1964).

The third pathway, described recently (Kunitoh et al. 1996), is named the
Microsomal Acetaldehyde Oxidizing System, also called MAOS. This system requires
the participation of cytochromes P-450, especially the CYP2E 1. It carries out the
oxidation of acetaldehyde into acetate in a reaction coupled to the oxidation of NADPH,
in a reaction analogous to that achieved by the MEOS.

The activity of this system is induced 2-fold in animals chronically treated with ethanol.
However, this system is as yet poorly characterized and thus its role and physiological
relevance are not fully recognized.

Interactions of Ethanol with Nutrients
Ethanol, generating 7.1 kcal/g, has profound effects on nutritional status (Feinman
and Lieber 1992). Many ethanol-nutrient interactions are described in detail elsewhere
(Feinman and Liber 1992, Lieber 1991). In general, an high intake of ethanol may cause
primary malnutrition by substituting other nutrients in the diet because of the high energy
and low nutrient contents of the alcoholic beverages or associated medical disorders. For
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example, as alcohol consumption increases, the percentage of energy derived from
protein, lipid, and carbohydrate decreases and the nutritional quality of the diet declines
(Hillers and Massey 1985, Sherlock 1984). Concurrently, intake of vitamin A, ascorbate,
thiamin, and folate may fall below their recommended daily allowances (Grochow et al.
1985). In addition, ethanol is directly toxic to many tissues and therefore influences the
nutrients by interfering with their intake, absorption, metabolism, and loss from the body.
Ethanol was reported to enhance nitrogen loss in the urine of man and thus increasing
protein requirements (Bunout et al. 1987).
Ethanol can affect nutrient entry to the body by interfering with digestive
functions and intestinal absorption. The secondary alcoholic malnutrition syndrome is
probably caused by a combination of factors, including the effect of alcohol on gastric
emptying, intestinal motility, digestive functions of the pancreas and liver, cellular
structure and function of the small intestine, and active transport of specific nutrients
(Feinmen et al. 1992, Korsten et al. 1992, Stowell 1989). For single nutrients, ethanol
seems to specifically impair the absorption of those that require an active mechanism for
their transport across the intestinal border. Alcohol has been found to impair absorption
ofthiamin, folic acid, vitamin B12, amino acids, pyridoxine, glucose and some minerals
(Feinmen and Lieber 1992, Lieber 1991, Thomson and Majumdar 1981).

TRANS FATTY ACIDS
Unsaturated fatty acids are formed in living tissues by the removal of pairs of
hydrogen atoms from adjacent methylene groups to produce at least one carbon-carbon
double bond. Two geometrical configurations around that double bond are the hydrogen
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atoms on the same side (cis) or on the opposite directions (trans). Figure 2-2 shows the
structure of cis and trans fatty acids. In addition, the double bond can be located in
various locations along the length of the fatty acid molecule, which give rise to a number
of positional isomers within each unsaturated fatty acid (Emken 1984).
Dietary Sources of TFA

Trans fatty acids (TF A) are formed when vegetable oils are partially or fully
hydrogenated to manufacture margarines, shortenings, salad oils, and cooking oils.
Catalytic hydrogenation, discovered in 1897, is established by subjecting liquid oils to
hydrogen gas under selected temperature, pressure, stirring speed, duration, and catalyst
(Emken 1984, Katan and Mensink 1992). Food industry applied this process to convert
liquid oils to semisolid fats with improved flavor and stability as well as lowered cost for
commercial and household use (Dutton 1979). Food manufacturers favor such partially
hydrogenated fats over fully hydrogenated fats, since the latter contains a high stearic
acid content which makes them unpleasant to eat (Katan 1998). The fractions of trans
isomers in hydrogenated vegetable oil varies widely with hydrogenation conditions. The
proportion of TF A increase with the accelerated degree of hydrogenation (ACAN/AIN
1996). Most hydrogenated vegetable oils contain between 5% and 30% trans isomers

(Enig et al. 1990) and most of the commercially produced trans isomers are monoenes
(ACAN/AIN 1996). The trans-18:1 isomers represent about 90% of the total TFA. The
9t, 12c-18:2 and 9c, 12t-18:2 isomers are present in about equal amounts and stand for
about 9% of the total TFA (Emken 1995).
TFA are also synthesized in the rumen of ruminant animals. They are the endproducts of anaerobic bacterial fermentation (Emken 1984, Lichtenstein 1997). Humans
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Figure 2-2 Structure of oleic (cis), elaidic (trans), and stearic (saturated) acids.
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consume them in the form of meat and dairy products. In general, butterfats contain 2 to
9% TFA and milk fats contain 2 to 5% TFA (Emken 1984, Katan and Mensink 1992).
About 90 to 95 % of dietary TF A are provided by partially hydrogenated
vegetable oils and the remaining 5 to 10 % from ruminant fats in the average American
diet (Emken 1984, Enig 1996). The principal TF A produced by the catalytic partial
hydrogenation is elaidic acid (C18:ln9t), whereas microbial biohydrogenation in
ruminants leads to the accumulation of mainly vaccenic acid (Cl8:ln7t) in dairy products
and meats (Jenkins 1994, Kris-Etherton and Nicolosi 1995, Senti 1985, Sommerfeld
1983).

Dietary Intake of TFA
The actual intake of TF A can not be easily determined, since there is no readily
available databases of fatty acids including TFA (Emken 1995, Enig 1996). In the U.S.,
the average intake of TFA is estimated to be 8.1 to 13.3 g per person per day, accounting
for 3 to 4% of total energy intake as assessed by availability or disappearance data (Enig
et al. 1990, Hunter and Applewhite 1991). Nonetheless, intake may be much higher in
individuals who eat large amounts of foods prepared with such fats (Enig et al. 1990,
Lichtenstein 1995), i.e., fast foods (hamburgers, fried chicken and fish, and french fries),
potato chips, com snacks, cheese snacks, doughnuts, cakes, cookies, pies and turnovers,
etc. (Ali et al. 1996, Enig et al. 1983, Enig et al. 1990, Smith et al. 1985, Wootan et al.
1996). Tables 2-4 to 2-7 show the trans fat contents of some popular foods. Recently,
the trans fat content in margarines have largely been phased out (Katan 1995). However,
shortenings and frying fats do remain high in trans fatty acids (Katan 1998).
Estimated intake ofTFA based on food questionnaire data, 2.6 to 4.6 g per day,
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TABLE 2-4
Trans fatty acids in french fries and fried chicken and fish 1
Calories
(Kcal)

Total fat (g)

Saturated fat
(g)

Trans fat
(g)

French fries:
Arby' s (large)

490

20

4

3

Hardee's (large)

430

19

4

4

McDonald's (large)

470

19

4

4

Burger King (large)

470

22

6

7

Wendy's (Biggie)

470

20

5

7

Burger King
fish sandwich

830

31

6

2

Burger King
chicken sandwich

700

30

6

2

McDonald's chicken
McNuggets (9 pieces)

500

28

6

3

1160

52

12

7

Long John Silver's
fish & more

1270

58

13

14

Red Lobster admiral's feast

2020

97

26

22

Fried chicken and fish:

Kentucky Fried Chicken
original recipe chicken
dinner

1

Modified from Wootan et al. (1996).
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TABLE 2-5

Trans fatty acids in margarines, fats, and oils (1 tablespoon/
Calories (Kcal)

Total fat (g)

Saturated fat (g)

Trans fat (g)

Butter

100

11

7

0

Beef tallow

120

13

6

0

Canola oil

120

14

Crisco, can

110

12

3

Fleischmann' s lower fat
margarine, tub

40

5

0

I can't believe it's not
butter!, tub

90

10

2

Land O' Lakes country
morning blend light, stick
or tub

50

6

3

Land O'Lakes country
morning blend margarine,
tub

100

11

2

Land O' Lakes margarine,
stick or tub

100

11

2

2

Land O' Lakes spread with
sweet cream, stick

90

10

2

3

Lard

120

13

5

0

Olive oil

120

14

2

0

Parkay, stick

90

10

2

3

Promise, stick

90

10

2

2

Promise, tub

90

10

2

0

Promise ultra fat free, tub

5

0

0

0

Promise ultra 70% less fat,
tub

30

4

0

0

120

14

2

0

Soybean oil
1

Modified from Wootan et al. (1996).

25

0

0

0

TABLE 2-6
Trans fatty acids in baked goods 1
Calories (Kcal)

Total fat (g)

Saturated fat (g)

Trans fat
(g)

Boston Market original
chicken pot pie ( 1)

750

25

7

4

Cinnabon Cinnabon ( 1)

670

34

9

6

Dunkin' Donuts old
fashioned cake donut ( 1)

310

19

5

6

Entenmann's homestyle
apple pie ( 1/6)

310

10

3

3

Entenmann' s rich frosted
donut (1)

310

18

4

5

Kentucky Fried Chicken
biscuit (1)

200

11

2

4

Kentucky Fried Chicken
chicken pot pie ( 1)

830

31

9

8

Little Debbie swiss cake
rolls (2)

300

12

3

4

McDonald's iced cheese
danish (1)

360

19

5

4

Nabisco nilla wafers (8)

150

4

Nabisco oreos (3)

160

7

Pillsbury grands!
Buttermilk biscuit ( 1)

230

11

3

4

Starbucks cholesterol
free blueberry scone ( 1)

420

15

4

4

1

Modified from Wootan et al. (1996).
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TABLE 2-7
Trans fatty acids in frostings, crackers, and snacks1
Total fat
(g)

Saturated fat
(g)

Trans fat (g)

140

4

2

1

Keebler Club Partners
Original Crackers (4)

70

3

1

Nabisco Ritz Crackers (5)

90

4

1

Nabisco Triscuits (7)

140

5

1

2

Nabisco Wheat Thins
(16)

150

5

1

2

Orville Redenbacher' s
natural Popcorn,
microwave (4 cups)

110

8

2

2

Pillsbury creamy supreme
vanilla frosting
(2 tablespoons)

150

8

2

2

Calories (Kcal)
Betty Crocker whipped
deluxe chocolate frosting
(2 tablespoons)

1

Modified from Wootan et al. (1996).
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are much lower than that calculated from the availability or disappearance data (Emken
1995). The differences mainly due to availability data tend to overestimate actual intake
whereas questionnaire, diet-record, and recall data generally underestimate intake (Mertz
et al. 1991 ) .
Because TFA are not synthesized by humans, analysis of human adipose tissue
provides another method of determining dietary TFA intake. Adipose tissue reflects the
long term average of dietary isomeric fatty acid content, since adipose tissue fatty acids
have a relatively long halflife. The cis and trans isomers have been detected in human
tissue in varying amounts, probably reflecting their dietary levels. Adipose tissue fatty
isomer profiles indicate that 90 to 95% of the TF A in this tissue comes from partially
hydrogenated vegetable oils and fats. This information has been used to predict a dietary
intake range from 11.1 to 27 .6 g per person per day (Enig et al. 1990).
Metabolism of TFA

TF A tend to have a "straight" chain structure similar to saturated fatty acids
(SFA), whereas cis fatty acids (CFA) have one or more kinks in them. The structural
property of trans bonding is responsible for the higher melting point of TF A compared to
CPA (Emken 1991 ). The melting points of oleic acid (Cl 8: ln9), elaidic acid, and stearic

acid (Cl8:0) are 13 °C, 44 °C, and 70°C, respectively. Animal studies with hydrogenated
fats showed that all isomers, including those with melting points higher than body
temperature, were absorbed as well as oleic acid (Wood 1979). Human studies with pure
triglyceride containing deuterated cis and trans positional octadecenoic acid isomers are
consistent with the animal studies (Emken 1984). Thus, melting point and geometry and
position of double bond have no measurable effect on the absorption of any isomer.
28

However, Bernard et al. (1987) used the 14 C-labeled oleic and elaidic acids to study their
absorption in rats and argued that the kinetics of absorption were different for the two
fatty acid isomers: oleic acid was absorbed in greater amount and more quickly than
elaidic acid.
Since the early work of Barbour (1933) and Sinclair (1935) revealed that TFA
accumulated in the lipids isolated from rat tissues, many other reports have shown that
TF A can be well incorporated into virtually every tissue and cell component examined.
In animals fed a diet containing TF A, the trans isomers have been found in all the major
organs and tissues (Atal et al. 1994, Decker and Mertz 1966, Hill et al. 1982, Moore et al.
1980, Pettersen and Opstvedt 1989;1992, Schrock and Connor 1975, Sgoutas et al. 1973,
Sugano et al. 1984, Wood et al. 1977), in the animal's microsomes (Blomstrand et al.
1985, Hietanen et al. 1978, Kirstein et al. 1983, Mahfouz et al. 1984, Morgado et al.
1998, Sgoutas et al. 1973, Sugano et al. 1984, Svensson 1983), mitochondria (Decker and
Mertz 1966, De Schrijver and Privett 1984, Hsu and Kummerow 1977, Ide et al. 1987,
Pettersen and Opstvedt 1989;1992, Sgoutas et al. 1973, Sugano et al. 1984), erythrocyte
(Decker and Mertz 1966, Moore et al. 1980), and various lipoprotein fractions (Egwim
and Sgoutas 1972, Emken 1984, Kummerow 1974, Schrock and Connor 1975). Studies
with animals have demonstrated that levels of TF A found in tissue lipids reflected levels
of these geometrical and positional isomers found in the animal's diet (Ruttenberg et al.
1983, Wood 1979).
Decker and Mertz (1966) found that the patterns of tissue distribution of elaidic
acid and other fatty acids was closely resembled in the depot fat than in the erythrocyte or
mitochondrial lipid in rats fed elaidinized olive oil. Considerable incorporation of dietary
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elaidic acid into different phospholipid (PL) fractions was reported in rat heart
mitochondria (Hsu and Kummerow 1977). Nearly half of the total octadecenoic acid was
trans isomer. There was little or no isomeric selectivity occurred during absorption,
transport, activation, esterification, etc., of TF A in all the tissue triglycerides of rats
(Wood 1979, Wood et al. 1977). In adipose tissue membrane PL like
phosphatidylcholine, TF A behave like SF A with respect to their pattern of incorporation.
The incorporation of TF A into this lipid class was accompanied by reduction of the
saturated fatty acid content, especially that of stearic acid. In the storage triglyceride, the
incorporation of TF A did not have any effect on the content of SFA. Thus, in
triglyceride, TF A did not appear to act like SFA. Furthermore, TF A apparently were not
readily incorporated into brain lipids to any extent (Wood 1979), whereas adipose tissue
and liver generally contain higher levels than other tissues (Heckers et al. 1977).
Pettersen and Opstvedt (1989;1992) also detected that 19 to 36% ofTFA in maternal
diets had no noticeable effect on the brain phosphatidylethanolamine composition but had
slight to moderate effects on the fatty acid profile of other organs in the newborn or
suckling piglets. Cook ( 1979), in contrast, reported that TF A were incorporated more
readily than oleic acid into developing rat brain tissue lipids. Moore et al. (1980)
observed that insignificant amounts of trans isomers were present in the tissues of rats
after the animals were transferred from high trans diets to trans free diet for 8 weeks, with
the exception of adipose tissue. The incorporation of TFA in the tissues of rat, rabbit,
hamster, mouse and piglets are summarized in Tables 2-8 to 2-10.
By measuring the fat samples from human placental, maternal, fetal, and baby
tissue for presence of TFA, Johnston et al. (1958) identified that the TFA present in
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TABLE 2-8
Trans fatty acids incorporated in rat tissues 1
Tissue

%TFAs
TL

PL

PC

PE

TG

Diet and feeding time

Reference

CE

Adipose
(epididymal)

24.8

8 wt% elaidinized olive oil for 6 weeks

Decker and Mertz
(1966)

(epididymal)

1) 39.8
2) 30.0

1) 20 wt% PHSF + 2 wt% com oil and
2) 20 wt% PHSF for 60 days

Sgoutas et al.
(1973)

(epididymal)

I) 10.0
2) 17.1

1) 4.2 wt% and 2) 8.5 wt% PHSO for 8
weeks

Ostlund-Lindovist et
al. (1985)

15 wt% hydrogenated fat diet for 12
weeks

Moore et al.
(1980)

8 wt% elaidinized olive oil for 6 weeks

Decker and Mertz
(1966)

15 wt% hydrogenated fat diet for 12
weeks

Moore et al.
(1980)

15 wt% hydrogenated fat diet for 12
weeks

Moore et al.
(1980)

22 wt% partially hydrogenated fat for
1) 1 week and 2) 6 weeks

Hsu and Kummerow
(1977)

1)7.9
2) 8.7

w
.......

30.4
Erythrocyte

13.9
12.7

Heart
Heart
mitochondria

13.6

17.1
1) 17.0
2) 21.6

1) 18.5
2) 28.8

Continued

TABLE 2-8 (Continued)
Trans fatty acids incorporated in rat tissues1
Tissue

%TFAs
TL

Ileum (lower)

15.5

Jejunum
(upper)

17.2

PL

PC

PE

IO.I
14.6

Liver

TG

21.8

Reference

7.6 wt% PHCO + 2.4 wt% safflower oil
for 35 days

Sugano et al.
(1984)

CE

20.4

13.5

Diet and feeding time

7.6 wt% PHCO
oil for 35 days
23.5

vJ

+ 2.4 wt% safflower

Sugano et al.

(1984)

20 wt% PHSF + 2 wt% com oil for
60 days

(1973)

Sgoutas et al.

N

29.5
18.6

23.6

48.4

32.6

15 wt % PHSO free fatty acids for 4
weeks

Wood et al.
(1977)

17.9

11.3

15 wt% hydrogenated fat diet for 12
weeks

Moore et al.
(1980)

20 wt% PHSBO for 3 1 weeks

Hill et al. ( 1982)

1) 20 wt% PHSF + 2 wt% com oil and
2) 20 wt% PHSF for 60 days

S goutas et al.
(1973)

13.3
Liver
cytosol

1) 26.5
2) 22.0

1) 30.5
2) 25.0

Continued

TABLE 2-8 (Continued}
Trans fatty acids incorporated in rat tissues 1
Diet and feeding time

Reference

1) 20 wt% PHSF + 2 wt% com oil
and 2) 20 wt% PHSF for 60 days

Sgoutas et al.
(1973)

1) 36 en% PHPO + 10 en% PO and
2) 36 en% PHMO + 10 en% PO for 13
or 16 weeks

Kirstein et al.
(1983)

1) 12.4
2) 7.7
3) 7.0

1) 20 wt% PHPO + safflower oil,
2) 20 wt% PHNCO + safflower oil, and
3) 20 wt% PHHO + safflower oil

Svensson
(1983)

12.4

12 wt% PHSBO and 3 wt% com oil for
6 weeks

Mahfouz et al.
(1984)

7 .6 wt% PHCO + 2.4 wt% safflower oil
for 30 to 32 days

Sugano et al.
(1984)

1) 12.6
2) 8.3
3) 11.7

1) 16.5 wt% PHLRSO + 3.5 wt% SSO,
2) 16.5 wt% PHHO + 3.5 wt% SSO,
and 3) 20 wt% PHLRSO for 10 weeks

Blomstrand et al.
(1985)

2.1 ±
0.2

15 wt% PHFO + 0.5 wt% sunflower
oil for 40 days

Morgado et al.
(1998)

Tissue

%TFAs
TL

PL

Liver
m1crosome

PC

PE

TG

CE

1) 13.4

1) 14.1

1) 22.5
2) 18.0

1) 17 .0
2) 14.2

1) 14.8
2) 11.0

w
w

13.1

10.3

9.9

Continued

TABLE 2-8 (Continued)
Trans fatty acids incorporated in rat tissues1
Tissue

%TFAs
TL

Liver
mitochondria

PL

PC

PE

TG

1) 13.0
2) 13.0

1) 24.2
2) 20.0

Reference

8 wt% elaidinized olive oil for 6 weeks

Decker and Mertz
(1966)

1) 20 wt% PHSF + 2 wt% com oil and
2) 20 wt% PHSF for 60 days

Sgoutas et al.
(1973)

8 wt% PHSBO + 2% safflower oil for 4
weeks

De Schrijver and
Privett (1984)

15 wt% PHCO supplemented with
safflower oil for 30 days

Ide et al.
(1987)

15 wt% hydrogenated fat diet for 12
weeks

Moore et al.
(1980)

CE

12.9
1) 13.6
2) 15.0

Diet and feeding time

1) 23.9
2) 19.5

14.0 ±
0.8
vJ

~

9.8
Kidney

10.0

22.7

Plasma

16.9

26.1

5.9

15 wt% hydrogenated fat diet for 12
weeks

Moore et al.
(1980)

24.3

8.6

15 wt% hydrogenated fat diet for 3
months

Moore et al.
(1980)

Testes

1

Abbreviation used: CE, cholesterol esters; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PHCO, partially hydrogenated com
oil; PHFO, partially hydrogenated fish oil; PHHO, partially hydrogenated herring oil; PHLRSO, partially hydrogenated low erucic acid rapeseed oil; PHMO, partially hydrogenated marline oil; PHNCO, partially hydrogenated Norwegian capelin oil; PHPO, partially hydrogenated
peanut oil; PHSF, partially hydrogenated soybean fat; PHSO, partially hydrogenated safflower oil; PHSBO, partially hydrogenated soybean
oil; PL, phospholipids; PO, peanut oil; SSO, sunflowerseed oil; TFAs, trans fatty acids; TG, triglycerides; TL, total lipids.

TABLE 2-9
Trans fatty acids incorporated in rabbit tissues1
Tissue

%TFAs
TL

PL

TG

Diet and feeding time

Reference

CE

Adipose
(epididymal)

1) 8.9±0.8
2) 19.2 ± 1.4

1) 3.2 wt% or 2) 6.0 wt% TFAs
(mixture of partially hydrogenated
safflower, soybean, and cottonseed
oils) for 5 months

Rutten berg et al. (1983)

Adipose (psoas)

21.7 ± 3.7

40 en% PROO for 3 weeks

Schrock and Connor (1975)

Erythrocyte

1) 4.8±0.3
2) 12.0 ± 0.7

1) 3.2 wt% or 2) 6.0 wt% TFAs for
5 months

Ruttenberg et al. (1983)

Liver
m1crosome

1)17.6±0.8
2) 35.2 ± 3.0

I) 3.2 wt% or 2) 6.0 wt% TFAs for
5 months

Ruttenberg et al. ( 1983)

Liver
mitochondria

1) 18.7 ± 2.0
2) 33.4 ± 2.4

1) 3.2 wt% or 2) 6.0 wt% TFAs for
5 months

Ruttenberg et al. (1983)

Plasma

1) 6.9±0.2
2) 13.2 ± 1.3

1) 3.2 wt% or 2) 6.0 wt% TFAs for
5 months

Ruttenberg et al. (1983)

40 en% PROO for 3 weeks

Schrock and Connor (1975)

w

Vl

Serum
1

10.4 ± 2.8

15.4 ± 2.4

6.0 ± 1.0

Abbreviations used: CE, cholesterol esters; PROO, partially hydrogenated olive oil; PL, phospholipids; TF As, trans fatty
acids; TG, triglycerides.

TABLE 2-10
Trans fatty acids incorporated in hamster, piglet, and mouse tissues 1
Tissue

%TFAs
TL

PL

PE

NL

CE

TG

Diet and feeding time

Reference

10 wt% PHCO +0.1 wt%
cholesterol for 2 weeks

Hayashi et al.
(1993)

Piglets were bred from the mother
sows fed 1) 14 wt% PHFO + 4
wt% SFO, or 2) 14 wt% PHSBO +
4 wt% SFO from 3 weeks of age
through pregnancy.

Pattersen and
Opstvedt (1989)

Hamster
Liver

5.3 ± 0.7

n.d.

4.4 ± 0.3

Plasma

1.5 ± 0.5

nd.

2.7 ± 0.5

Newborn Piglet
vJ
0\

Adipose
(subcutaneous)

1) n.d.
2) 0.1

Brain

1) n.d.
2)n.d.

Heart

1) 0.8
2) 1.0

Liver mitochondria

1) 2.2
2) 2.6

Plasma

1) 2.0
2) 2.1

Continued

TABLE 2-10 (Continued)
Trans fatty acids incorporated in hamster, mouse and piglet tissues 1
Tissue

%TFAs
TL

PL

PE

NL

CE

Diet and feeding time

Reference

I) 14 wt% PHFO + 4 wt% SFO, or
2) 14 wt% PHSBO + 4 wt% SFO
fed to mother sows from 3 weeks
of age through pregnancy. Piglets
were only allowed to suckle milk
from mother sows for 3 weeks.

Pattersen and
Opstvedt (1992)

10 wt% mixture of shortening
and com and soybean oils for 8
months

Atal et al.

TG

Sucking_mglet
Adipose
(subcutaneous)

w

I) 8.9
2) 11.2

Brain

I) n.d.
2) n.d.

Heart

I) 1.9
2) 3.8

Liver
mitochondria

I) 6.3
2) 7.6

-.....J

Plasma

I) 5.0
2) 8.9

Mouse
Adipose
(epididymal)

1

13.1

8.1

(1994)

Abbreviations used: CE, cholesterol esters; n.d., not detectable; PHCO, partially hydrogenated com oil; PHFO, partially
hydrogenated capelin oil; PHSBO, partially hydrogenated soybean oil; NL, neutral lipids; PE, phosphotidylcholine; PL,
phospholipids; SFO, sunflowerseed oil; TFAs, trans fatty acids; TL, total lipids.

human tissue apparently arose solely from dietary fat. Levels of TF A in human tissue
revealed that adipose tissue contained 2.4 to 12.2%; liver, 4.0 to 14.4%; heart, 4.6 to
9.3%, and aortic tissue, 2.3 to 8.8% (Johnston et al. 1957, Sgoutas and Kummerow 1970).
Perkins and associates (1977) found human serum lipid samples had 1.9% trans-18:1 and
0.8% trans, trans-18:2. The corresponding erythrocytes contained 2.4% trans-18:1 and
0.7% trans, trans-18:2. Ohlrogge et al. (1982) reported that the pattern of trans isomer
distribution in triglyceride of human tissues was similar to partially hydrogenated
vegetable oils (PHVO). The distribution of PL of human tissues, however, reflected
different pattern than PHVO. Higher levels of TFA, moreover, were found in triglyceride
as compared to the PL (Ohlrogge 1982;1983). Garland et al. (1998) compared fatty acid
content in adipose tissue with fatty acid intake calculated from both dietary records and
questionnaires from 140 participants in the Nurses' Health Study. They confirmed that
the amounts of TF A in adipose tissue reflect dietary intake. An estimate of TFA intake
from partially hydrogenated vegetable fats correlated much more strongly with adipose
TFA than did that from animal sources.
The incorporation of TFA in human tissues are summarized in Table 2-11.
Generally, the level of the TFA found in animals or humans depends on the following
factors:
1) the particular organ or tissue studied;
2) the PL and neutral lipid classes in the same tissue studied;
3) the amount of trans fat ingested;
4) the duration of time on the diet;
5) the form in which the trans fat is administered;
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TABLE 2-11

Trans fatty acids in human tissues
Tissue

%TFA

Method

No. of subject

Reference

Adipose

2.4 - 12.2

IR

24

Johnston et al. (1957)

1.5 - 6.8

IR

6 (F)

Johnston et al. (1958)

5.3

GLC

231 (M)

Thomas et al. (1981)

2.0 - 5.8

GLC

8 (3 F, 5 M)

Ohlrogge et al. (1981)

4.7

GC

5 (M)

Adlof & Emken (1986)

2.3 - 8.2

GC

115 (F)

London et al. ( 1991)

1.6

GC

1388 (M)

Aro et al. (1995)

2.8

GC

352 (M)

Roberts et al. (1995)

1.3

GC

1058 (700 M,
358 F)

Bakker et al. (1997)

1.2

GLC

698 (F)

Kohlmeier et al. ( 1997)

1.8 - 7.4

GC

161 (F)

Petrek et al. ( 1997)

6.1 ± 1.3

GC

141 (F)

Garland et al. ( 1998)

2.3 - 8.8

IR

24

Johnston et al. (1957)

1.0

GLC

17 (M)

Heckers et al. ( 1977)

1.4 - 3.9

GLC

8 (3 F, 5 M)

Ohlrogge et al. (1981)

Atheroma

2.3 - 8.8

IR

24

Johnston et al. (1957)

Brain

0.2 - 0.9

GLC

8 (3 F, 5 M)

Ohlrogge et al. (1981)

0.3

GC

4 (M)

Adlof & Emken (1986)

4.6 - 9.3

IR

24

Johnston et al. ( 19 57)

1.2-4.1

GLC

8 (3 F, 5 M)

Ohlrogge et al. (1981)

Aorta

Heart

Continued
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TABLE 2-11 (Continued)
Trans fatty acids in human tissues1

Tissue

%TFA

Method

No. of subject

Reference

Heart

2.0

GC

3 (M)

Adlof & Emken (1986)

Jejunum

0.6

GLC

17 (M)

Heckers et al. (1977)

Liver

4.0 - 14.4

IR

24

Johnston et al. (1957)

1.1 - 2.5

GLC

8 (3 F, 5 M)

Ohlrogge et al. ( 1981)

1.5

GC

6 (M)

Adlof & Emken ( 1986)

Kidney

1.5

GC

5 (M)

Adlof & Emken (1986)

Myocardium

0.9

GLC

23 (M)

Heckers et al. ( 1977)

Placenta

0.0 - 0.5

IR

6 (F)

Johnston et al. (1958)

Fetal liver

0

IR

5

Johnston et al. (1958)

Infant adipose

0.1 - 0.9

GLC

2

Ohlrogge et al. (1982)

Infant plasma PL

1.1±0.1

GLC

29

Koletzko (1992)

Infant plasma TG

1.6 ± 0.1

GLC

29

Koletzko (1992)

Children plasma PL

1.8 ± 0.1

GC

31 (M)

Decsi & Koletzko (1995)

!Abbreviations used: F, females; GC, gas chromatography; GLC, gas-liquid
chromatography; IR, infrared chromatography; M, males; PL, phospholipids; TFA, trans
fatty acids; TG, triglycerides.
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6) the animal species being fed.
Elaidic and oleic acids were shown to be catabolized to CO 2 to the same extent
(Coots 1964, Ono and Fredrickson 1964). Similar rates of digestion, absorption and
transport in the lymph as triglyceride were also reported in these studies. Munsch et al.
( 1969b) compared the metabolism of oleic and elaidic acids in the rat with respect to
oxidation to CO2 and their retention in the lipids of blood, brain, excreta, liver and
carcass. In addition to the similar behavior already noted by previous workers in relation
to ease of oxidation, they found that their retention pattern in the tissues was quite
similar: liver and carcass lipids incorporated most of the ingested radioactivity over a
time period of 3 Yi hours. However, these two isomers showed interesting differences in
behavior regarding the distribution, turnover and desaturation (Munsch et al. 1969a).
While elaidate was referentially localized in the PL, oleic acid was largely found in the
triglyceride. The turnover rate of oleate was faster than elaidate in both the liver and
plasma lipids.
A few in vitro studies showed that trans octadecenoic acids were oxidized at a
slower rates than their cis isomers in the mitochondria isolated from rat hearts and livers
(Ide et al. 1987, Lawson and Holman 1981, Lawson and Kummerow 1979) and in rat
heart homogenates (Lanser et al. 1986). The cis monoenes were the preferred substrates
and of the trans isomers, vaccenoly-CoA was oxidized more rapidly than elaidoyl-CoA (
Lawson and Kummerow 1979). These results are not in accord with in vivo experiments,
which showed no difference on mitochondrial respiratory function when rats received
none and 8% of partially hydrogenated soy oil (De Schrijver and Privett 1984).
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Interactions of TFA with Essential Fatty Acids (EFA) Metabolism
The influence of dietary TF A on linoleic acid metabolism and essential fatty acids
(EFA) deficiency states have been examined extensively. Several studies have shown
that the trans monoenes were substrates for desaturation and therefore competed with the
cis acids for this activity (Hill et al. 1982, Mahfouz et al. 1980; 1981, Rosenthal and
Doloresco 1984, Rosenthal and Whitehurst 1983). When TF A were present in the
experimental diets, noted decreases in the activities of d6-desaturase (De Schrijver and
Privett 1982, Kurata and Privett 1980, Mhfouz et al. 1980, Shimp et al. 1982, Svensson
1983), d5-desaturase (Kurata and Privett 1980, Mahfouz et al. 1980, Svensson 1983),
and d9-desaturase (Kurata and Privett 1980, Mahfouz et al. 1980) were shown in in vitro
studies. In vivo studies further demonstrated that dietary TFA decreased desaturase
activities. Examination of the tissue lipids revealed an increase in the ratio of C20:3n9/C20:4n-6 (Hill et al. 1982, Kurata and Privett 1980, Watkins 1988), an indicator of
EF A deficiency states. Elevated ratios of C 18 :2n-6/C20:4n-6 were also detected (De
Schrijver and Privett 1982, Kurata and Privett 1980, Hill et al. 1982, Watkins 1988).
Results of cultured human skin fibroblasts grown in media with various fatty acid isomers
confirmed that both elaidate and linoelaidate are potent inhibitors of the d6- and d5desaturase (Rosenthal and Doloresco 1984, Rosenthal and Whitehurst 1983). However,
the linoelaidate-induced suppression of arachidonic acid can be readily overcome by
increasing the concentration of available linoleate (Chem and Kinsella 1983).
Consequently, TFA in the diet appear to increase the need for EF A. However, dietary
TF A do not pose a serious problem in the presence of adequate levels of dietary linoleic
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acid. On the other hand, in marginally EF A deficient states, the presence of dietary TF A
could exacerbate the deficiency condition. It has been established that dietary TF A had
no interference with mitochondrial function when dietary linoleate was provided no less
than 2% of total calories (Zevenbergen et al. 1988).
The interactions of TFA with EF A may be of particular importance in early
childhood. Metabolites of EF A need to be deposited in large amounts in growing tissues,
especially the brain, and their availability during rapid growth is related to functional
development. C22:6n3 status during the first months of life correlates with development
of visual acuity both in preterm and full-term infants, and C20:4n6 status correlates with
early human growth (Decsi and Koletzko 1994). Koletzko (1992) studied the possible
untoward effects of TF A in a group of 29 stable premature infants, who have limited EF A
stores and probably a low activity of enzymatic conversion. Plasma samples obtained on
the fourth day of life were assayed for fatty acid composition. It was found that TF A in
plasma sterol esters were not related to the precursor EFA - linoleic and a-linolenic
(Cl8:3n3) acids, but significantly inverse correlated with their major metabolites
arachidonic and docosahexaenoic (C22:6n3) acids. TFA were also significantly
associated with the product/substrate ratios of n6 and n3 fatty acid desaturation and
elongation. Likewise, in 53 healthy well-nourished children aged 1 to 15 years,
significant inverse correlations of trans-18: 1 and total TFA to the principal metabolite
arachidonic acid was observed (Decsi and Koletzko 1995). There was also an inverse
correlation of total TFA to the ratio of arachidonic to linoleic acid. Hence, the questions
abut the physiological effects of TFA should be further emphasized.
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Interactions ofTFA with Membrane and Membrane-Bound Enzymes
Incorporation of TF A into membrane PL could have an influence on the physical
properties of the membrane and the membrane bound enzymes. Several studies of
membrane fluidity lead to the conclusion that TF A generally substitute for SFA in animal
membranes with little change in membrane physical properties (Senti 1985). When the
TF A became the predominant fatty acid in the membrane, the TF A could bring about
decreased fluidity, associated changes in permeability and other metabolic parameters
(Tsao and Lands 1980). Elaidic acid have been shown to lower the content of PL and
microsomal cytochrome P-450 in rats fed at a dose of 200 mg/kg every other day for 4
weeks (Hietanen et al. 1978). Trans isomers were also found to inhibit the activities of
Na+, K+-ATPase and adenylate cyclase in rat heart membrane (Alam et al. 1989). In
contrast, in rabbits fed either 3.2% or 6% TFA for 5 months, Ruttenberg et al. (1983)
were unable to demonstrate significant differences in activities of 5 hepatic enzymes
including glucose-6-phosphatase (microsomal), FA synthetase (cytosolic ), malate
dehydrogenase, beta-hydroxybutyrate dehydrogenase, and monoamine oxidase
(mitochondrial). Sugano et al. (1984) also reported no difference in the content of
cytochrome P-450 in hepatic microsomes ofrats fed cis- or trans-fat.
Other Health Concerns of TFA
Most studies with TF A have focused on these isomers and the risk of coronary
heart disease (CHD). To date, no consensus conclusions have been reached. High intake
of TF A appears to be associated with increased risk of coronary heart disease in
epidemiologic studies. Willett and colleagues (1993) calculated the dietary intake of
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TFA in 85,095 women who were followed for 8 years. They noted that increased intake
of dietary TF A was directly related to risk of CHD after adjustment for age and other
factors. The increased risk was linked to partially hydrogenated vegetable oils in
margarine and other foods that contain vegetable shortening, including cookies, cake and
white bread. New data in a follow-up report, which extended the study period to 14
years, confirmed the initial findings and concluded that TF A may be more dangerous for
the heart than saturated fats (Hu et al. 1997).
Troisi et al. (1992) assessed the relationship of trans fats intake to fasting serum
lipid concentrations in 748 men aged 43 to 85 years. They found that intake of trans fats
was directly related to total and low-density-lipoprotein (LDL) cholesterol, and inversely
related to high-density lipoprotein (HDL) cholesterol. Trans fats intake was also
positively associated with the ratios of total to HDL cholesterol and LDL to HDL
cholesterol. In the Seven Countries Study involving 12,763 middle-aged men, strong
positive associations were observed between 25-year death rates from coronary heart
disease and average intake of elaidic acid®= 0.78, P < 0.001) (Kromhout et al. 1995).
After observing 832 men from Framingham Heart Study for two decades, Gillman et al.
( 1997) reported that the risk ratio of CHD for each increment of 1 teaspoon per day of
margarine was 0.98 for the first 10 years of follow-up and 1.10 for follow-up years 11 to
21. A significant positive association between the intake of TF A and the risk of coronary
death was also found in 21,930 Finnish men aged 50 to 69 years (Pietinen et al. 1997).
Men with an intake of 6.2 g TFA per day had a risk of CHD of 1.39 related to men with
lower TF A intake.
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In a case-control study, Thomas et al. (1983a;1983b) examined the depot fat taken
from 136 cases died of ischaemic heart disease and from 95 controls died of unrelated
causes. It was concluded by the authors that the cases consumed a higher proportion of
hydrogenated fats rich in C16:1- and C18:1-trans fatty acids than did the controls
(Thomas et al. 1983a;1983b). With the same experimental design, Ascherio et al. (1994)
also reported that intake of TF A was directly related to risk of myocardial infarction
(relative risk for highest compared with lowest quintile, 2.44) in 239 patients and 282
control subjects. In particular, intake of margarine, the major source of trans isomers,
was significantly associated with risk of myocardial infarction.
TF A also manifest undesirable lipoprotein profiles in humans, e.g., raise serum
total cholesterol or LDL cholesterol concentrations and may reduce high-densitylipoprotein (HDL) cholesterol concentration by comparison with their cis isomers. In a
controlled trial, Mensink and Katan (1990) examined the effects of TFA on HDL and
LDL cholesterol levels in 59 healthy subjects. Each subject received three diets for 3
weeks each, in a random order and without washout periods. The 3 study diets were rich
in oleic, elaidic or a mixture of !auric, myristic and palmitic acids. It was found that HDL
cholesterol was significantly lower (P < 0.0001) on the elaidic acid diet (1.25 mmol/L)
than on the other two diets (1.42 mmol/L). LDL cholesterol was 3.04 mmol/L on the
trans Cl8:1 diet, 2.67 mmol/L on the oleic acid diet, and 3.14 mmol/L on the SPA diet.
Therefore, elaidic acid, in comparison with oleic acid, had unfavorable effects on plasma
lipoproteins because HDL cholesterol was reduced and LDL cholesterol was elevated
However, the trans C18:1 isomers in the trans diet accounted for 11 % of total energy
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intake, an amount 2 to 4 times higher than in a typical Western diet. In another study
conducted in 56 healthy subjects, similar effects of elaidic acid on LDL and HDL
cholesterols were confirmed (Zock and Katan 1992). The trans diet contained just under
8% total energy form elaidic acid was compared to diets in which energy derived from
trans C18:1 was replaced by linoleic or stearic acids. LDL cholesterol levels rose from
2.83 mmol/L with linoleate to 3.00 mmol/L with stearic acid and to 3.07 mmol/L with
TF A. In contrast, HDL cholesterol levels reduced by 0.06 mmol/L with stearic acid and
by 0.10 mmol/L with TFA.
Nestel and co-workers (1992) studied the effects of trans C18:1 on plasma
lipoprotein levels in a 27 mildly hypercholesterolemic men. Each subject consumed 3
test diets for 3 weeks each. The dietary fat provided 35% total energy. The fatty acid
composition of the three diets were comparable; 4 to 5% of energy as trans C 18: 1 was
exchanged exclusively for either oleic or palmitic acid. Compared with the oleic acid
diet, the trans diet raised both total and LDL cholesterol levels by 0.36 mmol/L, but HDL
cholesterol levels were unaffected. Palmitic acid raised total, LDL, and HDL cholesterol
levels by 0.28, 0.26, and 0.10 mmol/L, respectively, as compared to the oleic acid diet.
It was thus concluded that both TF A and palmitic acid raised cholesterol levels to about

the same extent but that TFA, at about 7% energy, did not lower HDL cholesterol levels
relative to oleic acid.
Lichtenstein et al. (1993) compared the effect s of a com oil-enriched diet with
those of a diet rich in partially hydrogenated com oil in the form of margarine in 14
moderately hypercholesterolemic middle aged and elderly subjects. The margarine diet
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contained about 3. 7% more energy as trans mono unsaturated fatty acids than the
unhydrogenated com oil diet, at the expense of cis mono- and polyunsaturated fatty acids.
The margarine diet yielded significantly higher levels of total and LDL cholesterol than
the unhydrogenated oil diet. Again, no change in HDL cholesterol levels was detected.
Wood et al. (1993) studied 38 healthy men with normal plasma lipid
concentrations, whose diets were supplemented with butter, butter enriched with olive oil
or sunflower oil, hard margarine (29% TF A), or soft margarine (no TF A). The dietary fat
provided approximately 40% total energy. The overall changes were relatively small,
with the largest difference in total cholesterol levels occurring between the butter and soft
margarine diets (5.48 ± 0.85 vs. 4.86 ± 0.80 mmol/L, respectively). Soft margarine diet
significantly reduced LDL cholesterol and apolipoprotein B as compared to all the other
diets. Hard margarine caused a reduction in apolipoprotein A-1 and B levels, but did not
change total or LDL cholesterol levels, relative to habitual diet. HDL cholesterol levels
remained unchanged among all diets. Since the percentages of total saturated and
unsaturated (including trans) were equal in the two margarine diets, it was assumed that
the different lipid response was attributed to the TF A in the hard margarine.
Judd et al. (1994) carried out a large, well-controlled trial in 29 men and 29
women. Each individual consumed four different diets in random order for 6 weeks each.
One diet was high in oleic acid, and two were enriched with different amounts of partially
hydrogenated soybean oil; supplying 3 and 6% of energy as trans-18:1, respectively. In
the fourth diet, 6% of energy was obtained from a mixture of SFA, which were
substituted for oleic acid. Compared with levels on the oleic acid diet, LDL cholesterol
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levels elevated by 0.2 mmoVL with the 3% trans-18:1 diet, and by 0.3 mmoVL with the
SFA diet. HDL cholesterol levels were not lowered significantly on the 3% TF A diet,
and they decreased by 0.04 mmoVL on the 6% TF A diet relative to the levels on the oleic
acid diet. Changes in apolipoprotein Al and B corresponded with changes in the
lipoprotein cholesterols. Thus, compared with oleic acid, dietary TF A raise LDL
cholesterol, but to a slightly lesser degree than saturates, and high amount of TFA could
result in minor declines of HDL cholesterol. A possible dose-dependent effect of dietary
TF A on lipoproteins has been notified by some researchers (Khosla and Hayes 1996,
Zock and Mensink 1996).
The contradictory results regarding TF A and the risk of CHD have been reported
by several researchers. The plasma cholesterol and triglyceride levels in the subjects
consumed a diet rich in TFA were not different from the control group received a diet
rich in cis isomers (Mattson et al. 197 5). Hudgins et al. ( 1991) found no correlation
between the adipose tissue concentrations of total TF A and clinical risk factors for CHD
in 76 free-living males. Aro et al. (1995) compared the trans-18:1 content in adipose
tissue samples of 671 men who had survived an acute myocardial infarction (AMI) with
717 controls in ten centers in eight European countries and Israel (the EURAMIC study).
There was no association overall between high trans-18: 1 intake and AMI, but the
possibility that TFA had a significant impact on risk of CHD could not be excluded. In
U. K., a population case-control study of sudden cardiac death in men was conducted to
evaluate the effect of trans isomers of oleic acid and linoleic acid on the risk of CHD
(Roberts et al. 1995). The percentages ofTFA in adipose tissue samples were obtained
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from 66 cases of sudden cardiac death were compared with those from 286 healthy age
and sex matched controls. No overall association was found between trans isomers of
oleic and linoleic acids combined and sudden cardiac death. However, elaidic acid was
negatively associated with risk of sudden cardiac death, whereas no association with trans
forms oflinoleic acid was seen. Recently, Judd et al. (1998) compared the effect ofbutter
and tub-type margarines on blood lipid profiles in a crossover feeding trial. Twenty-three
male and 23 female normolipemic adults randomly consumed 3 different diets for 5
weeks each. The 3 dietary fat sources, including butter, margarine high in TF A (TF AM), and margarine high in PUFA (PUFA-M) and free ofTFA, were supplied as table
spreads. These table spreads provided 8.3% of energy as fat. After consumption of TFAM and PUFA-M, total cholesterol was 3.5% and 5.4% significantly lower (P < 0.01)
compared to butter, respectively. Neither margarine differed from butter in its effect on
HDL cholesterol or triglyceride. It was thus concluded that consumption ofTFA-M or
PUF A-M improved blood lipid profiles when compared with butter, with a greater
improvement with PUFA-M than TFA-M.
TFA may also increase the concentration oflipoprotein (a) [Lp(a)], which is
considered to be a risk factor for coronary heart disease. Nestel et al. (1992) found that
the elaidic acid-rich diet led to significant elevations in the levels ofLp(a) compared to
the other diets rich in palmitic or lauric/myristic/palmitic acids. The mean Lp(a) levels
were not different between the diets rich in elaidic and oleic acids. When TF A were
consumed at a dose of 11 % of energy, median Lp(a) levels in the trans diet group were
significantly higher than those in the SFA diet or in the oleic acid diet (Mensink et al.
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1992). At 8% of energy as TF A, median Lp( a) levels in trans diet were higher than those
in stearic and linoleic acid diets. Lichtenstein et al. ( 1993) did not detect an increase in
Lp(a) levels on a diet containing partially hydrogenated com oil (trans-18:1 at 4.16% of
energy) compared with unmodified com oil or the baseline saturated fat (trans-18:1 at
0.44 and 0. 77% of energy, respectively) diet. In a Norwegian study by Almendingen et
al. (1995), the Lp(a) levels were measured in 31 young men who consumed three diets
rich in butterfat, partially hydrogenated soybean oil (PHSO-diet), and partially
hydrogenated fish oil (PHFO-diet) for 19 to 21 days in a random order. It was found that
when 8 to 9% of the dietary energy was obtained from TFA, median Lp(a) levels were
significantly higher on the PHSO and PHFO diets compared to those on butterfat diet. In
a Malaysian study with a crossover design, Lp(a) levels were also higher on a TFA rich
diet (elaidic acid at 5.5% of energy) than on cis or saturated fat diets in twenty-seven
healthy subjects (Sundram et al. 1997). Similar results were also reported by Aro et al.
(1997) in a study including 80 healthy subjects. The baseline diet contained TFA and
stearic acid at 0.8% and 3.6% of energy, respectively. Lp(a) levels significantly increased
more with TFA at 8.7% of energy than with stearic acid at 9.3% of energy (30%
compared to 10%, P < 0.01) compared to the baseline diet. However, in a double-blind
study of 29 men and 29 women who received 4 controlled dits in random order for 6
weeks each, the trans diets had no adverse effect on Lp(a) levels compared to the oleic
diet when all subjects were considered collectively (Clevidence et al. 1997). A subgroup
with initially high levels ofLp(a) responded to the high trans diet (6.6% energy as TFA)
with a slight increase (5%) in Lp(a) levels relative to the oleic (16.7% energy as oleic
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acid) and moderate trans (3 .8% energy as TF A) diets. Therefore, TF A appear to be one
of the rare dietary factors that influence Lp(a) levels, especially at high intake. Judd et al.
(1998) reported that Lp(a) concentrations were significantly lower after the butter diet
than after the tub-type margarines diet. No apparent effect of dietary TFA on Lp(a),
however, was evident while comparing margarines containing TF A or no TF A.
The inconsistent cardiovascular effects of TF A are mainly due to the different
experimental designs (Kris-Etherton and Nicolosi 1995). In addition, the discrepancy
could arrive from methodological difficulties in assessing dietary intake, the inadequacy
of single plasma cholesterol measurements, and the absolute amount of fat consumed
(Borlak and Welch 1994). The effect of other factors, such as genetic make up and
differences in life style, dietary habits long before the study period, could also have
influence on the association ofTFA with CHD development (Bodak and Welch 1994).
In addition, TF A have been shown to increase the activity of serum
cholesterylester transfer protein (CETP) in animal and man (Abbey and Nestel 1994,
Lagrost 1992, Khosla et al. 1997, van Tol et al. 1995), inhibit both human and rat
lecithin:cholesterol acyltransferase (LCAT) activities (Subbaiah et al. 1998), increase fat
cell size in rats (Ostlund-Lindqvist et al. 1985), depress milk fat content in the lactating
mice in the presence of adequate dietary linoleic acid (Teter et al. 1990), reduce fat
accumulation in 3T3-Ll cells (Panigrahi and Sampugna 1993), and decrease epididymal
and perirenal fat weight, epididymal fat cell number, and the triglyceride to polar lipid
ratio in epididymal fat pads in mice (Atal et al. 1994), which might be explained by
enhanced lipolysis and inhibited glucose utilization (Cromer et al. 1995).
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Results on the potential link of TF A with cancer are also not consistent. Some
data reveal that TF A are no more carcinogenic than their cis isomers (Ip 1997, Ip &
Marshall 1996, Roberts 1995). Furthermore, in women with breast cancer, Petrek et al.
(1997) found that the odds of having positive lymph nodes were significantly lower for
women with a higher adipose tissue proportion of TF A. Nevertheless, in the EURAMIC
study, the adipose concentrations of TFA were positively associated with breast cancer
(Bakker et al. 1997, Kohlmeier et al. 1997) and colon cancer (Bakker et al. 1997).

DIETARY FATS AND ETHANOL METABOLISM
Studies show that the quantity and type of dietary lipids have a critical effect on
ethanol metabolism. When rats were fed nutritionally adequate diets varying in fat
content (5, 10, 20, and 43% of total calories) for 3 weeks, fatty liver developed only in
rats fed a high fat diet (43%) plus ethanol (Jones and Greene 1966). The quantitative
relationship between dietary fat content and hepatic lipid accumulation after ethanol
intake was also accessed by Lieber and DeCarli ( 1970). They found that hepatic lipid
accumulation produced by ethanol was increased by feeding a high fat diet starting at
25% of total calories in rats. Utilizing a continuous intragastric feeding rat model of
chronic ethanol ingestion, Tsukamoto and colleagues investigated the role of the amount
of dietary fat on ethanol-induced hepatic fibrosis in a series of studies. When the diet
contained 5% of calories as com oil, rats developed fatty liver and necrosis but no fibrosis
in the liver (Tsukamoto et al. 1985). When com oil was fed as 25% of calories, the rats
had more severe fatty change, necrosis, and inflammation (Tsukamoto et al. 1986,
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Tsukamoto and French 1985). As the dietary fat was further increased to 32% and 35%
of total calories, the fibrogenic effects of ethanol was enhanced in the com oil-fed rats
(French et al. 1986). The rates of liver fibrosis in the ethanol-infused rats fed varying fat
content (5, 25, 32 or 35% of total calories) diets were 0%, 59%, 67%, and 43%,
respectively (French et al. 1986). Thus, high dietary fat was essential to induce hepatic
fibrosis in rats fed ethanol.
Several ethanol-induced biochemical abnormalities also seem to depend on a high
fat diet. The ethanol elimination rate after 1 month of ethanol feeding is faster when the
rats were fed a high fat diet (Kanayama et al. 1984). MEOS exhibited greater activity in
the rats fed the high fat diet and high fat diet worsened ethanol-pyrazole hepatitis
compared with low fat diet (Takada et al. 1986). Free radical generation in the liver, as
measured in vivo, was increased after ethanol ingestion when the diet was high in fat
(Reinke et al. 1987).
In a chronic ethanol study carried out by Jones and Greene ( 1966), high hepatic
content of fat was induced by a high fat diet (43%) and alcohol in rats regardless of the
type of dietary fat (coconut and safflower oils). However, replacement of the long chain
fatty acid in the dietary triglyceride with medium chain fatty acids reduced the capacity of
ethanol to cause fatty liver in rats after 24 days of ethanol administration (Lieber et al.
1967). An epidemiological study involving 16 countries has been published in which per
capita consumption of beef, pork, and alcohol has been related to liver cirrhosis (Nanji
and French 1985). The correlation between cirrhotic mortality and ethanol or pork
consumption was 0.64 and 0.40, respectively. There was no correlation between beef
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consumption and cirrhotic mortality. When the product of pork and ethanol consumption
was correlated with cirrhosis mortality, the correlation was highly significant®= 0.98, P
< 0.001). In another study, dietary saturated fats were relatively protective against the
process of alcoholic liver disease (ALD), whereas unsaturated fats promoted ALD based
on calculations of the deviation from expected mortality in 17 countries (Nanji and
French 1986). These results suggested that the type of dietary fats had discrete effects on
ethanol metabolism. When rats were pair-fed diets high in either beef fat, pork fat, corn
oil, or fish oil with or without ethanol by intragastric tube feeding for up to 6 months, the
liver pathology was very different among groups. Rats fed ethanol with tallow or
saturated fats developed none of the features of ALD (Nanji & French 1989, Nanji et al.
1989; 1994a; 1994b, Takahashi et al. 1992), even their ethanol intake was significantly
increased (P < 0.01) to achieve comparable BEC found in lard and corn oil groups (Nanji
and French 1988). Animals fed lard and ethanol had minimal to moderate ALD (Nanji &
French 1989, Nanji et al. 1989). Animals fed ethanol with corn oil developed severe
ALD (Nanji et al. 1989, Nanji et al. 1994a;1994b;1995, Takahashi et al. 1992, Tsukamoto
et al. 1986). Rats fed ethanol and fish oil had more severe alcoholic liver injury when
compared to rats pair-fed corn oil and ethanol (Morimoto et al. 1994, Nanji et al. 1994c).
Moreover, MEOS and CYP2El induction were significantly greater in the rats fed corn
oil (25% of calories) and ethanol compared to those fed tallow and ethanol (Nanji et al.
1994b, Takahashi et al. 1992). The induction of CYP2El was even higher in the fish oil
versus corn oil group when the dietary fat content was at 25% of total calories (Nanji et
al. 1994c). However, when the dietary fat content was increased to 35% of total calories,
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CYP2El induction was comparable between the fish and com oil (Morimoto et al. 1994).
Rats fed a diet enriched in SFA were found to have lower rates of ethanol clearance than
those fed a diet rich in USF A (Cha and Sachan 1994). Review of dietary fats and ethanol
metabolism is listed in Table 2-12.

CARNITINE AND ETHANOL METABOLISM

Camitine, chemically known as P-hydroxyl-y-trimethylammonium butyrate, is
present in the body as free camitine and as acylcamitines. The acyl group in the
acylcamitines range from short-chain like acetyl to long-chain like palmitoyl. Acetylcamitine is the predominant acylcamitine identified in rat tissues and in blood and urine
(Choi and Bieber 1977).
The well recognized physiologic function of camitine is the transport of fatty
acyl-coenzyme A (CoA) across the inner mitochondrial membrane for P-oxidation
(Carter et al. 1995, Feller and Rudman 1988). Without camitine, most of the ingested
fatty acids would not be fully metabolized for energy and the body would be forced to
store the fatty acids as triglyceride in adipose tissue (Bieber 1988). This strategic role of
camitine in long-chain fatty acid metabolism has received much attention and has
prompted several studies on its potential to help prevent the ethanol-induced liver
diseases.
Camitine was found to significantly diminish serum triglyceride in rats receiving
ethanol (Hosein and Bexton 1975). The addition of camitine to a diet containing 36%
calories as ethanol significantly depressed ethanol-induced increases of total lipids, free
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TABLE 2-12
Review of dietary fats and ethanol metabolism in animal studies 1
Author (year)

Animal model

Fat source and level

Ethanol level and
duration

Results

Jones and Greene
(1966)

Male albino rats,
weighing 63 to 73 g

Coconut or safflower oil at
5 and 43 en%

36 en% ethanol for 3
weeks, oral

Fatty livers developed only in
rats fed 43 en% of dietary fat
with ethanol regardless of the
type of fat sources

Lieber et al.
(1967)

Male Charles River
rats, weighing 100 to
150 g

LCT (olive-com oil
mixture), or MCT at 41
en%

36 en% ethanol for 24
days, oral

Hepatic TG accumulation
was significantly higher in
the LCT group than in the
MCT group

Lieber and DeCarli
(1970)

Male S. D. rats,
weighing 120 to 150 g

Mixture of ethyl linoleate,
olive and com oils at 2, 5,
10, 15, 25, 35, and 43 en%

36 en% ethanol for 24
days, oral

~25 en% of dietary fat
significantly increased
hepatic lipid accumulation

Kanayama et al.
(1984)

Male Wistar rats,
weighing ca. 200 g
each

Com oil at 15 and 36 en%

36 en% ethanol for 4
weeks, oral

Ethanol metabolism was
accelerated by the high fat
diet (36 en%)

Tsukamoto et al.
(1985)

Male Wistar rats,
weighing 350 to 400 g

Com oil at 5 en%

32 to 41.4 en% ethanol
for 15 to 85 days,
intragastric

Severe and progressing fatty
liver developed in the
alcoholic rats

Takada et al.
(1986)

Male Wistar rats,
weighing ca. 150 g
each

Com oil at 15 and 35 en%

36 en% ethanol for 12
weeks, oral

Alcohol-pyrazole hepatitis
was accelerated by the high
fat diet (35 en%)
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Author (year)

Fat source and level

Animal model

Ethanol level and duration

Results

Tsukamoto et al.
(1986)

Male Wistar rats,
weighing 350 to 400 g

Com oil at 25 en%

32 to 47 en% ethanol for
30 to 120 days, intragastric

Alcohol-induced liver injury
increased with raising dietary
fat level

Reinke et al.
(1987)

Female S. D. rats,
weighing 140 to 150 g

Mixture of olive, com,
and safflower oils at 12
and 35 en%

36 en% ethanol for 2
weeks, oral

Level of cytochrome P-450
was increased by a high fat
diet plus ethanol

Nanji and French
(1989)

Male Charles River
rats,
weighing 220 to 355 g

Lard, tallow, or tallow
supplemented with 2.5%
linoleic acid at 25 en%

8 to 17 g/kg/day for 2 to 6
months, intragastric

With ethanol intake, ALD
was none in the tallow group,
moderate in the lard group,
and most severe in the tallow
plus linoleic acid group

Nanji et al.
(1989)

Male Charles River
rats,
weighing 220 to 355 g

Com oil, lard, or tallow
at 25 en%

8 to 17 g/kg/day for 2 to 6
months, intragastric

With ethanol intake, ALD
was none in the tallow group,
moderate in the lard group,
and most severe in the com
oil group

Takahashi et al.
(1992)

Male Wistar rats,
weighing 200 to 250 g

Com oil or tallow at 25
en%

42 en% ethanol for 5 to 24
weeks, intragastric

Severe fatty change was
observed in the com oil and
ethanol group
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Cha and Sachan
(1994)

Male S. D. rats,
weighing 75 to 92 g

10 wt% com oil (UFA)
or coconut oil (SFA)

3 g/kg body weight ethanol
solution (13%)
administrated on days 30,
90, 105 and 120, oral

Ethanol metabolism is slower
in the SFA group than in the
UFA group

Nanji et al.
(1994a)

Male Wistar rats,
weighing 225 to 250 g

Com oil or saturated fat
at 25 en%

8 to 17 g/kg/day for 2 and
4 weeks, intragastric

Alcoholic liver injury was
limited to rats fed the corn
oil for 4 weeks

Nanji et al.
(1994b)

Male Wistar rats,
weighing 225 to 250 g

Com oil or saturated fat
at 25 en%

8 to 17 g/kg/day for 2 and
4 weeks, intragastric

Ethanol induced increase in
CYP2El was greatest in rats
fed the com oil for 2 and 4
weeks

Nanji et al.
(1994c)

Male Wistar rats,
weighing 225 to 250 g

Com or fish oil at 25
en%

8 to 17 g/kg/day for 4
weeks, intragastric

Alcoholic liver injury was
more severe in the fish oil
versus com oil group;
CYP2E 1 was highest in the
fish oil and ethanol group

Morimoto et al.
(1994)

Male Wistar rats,
weighing 210 to 240 g

Com or fish oil at 35
en%

8 to 14 g/kg/day for 72
days

Alcoholic liver injury
occurred in both groups;
ethanol inducible CYP2E 1
content was similar between
the 2 groups
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Fat source and level

Animal model

Ethanol level and duration
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Nanji et al.
(1995)

Male Wistar rats,
weighing 225 to 250 g

Fish oil at 35 en% and
ethanol for 6 weeks, then
fish or palm oil without
ethanol for 2 weeks

8 to 16 g/kg/day for 6
weeks, intragastric

By 6 weeks, all rats fed fish
oil and ethanol developed
alcoholic liver injury. Rats
then fed palm oil and
dextrose for 2 more weeks
showed near normal liver
histology.

1

~

Abbrevations used: LCT, long-chain triglycerides; MCT, medium-chain triglycerides; S. D., Sprague-Dawley; TG,
triglycerides.

and esterified cholesterol, triglyceride and phospholipids in the liver samples of rats in a
dose-dependent manner (Rhew and Sachan 1986, Sachan et al. 1984, Sachan and Rhew
1983). Under both acute and chronic doses of ethanol, dietary camitine administration
also reduced hepatic lipids and raised blood ethanol concentrations (BEC). The increase
in BEC was dependent on the level of the supplemented camitine (Berger & Sachan
1986; 1991, Sachan 1992, Sachan and Berger 1987). Similar results were reported by
Smith et al. (1994) that camitine delayed ethanol metabolism and expanded the half-life
of ethanol in broilers. It is believed that camitine supplementation lowered oxidation of
ethanol in the rats and decreased the burden of ethanol-derived metabolites on the liver.
However, the ex vivo activities of ethanol-metabolizing enzymes were not significantly
affected by supplementary camitine (Mynatt and Sachan 1992, Sachan 1992). In
addition, rats fed SF A diet had significantly higher plasma camitine concentrations of
different types as compared to those fed USF A diet (Cha and Sachan 1994). These
results support that camitine offers protection to the animal model against ethanolinduced lipid abnormalities by retarding ethanol metabolism.
In contrast to the results from animal studies, the camitine mediated rise in BEC
was not observed in a randomized double-blind and crossover human study (Adamo et al.
1988). The BEC were compared in 15 healthy men receiving ethanol (0.5 g/kg) in the
form of white wine and a concomitant intravenous of L-camitine (3 g/100 mL of saline
solution) or saline solution. The plasma acetate concentrations, however, were
significantly decreased (P < 0.05) by L-carnitine administration following ethanol
ingestion. Besides, the urinary acetylcarnitine concentrations were significantly
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increased (P < 0.02) following administration of ethanol plus camitine, but not when Lcamitine was administrated alone. Therefore, the investigators suggested that L-camitine
supplementation might trap excess acetyls derived both from free acetate, formed by
ethanol oxidation, and from acetyl coenzyme A, accumulated as a result of the ethanolinduced decrease in the Krebs cycle flux.
In the isolated rat hepatocytes, the rates of ethanol oxidation were reduced by
adding acetylcamitine and L-carnitine to the media as compared to those without
acetylcarnitine or L-camitine (Cha and Sachan 1995). The maximal inhibition of ethanol
oxidation in the hepatocytes was clearly evident at 100-fold lower concentration of
acetylcamitine than camitine. Therefore, the inhibition of ethanol oxidation by camitine
had to be mediated by the formation of acetylcamitine in the isolated hepatocytes as well
as in the intact animal (Cha and Sachan 1995). It has been found that the activity of
ADH, not MEOS, was significantly inhibited by acetylcamitine at NAD+:acetylcamitine
:$;

1. The inhibition is of a competitive nature where acetylcarnitine competes with NAD+

(Sachan and Cha 1994).

DIETARY FATTY ACIDS AND SMALL INTESTINE

Absorption of almost all major dietary products take place in the small intestine
(Castro 1981 ). Experimental evidence demonstrate that dietary fat modifications alter the
absorption of ingested nutrients (Thomson and Rajotte 1983, Thomson et al. 1986;1989),
which may be due to the changes in the fatty acid composition and fluidity of intestinal
cell membranes.
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Information concerning the influences of feeding TFA on the intestinal uptake of
nutrients is not complete. Sugano et al. (1984) found that the cholesterol absorption rate
was markedly lower in rats fed trans-fat than in those fed cis-fat. The trans C 18: 1 content
was relatively higher in the intestinal epithelial cells than in the serum of these animals.
An in vitro study carried out by Manteca et al. (1994) demonstrated that elaidic acid
increased the intestinal uptake of cholesterol as compared to oleic acid. On the other
hand, Thomson et al. ( 1994) observed that feeding TF A to rats for 2 weeks had no
influence on the jejuna! or ileal uptake of glucose, fatty acids (lauric, stearic, oleic,
linoleic, and linolenic acids) or cholesterol. The effects of TF A feeding on many other
nutrients and xenobiotics, especially ethanol, pesticides, and herbicides, are unknown.

RESEARCH OBJECTIVES
The review of the literature indicates that both the quantity and the saturation
degree of fatty acid alter ethanol metabolism. There is, however, no published data of the
effects of various fatty acid geometric and positional isomers on ethanol metabolism.
Use of margarines and shortenings in place of butter and other saturated fats has become
an increasingly popular dietary practice. These fats are usually utilized in preparation of
convenient and snack foods which are frequently eaten with alcoholic beverages.
Therefore, the overall objective of this study was to determine the effects of geometric
isomers (cis and trans) of unsaturated fatty acids on the bioavailability and metabolism of
ethanol and compare these results to those of the SF A. As a result, the following
questions were proposed to address the overall objective:
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1.

Will TF A alter blood ethanol clearance? If so, would the effects be similar to
those of saturated or cis fatty acids?

8.

Can the alteration ofBEC by TFA be explained by changes in hepatic ADH
activity?

9.

Can the alteration ofBEC by TFA be explained by changes in acylcamitine
profiles?

10.

Can the alteration ofBEC by TFA be explained by changes in urinary excretion of
ethanol?

11.

Can the alteration of BEC by TF A be explained by changes in the intestinal
transport of ethanol?

12.

Can the alteration ofBEC by TFA be explained by changes in fatty acid
composition?
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CHAPTER III
EFFECTS OF SATURATED, CIS, AND TRANS FATTY ACIDS ON
BLOOD ETHANOL CONCENTRATIONS IN RA TS

ABSTRACT
Two experiments were conducted to determine the effects of different types of
fatty acids on blood ethanol clearance in 5-week-old male Sprague-Dawley rats. In
Experiment 1, 18 rats were randomly assigned to one of the modified AIN 76 diets
containing a predominance of saturated fatty acids (SF A), cis fatty acids (CF A), or trans
fatty acid (TF A). Various edible fats, oils and one fatty acid were mixed to generate the
diets of comparable fatty acid profiles. After 2, 4, and 6 weeks of dietary treatment, an
oral dose of ethanol (3 g/kg body weight) was given to the animals. Serial tail vein blood
samples were collected from 15 to 360 minutes post-ethanol administration and assayed
for blood ethanol concentration (BEC). After 2 weeks of feeding, the BEC of SF A and
CF A groups were higher than those of TF A group. However, these differences in BEC
were not significant after 4 and 6 weeks of feeding the diets. Experiment 2 was
undertaken to confirm the changes in BEC by feeding CF A and TF A diets for 2 weeks in
24 rats. Compared with rats fed the CF A diet, animals fed the TF A diet had an enhanced
blood ethanol clearance as observed in the first experiment. Based on the BEC data, it is
concluded that rats fed TFA for 2 weeks accelerated blood ethanol clearance compared
with CF A. In addition, liver triglycerides were significantly lowered in the TF A group,
whereas the plasma triglycerides were not affected by the dietary fatty acids.
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INTRODUCTION
Ethanol-induced liver injury proceeds through three main stages, namely fatty
liver, hepatitis, and finally cirrhosis (Sherlock 1995). Lipid is one of dietary factors
known to affect the metabolism of ethanol and thus the pathogenesis of alcoholic liver
disease (ALD). To investigate the relationship between the dietary fat and mortality rate
of cirrhosis, Nanji and French (1985) observed a highly significant correlation®= 0.98,
P < 0.001) between cirrhosis mortality rate and the product of ethanol and pork

consumption in 16 countries. Another epidemiological study in 17 countries indicated
that saturated fats were relatively protective against the alcoholic cirrhosis, whereas
polyunsaturated fats promoted alcoholic cirrhosis (Nanji and French 1986). The
epidemiological correlations were further confirmed in animal studies. Using a
continuously intragastric ethanol feeding model, Nanji and French (1988) detected that
rats fed tallow needed significantly higher (P < 0.01) intake of ethanol to achieve
comparable BEC than that found in the lard and com oil groups. While rats fed ethanol
and beef fat developed no hepatic damage, those fed ethanol and lard exhibited minimal
to moderate ALD, and those fed ethanol with com oil had all of the features of ALD
(Nanji et al. 1989). It was suggested that the severity of ALD was related to the amount

oflinoleic acid in the dietary fat source (tallow 0. 7%, lard, 2.5%, and com oil 56.6%)
(Nanji et al. 1989). When rats were fed ethanol and tallow supplemented with linoleic
acid (2.5%), the pathological changes of ALD (fatty liver, necrosis, and inflamation) were
more severe than those in the group fed lard and ethanol (Nanji and French 1989).
Therefore, linoleic acid was proposed to be essential for the development of ALD in the
rat model (Nanji and French 1989, Nanji et al. 1989).
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To study the effects of saturated fatty acids (SF A) and unsaturated fatty acids
(USF A) diets on ethanol pharmacokinetics after acute ethanol treatment, rats were fed
diets containing 10% (w/w) coconut or com oil (Cha and Sachan 1994). Feeding of the
USF A diet consistently accelerated blood ethanol clearance compared to feeding the SF A
diet to rats for 30, 90, 105, and 120 days.
USF A contain both cis fatty acids (CF A) and trans fatty acids (TF A). TF A
resemble SF A in chemical structure and hypercholesterolemic effect (Katan and Mensink
1992). To our knowledge, there are no data in the literature on the effect of dietary TF A
on ethanol metabolism. Therefore, the objective of the present study was to study the
relative effects of diets rich in SFA, CFA, or TFA on blood ethanol clearance as indicated
by the BEC curves.

MATERIALS AND METHODS
Animals. The experimental protocol was approved by the University of Tennessee
Committee on Humane Care and Use of Laboratory Animals. After 1 week of
acclimation with Purina Rodent Chow diet (Ralston Purina Co., St. Louis, MO), male
Sprague-Dawley rats (Harlan Sprague Dawley Inc., Indianapolis, IN), approximately 5
weeks of age, were randomly divided into different dietary groups. Each rat was
individually housed in a stainless steel wire bottom cage in a temperature controlled room
(23 ± 2°C). Lighting was controlled automatically for 6:00 to 18:00. All animals had
free access to food and water through the 6-week study. Body weights were measured
weekly and food intakes were recorded on a daily basis.

Diets. The rats were fed modified AIN76 diets enriched with 10% (w/w) SFA, CFA or
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TF A. Various edible fats, oils, and one fatty acid were mixed to generate the diets of
comparable fatty acid compositions. All diets were prepared weekly and stored at -20°C.
To prevent oxidation, fresh food was provided daily to the animals. The fatty acid
compositions of the different diets were analyzed in a Hew let-Packard Model 5890 series
II chromatograph equipped with a flame ionization detector and a DB23 fused silica
capillary column (0.25 mm I.D. x 30 m x 0.25 µ film, J & W Scientific, Folsom, CA). In
Experiment 1 (Table 3-1 ), the fat source of the SFA diet included coconut and com oils.
Butter, com oil, and olive oil were combined for the CFA diet. Margarine and free
elaidic acid were the source of the TF A diet. The dietary fatty acid composition data of
the first experiment are shown in Table 3-2. In Experiment 2 (Table 3-3), the fat sources
of the CF A diet consisted of butter, com oil, and olive oil. Margarine, free elaidic acid,
and butter were used as the fat sources of the TF A diet. Table 3-4 presents the dietary
fatty acid compositions used in the second experiment.

Experimental design. In Experiment 1, 18 male Sprague-Dawley rats were randomly
divided into 3 dietary groups (n = 6): SFA, CFA, and TFA. After 2, 4, and 6 weeks of
dietary treatment, the rats given a single oral dose of 3 g ethanol per kg body weight as
13% aqueous solution (v/v) via a gastric canula. Tail vein blood samples (20 µL each)
were collected at 15, 30, 60, 120, 180, 240, 300, and 360 minutes after ethanol
administration for determination of BEC . At the end of the 6-week study period, blood
samples were collected by cardiac puncture under Metaphane anesthesia. Following the
blood collection, liver (perfused) was removed, frozen in liquid nitrogen, and stored at 80°C until assayed for triglyceride.
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TABLE 3-1
Composition of the experimental diets used in Experiment 1 1
Diet
Ingredient
SFA

CFA

TFA

g/kg
200

200

200

3

3

3

Com starch

150

150

150

Sucrose

450

450

450

Cellulose

50

50

50

Vitamin mix 2

10

10

10

Mineral mix 2

35

35

35

Coconut oir

65

Com oila

35

Casein
DL-Methionine

37

Olive oila

58

Butter3a

6.14

Margarine4a

111.8

Elaidic acid 5a
Choline bitartrate

10
2

2

1

2

Abbreviations used: SFA, saturated fatty acids; CF A, cis fatty acids; TF A, trans fatty
acid.
2
AIN 1977.
3
Butter: 113 g of butter contains 92 g of fat; therefore, there is about 81 % fat in butter.
4
Margarine: 113 g of butter contains 91 g of fat; therefore, there is about 80% fat in
butter.
5
Elaidic acid (Sigma, St. Louis, MO).
a Differences presented in fat sources are due to their compositions of fatty acids which
are balanced between the three experimental diets.
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TABLE 3-2

Fatty acid composition of the experimental diets used in Experiment 1 (mole%/' 2
Dietary group
Fatty acid
SFA

CFA

TFA

ClO:O

4.6

0.6

0.7

CI2:0

34.1

0.2

0.0

C14:0

13.l

0.6

0.1

CI6:0

10.6

17.3

12.4

C16:1

0.0

1.5

0.1

CI8:0

4.1

3.1

8.6

12.3

43.2

25.5

0.1

0.0

19.0

C18:2 (n-6)

20.7

32.6

29.4

C18:3 (n-3)

0.4

0.9

4.2

~SFA

66.5

21.8

21.8

~MUFA

12.4

44.7

44.6

~PUPA

21.1

33.5

33.6

0.3

1.5

1.5

Y2/l.5

Y~l.5

cis Cl 8: 1 (n-9)
trans C 18: 1 (n-9)

P:S

S:M:P

2/0.4/0.6

1

Diets were analyzed for fatty acid compositions in a Hewlet-Packard Model 5890
series II gas chromatograph equipped with a flame ionization detector and a DB23 fused
silica capillary column (0.25 mm I.D. x 30 m x 0.25 µ film, J & W Scientific, Folsom,
CA).
2
Abbreviations used: CF A, cis fatty acids; TF A, trans fatty acid; MUF A, monounsaturated fatty acids; PUF A, poly-unsaturated fatty acids; ~ SFA, total saturated fatty
acids; ~ MUF A, total mono-unsaturated fatty acids; ~ PUFA, total poly-unsaturated fatty
acids; PIS, PUF A:SFA ratio; S/M/P, SFA:MUFA:PUF A ratio.
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TABLE 3-3
Composition of the experimental diets used in Experiment 2 1
Dietary group
Ingredient

CFA

TFA
g/kg

200

200

3

3

Corn starch

150

150

Sucrose

450

450

Cellulose

50

50

Vitamin mix

10

10

Mineral mix

35

35

Corn oila

52

Olive oiia

37

Buttera

14

Casein
DL-Methionine

Margarine3a

110.73
12

Elaidic acida
Choline bitartrate

1.27

2

1

2

Abbreviations used: CFA, cis fatty acids; TF A, trans fatty acid.
Butter: 113 g of butter contains 92g of fat; therefore, there is about 81 % fat in butter.
3
Margarine: 113 g of margarine contains 91 g of fat; therefore, there is about 80% fat in
marganne.
a Differences presented in fat sources are due to their compositions of fatty acids which
are balanced between the three experimental diets.
2
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TABLE 3-4

Fatty acid composition of the experimental diets used in Experiment 2 (mole%/· 2
Dietary group
CFA

TFA

ClO:O

0.2

0.0

C12:0

0.4

0.0

C14:0

1.3

0.2

C16:0

14.0

12.2

C16:1

0.5

0.1

C18:0

4.0

7.4

44.5

26.1

0.1

19.2

C18:2 (n-6)

33.1

33.1

C18:3 (n-3)

0.9

0.7

~SFA

20.6

20.6

~MUFA

45.4

45.5

~PUFA

34.0

33.9

Fatty acid

cis C18: 1 (n-9)
trans Cl 8: 1 (n-9)

PIS
S/M/P

1.7
1/2.211.7

1

1.7
1/2.211.7

Diets were analyzed for fatty acid compositions in a Hewlet-Packard Model 5890
series II gas chromatograph equipped with a flame ionization detector and a DB23 fused
silica capillary column (0.25 mm I.D. x 30 m x 0.25 µ film, J & W Scientific, Folsom,
CA).
2
Abbreviations used: CF A, cis fatty acids; TF A, trans fatty acid; MUF A, monounsaturated fatty acids; PUF A, poly-unsaturated fatty acids; ~ SFA, total saturated fatty
acids; ~ MUF A, total mono-unsaturated fatty acids; ~ PUF A, total poly-unsaturated fatty
acids; PIS, PUFA:SFA ratio; S/M/P, SFA:MUFA:PUFA ratio.

72

Two groups (n = 12) of male Sprague-Dawley rats were fed CFA or TFA diets for
2 weeks in Experiment 2. Tail vein blood samples were collected at 30, 60, 90, 120, 150,
180, 210, 240, 270, 300, and 360 minutes after ethanol administration for BEC assay. At
the end of the 2-week experimental period, the liver was perfused, removed, weighed, and
stored at -80°C.

Determination of BEC. The modified enzymatic method of Bernt and Gutmann
(1974) was used for the determination of BEC. Briefly, a blood sample (20 µL) was
taken from the tail vein and immediately diluted with 980 µL of cold saline in a microcentrifuge tube. The dilution was rapidly mixed and kept on ice until assayed. A total of
2.5 mL of reaction mixture containing 71 mmol/L pyrophsophate buffer (pH 8.7), 71
mmol/L semicarbazide, 20 mmol/L glycine, 0.96 mmol/L NAD+, and ADH was prepared
for each test sample. Ethanol standards were prepared by diluting the working standard,
0 to 100 µL, with cold normal saline. A 0.1 mL aliquot of supernatant from each
centrifuged standard or sample was mixed with the reaction mixture and then incubated
for 25 minutes in a 37°C water bath. After cooling to room temperature, the absorbance
of each sample was determined by a spectrophotometer at 340 nm. The BEC was
expressed as mmol/L.

Determination of triglyceride. The triglyceride in the plasma or liver homogenate was
assayed by the method ofGiegel et al. (1975). The triglyceride content in 200 µL of
plasma or liver homogenate was extracted with 5 mL of n-nonane and isopropanol
(2.0:3.5 v/v) mixture and acidified with 1 mL of 40 mmol/L sulfuric acid. A series of
standards was made using Oto 600 µL oftriolein standard. Standards and samples were
then centrifuged at 1500 x g for 10 minutes at 4 °C. A 500 µL aliquot of the clear upper
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phase from each extraction was mixed with 500 µL of transesterifying reagent (KOH in
isopropanol, 100 nmoVL). After standing at room temperature for 5 minutes, 500 µL of
oxidizing reagent (18 mmoVL sodium periodate in 2 moVL acetic acid) was added to each
tube, and the mixture was allowed to stand for an additional 5 minutes at room
temperature. Once the two-phase system was developed, 6 mL of working color reagent
(6 moVL ammonium acetate, pH 6.0) was added to each tube and vortexed. All tubes
were incubated in a water bath at 60°C for 10 minutes for color development. The
absorbance was measured at 415 nm against a water blank. The triglyceride levels were
expressed as mg triglyceride/dL plasma or mg triglyceride/g wet liver.

Statistics. All data were expressed as the group means ± SEM. The statistical
significance was evaluated by student's t test when there were 2 dietary fatty acid groups.
ANOV A was used to detect the statistical significance among the 3 dietary fatty acid
groups and Duncan's multiple range test was used for multiple comparisons. The level of
statistical significance was set at P < 0.05. All statistical analyses were performed using
SAS for Unix system (version 6, SAS Institute, Cary, NC). In addition, the
UNIVARIATE procedure of SAS was applied to check the outliers ofBEC.

RESULTS

Weight gain,food intake, and liver weight of the rats. In Experiments I and 2, the
weight gains and liver weights were not significantly different between rats fed different
types of dietary fatty acids (Table 3-5 and 3-6). In Experiment 1, the TF A group had
slightly but significantly greater (P < 0.05) food intake than the SFA and CFA groups,
but the feed efficiencies were virtually the same in the 3 dietary groups (Table 3-5). The
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TABLE3-5
Body weight, food intake, liver weight, and triglyceride in rats fed saturated, cis, or
trans fatty acids diet for 6 weeks from Experiment 1 1' 2
Dietary group
Parameter
SFA

CFA

TFA

Initial body weight (g)

152.0 ± 12.63

149.2 ± 15.03

148.5 ± 15.93

Weight gain (g)

173.2 ± 14.43

166.7 ± 13.3 3

183.2 ± 10.3 3

Food intake (g)

666.3 ± 18.7b

648.0 ± 8.6b

720.8 ± 13.43

Feed efficiency3 (%)

25.9 ± I.Sa

25.7 ± 1.93

25.5 ± 1.63

Liver weight (g)

12.7 ± 0.6 3

12.4 ± 0.4 3

13.1 ± 0.5 3

3.9 ± O.la

3.9±0.1 3

3.9± O.la

Hepatic triglyceride
(mg/g liver)

4.0 ± 0.5 3

3.0 ± 0.3 3

2.3 ± 0.2b

Plasma triglyceride
(mg/dL plasma)

81.4± 15.1 3

63.2 ± 8.4 3

71.2 ± 9.4 3

(% body weight)

1

Values are group means ± SEM (n = 6) and those with the same superscripts in a row
are not significantly different at P < 0.05.
2
Abbreviations used: SFA, saturated fatty acids; CFA, cis fatty acids; TF A, trans fatty
acid.
3
Feed efficiency was calculated as the amount of weight gained in grams per gram of
experimental diets.
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TABLE 3-6
Body weight, food intake, and liver weight in rats fed cis or trans fatty acids diet for
2 weeks from Experiment 2 1•2
Dietary group
Parameter
CFA

TFA

Initial body weight (g)

131.3±1.8a

131.4 ± 2.0a

Weight gain (g)

112.1±3.3a

108.8 ± 3.7a

Food intake (g)

293.9 ± 5.5a

290.0 ± 7.4a

Liver weight (g)

15.4 ± 0.5a

15.8 ± 0.6a

6.3 ± O.la

6.6 ± 0.2a

(% body weight)
1

Values are group means± SEM (n=12) and those with the same superscripts in a row
are not significantly different at P < 0.05.
2
Abbreviations used: CFA, cis fatty acids; TFA, trans fatty acid.

food intake was not significantly different between the 2 dietary groups in Experiment 2
(Table 3-6).

BEC and pharmacokinetics. Time-dependent changes ofBEC in rats fed different
fatty acid diets for 2, 4, and 6 weeks from Experiment 1 are shown in Figure 3-1. The
measured BEC values are present in Appendix I, Tables 1-1 to 1-3. When outliers for
BEC were indicated by the UNIVARIATE procedure of SAS, the whole set ofBEC data
for that specific animal was excluded. Thus, the sample size was 5, 6, or 5 for BEC
measurement in rats after 2, 4, and 6 weeks of feeding, respectively. The BEC was
significantly higher in the SFA and CF A groups than in the TF A group (P < 0.05) at
certain time points after 2 weeks of dietary treatment. However, these differences in BEC
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FIGURE 3-1 Blood ethanol concentrations (BEC, mmol/L) in rats fed saturated (e), cis
(•), or trans(£) fatty acids diet for 2 (A), 4 (B), and 6 (C) weeks from Experiment 1.
Values are group means± SEM (n = 5, 6, and 5 for A, B, and C, respectively) and
asterisks indicate time points of statistically significant difference by ANOV A and
Duncan's tests at P < 0.05.
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were not significant after 4 and 6 weeks of dietary treatment. The pharmacokinetic
parameters calculated from the BEC data (Figure 3-lA) after 2 weeks of dietary
treatment are shown in Table 3- 7. Compared to the TFA group, the SF A and CFA
groups had higher (67 to 74%) peak BEC, greater (23 to 55%) zero time BEC (C 0), larger
(72 to 82%) area under the curve (AUC), and longer (17 to 25%) half-life (T Yi). The
absorption rate was 20% higher in the CF A group than in the TF A group. The
elimination rate was 39 to 41 % and volume of distribution (Vd) was 20 to 33% lower in
the SF A and CF A groups than in the TF A group. The peak time showed the least
difference among the 3 dietary groups. The pharmacokinetic parameters calculated form
the BEC data after 4 and 6 weeks of dietary treatment (Figure 3-lB and C, respectively)
are presented in Tables 3-8 and 3-9.
In Experiment 2, the time-dependent changes of BEC were significantly higher in
the CFA group than in the TF A group at certain time points after 2 weeks of dietary
treatment (P < 0.05) (Figure 3-2). The numerical BEC values are presented in Appendix

I, Table 1-4. The pharmacokinetic parameters calculated from the BEC data (Figure 32) after 2 weeks of dietary treatment are shown in Table 3-10. The peak BEC was 31 %,
peak time; 45%, elimination rate; 54%, zero time BEC (C 0); 193%, and area under the
curve (AUC); 32% higher in the CFA groups than in the TFA group. The absorption rate
was 58%, volume of distribution (V d); 65%, and half life of ethanol (TYz); 36% lower in
the CF A group than in the TF A group.

Liver and plasma triglyceride. The liver triglyceride concentrations were significantly
higher (P < 0.05) in the SF A and CFA groups than in the TF A group in Experiment 1.
There was no significant difference among the plasma triglyceride concentrations of the 3
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TABLE 3-7
Pharmacokinetics of ethanol in rats fed saturated, cis or trans fatty acids diet
for 2 weeks from Experiment 1 1' 2
Pharmacokinetic
parameters
Peak BEC (mmol/L)
Peak time (min)
Absorption rate (µmol/L/min)

Dietary group
SFA

CPA

TFA

25.0 (74% i)

24.1 (67%i)

14.4

134.4 (3% i)

130.9

14.4 (20% i)

12.0

4.1 (13%1)

3.9 (17%1)

4.7

66.9 (55% i)

53.2 (23% i)

43.1

Vd (L/kg)

1.0 (33%1)

1.2 (20%1)

1.5

AUC (mol/L/m)

7.1 (82%T)

6.7 (72% i)

3.9

T Yi (hour)

2.8 (17% i)

3.0 (25% i)

2.4

Elimination rate (µmol/L/min)
C0 (mmol/L)

11.8 (2%1)

123.1 (6%1)

1

The values of pharmacokinetic parameters were calculated from the mean blood
ethanol concentrations (BEC) values of each group (n = 5), with the difference as
compared to the TF A group in parentheses.
2
Abbreviations used: SFA, saturated fatty acids; CF A, cis fatty acids; TF A, trans fatty
acid; C0 , zero time BEC; V d, volume of distribution; AUC, area under the curve; T Yi,
half life.
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TABLE 3-8
Pharmacokinetics of ethanol in rats fed saturated, cis or trans fatty acids diet
for 4 weeks from Experiment 1 1' 2
Pharmacokinetic
parameters
Peak BEC (mmol/L)
Peak time (min)
Absorption rate (µmol/L/min)

Dietary group
SFA

CFA

TFA

29.4 (20% i)

29.0 (18% i)

24.6

117.9(17%1)

142.6

15.9 (4%1)

16.6

139.6 (2%1)
10.8 (35%1)
4.3 (126% i)

3.7 (95% i)

1.9

90.1 (146% i)

58.9(61%i)

36.6

Vd (L/kg)

0.7 (60%1)

1.1 (39% l)

1.8

AUC (mol/L/m)

8.3 (12% i)

8.0 (8% i)

7.4

T Yz (hour)

2.7(55%1)

3.1 (48%1)

6.0

Elimination rate (µmol/L/min)
C0 (mmol/L)

1

The values of pharmacokinetic parameters were calculated from the mean blood
ethanol concentrations (BEC) values of each group (n = 6), with the difference as
compared to the TF A group in parentheses.
2
Abbreviations used: SF A, saturated fatty acids; CF A, cis fatty acids; TF A, trans fatty
acid; C0 , zero time BEC; Vd, volume of distribution; AUC, area under the curve; T Y2,
half life.
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TABLE 3-9
Pharmacokinetics of ethanol in rats fed saturated, cis or trans fatty acids diet
for 6 weeks from Experiment 1 1•2
Pharmacokinetic
parameters

Dietary group
SFA

CFA

TFA

40.5 (0.2% i)

36.7 (9%1)

40.4

129. 7 (40% i)

107.6(16%f)

92.5

Absorption rate (µmol/L/min)

9.2 (64%1)

15.4 (40%1)

25.6

Elimination rate (µmol/L/min)

6.3 (91 % i)

5.0 (52% i)

3.3

296.1 (373% i)

92.6(48%i)

62.6

0.2 (80%1)

0.7 (30%1)

1.0

9.6(11%1)

10.8

2.3 (34%1)

3.5

Peak BEC (mmol/L)
Peak time (min)

C0 (mmol/L)
Vd (L/kg)
AUC (mol/L/m)
T Yi (hour)

11.0 (2% i)
1.8(48%1)

1

The values of pharmacokinetic parameters were calculated from the mean blood
ethanol concentrations (BEC) values of each group (n = 5), with the difference as
compared to the TF A group in parentheses.
2
Abbreviations used: SFA, saturated fatty acids; CF A, cis fatty acids; TF A, trans fatty
acid; C0, zero time BEC; V d, volume of distribution; AUC, area under the curve; T Yi,
half life.
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Figure 3-2 Blood ethanol concentrations (BEC, mmol/L) in rats fed cis (•) or trans (A)
fatty acids diet for 2 weeks from Experiment 2. Values are group means± SEM (n = 12)
and asterisks indicate time points of significant differences between the 2 groups by
student's t test at P < 0.05.
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TABLE 3-10

Pharmacokinetics of ethanol in rats fed cis or trans fatty acids diet
for 2 weeks from Experiment 2 1' 2
Pharmacokinetic
parameters

Dietary group
CFA

TFA

Peak BEC (mmol/L)

24.6 (31 % i)

18.8

Peak time (min)

80.5 (45% i)

55.5

Absorption rate (µmol/L/min)

18.0 (58%1)

43.2

Elimination rate (µmol/L/min)

8.0 (54% i)

5.2

83.4 (193% i)

28.5

Yd (L/kg)

0.8 (65%1)

2.3

AUC (mol/L/min)

5.3 (32% i)

4.0

T Yi (hour)

1.4 (36%1)

2.2

C0 (mmol/L)

1

The values of pharmacokinetic parameters were calculated from the mean blood
ethanol concentrations (BEC) values of each group (n = 12), with the difference as
compared to the TF A group in parentheses.
2
Abbreviations used: CF A, cis fatty acids; TF A, trans fatty acid; C0 , zero time BEC;
V d, volume of distribution; AUC, area under the curve; T Y2, half life.
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dietary groups {Table 3-5).

DISCUSSION

In Experiment 1, Sprague-Dawley rats were fed diets enriched in saturated, cis, or
trans fatty acids. The proportion of individual dietary fatty acid could not be exactly
matched, but the saturation of dietary fats was well controlled between the CF A and TF A
diets (Table 3-2). Stick margarine was used as the major fat source for the TFA diet
because of its high TF A content (Enig et al. 1983; 1990, Smith et al. 1985, Wootan et al.
1996), especially octadecenoic fatty acids (Kris-Etherton and Nicolosi 1995, Senti 1985).
Since the composition of food fats is changing, the TF A content is decreasing (Katan
1995). The TFA content was 9 mole% in the margarine used in the present study, which
is lower than the reported values of 11 to 30% (Slover et al. 1985). In order to mimic the
average TF A intake in humans, free elaidic acid was added to the diet to increase the TF A
content to 19 mole%. The absorption of elaidic acid as free fatty acid was demonstrated
to be equal to its triglyceride form in rats (Clement et al. 1965). Experimental diets were
prepared in the same manner for Experiment 2. The content of elaidic acid in margarine
used for the second experiment was lower than that for the first experiment. Thus, more
elaidic acid was added to the TF A diet in Experiment 2 to maintain the desirable level of
this TF A {Table 3-4).
Among the 3 dietary groups in Experiment 1, even though the food consumption
was higher in rats on the TF A diet, their body weight gains and liver weights were similar
to those ofrats on the SFA and CFA diet. Sugano et al. (1984) have also reported
significantly greater food intake by rats fed trans fat than by those fed cis fat without
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showing a difference in weight gains and relative liver weights.

It is estimated that the dose of 3 g ethanol/kg body weight in a rat is equivalent to
about 210 g or 266 ml of absolute ethanol, approximately the amount in 5 portions (3 .5
ounces) of 50% ethanol ingested by a man of 70 kg. However, more importantly, this
specific dose (3 g/kg body weight) produced peak BEC from 0.1 to 0.2% in rats. These
levels are physiologically similar to humans who are legally drunk ( 0.1 %). Moreover,
the LD 50 (lethal dose at which 50% of animals will die) for ethanol is 13.7 g/kg body
weight; thus, this dose (3 g/kg body weight) at less than one fourth of the LD 50 avoids the
life threat to the experimental animals throughout the study.
In Experiment 1, the blood ethanol clearance was accelerated by the TF A diet
compared to the SFA and CFA diets after 2 weeks of dietary treatment (Figure 3-lA).
The pharmacokinetic data revealed that the TFA diet caused smaller AUC, greater V0,
and shortened TYi of ethanol compared to the SFA and CF A diets (Table 3-7). This
effect of TFA was most likely due to a relatively faster metabolism of ethanol; however,
low absorption of ethanol in the gastrointestinal tract and rapid elimination of ethanol in
the urine remained possibilities. The shorter TYi of ethanol in rats fed the TFA diet
could be expected to increase the burden of ethanol-metabolites on these livers. Thus, it
appeared that TF A was responsible for the faster blood ethanol clearance observed in the
present study. The fact that TFA acted unlike SFA and that the CFA was similar to SFA
with regard to ethanol metabolism is contrary to the expectation. For example, the
hypercholesterolemic effect of TF A have been shown to resemble SFA (Judd et al. 1994,
Lichtenstein et al. 1993, Mensink and Katan 1990, Troisi et al. 1992).
As the animals grew older, the effect of the TFA diet was minimized or reversed
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(Figure 3-lB,C), as indicated by the pharmacokinetic data (Tables 3-8 and 3-9). The

lack of sustained effect of TF A on ethanol metabolism is surprising because such
inconsistency was not seen in rats fed SFA or USF A diet for 30, 90, 105 and 120 days
(Cha and Sachan 1994). These results were perhaps a consequence of unknown effects of
sources used in the diet preparations. In the present study, the fat source of CF A was
from a mixture of com and olive oils and that of TFA was from the combination of
margarine and free elaidic acid. In the study of Cha and Sachan (1994), com oil was used
as the sole source of USF A. In addition, Hsu and Kummerow ( 1977) demonstrated that
TFA decreased the oxidation rates of acylcamitines, glutamate, and pyruvate in the heart
mitochondria of rats after 1 week of feeding. The significance, however, disappeared
after 6 weeks of feeding. Chiang and Lu (1996) reported that TF A significantly increased
plasma total and low density lipoprotein cholesterol levels in rats after 2 weeks of feeding
and the significant difference was not found after 4 weeks of feeding. Therefore, it is
possible that undefined metabolic adaption compromised the dietary fatty acid related
changes in BEC.
Experiment 2 confirmed the results of the first experiment that the time-dependent
BEC were higher in the CFA group compared to the TFA group with increased number
of animals (Figure 3-2). There were 6 rats in the first experiment and 12 rats in the
second experiment. Pharmacokinetic data based on the BEC curves suggested that the
CFA group had lower V 0 and higher AUC than the TFA group (Table 3-10). These
results were consistent with the observations of the first experiment (Table 3-7).
However, the theoretical absorption and elimination rates and half-lives were opposite to
the earlier data (Table 3-7). The reasons for the inconsistency of the 3 parameters were
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not immediately understood. In Experiment 1, only a single dose of ethanol was given to
the rats to measure the BEC. However, 2 doses of ethanol were administrated to the rats
2 days apart to determine the urinary ethanol concentrations and BEC in Experiment 2.
This difference might have some unexplainable effect in the expression of the
pharmacokinetic data. Furthermore, there were only 2 data points in the absorption phase
of the BEC curve from which pharmacokinetic program extrapolated to draw a line and
calculate absorption slope. Therefore, absorption parameters can not be entirely reliable
and other pharmacokinetic parameters presented in Table 3-10 should be interpreted with
caution.
The plasma triglyceride concentrations of the TF A group were not statistically
different from the SFA and CFA groups in Experiment 1 (Table 3-3). However, the liver
triglyceride content was lower in rats fed the TF A diet than in those fed the CFA diet

(Table 3-3), which is in agreement with the observation of other investigators (Chiang
and Yu 1996, Sugano et al. 1984). Therefore, it would appear that the TFA diet will offer
protection against ethanol-induced fatty liver. The basis for this result may be in the fact
that TFA impair fatty acid synthesis as they depress the activities of liver acetyl CoA
carboxylase and fatty acid synthetase in rats (Egwim and Sgoutas 1972).
In summary, the results from the 2 experiments presented here demonstrate that
TF A caused lower BEC which is due to a combination of higher volume of distribution,
decreased rate of absorption, and enhanced rate of elimination of ethanol. It is note
worthy that TFA did not act like SF A regarding ethanol metabolism and that TF A
lowered liver triglycerides without affecting plasma triglycerides.
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CHAPTER IV
EFFECTS OF SATURATED, CIS AND TRANS FATTY ACIDS ON
HEPATIC ADH ACTIVITY, MITOCHONDRIAL CPT-1 ACTIVITY,
AND CARNITINE CONCENTRATIONS IN RATS

ABSTRACT

It has been shown that rats fed the trans fatty acid (TF A) diet for 2 weeks had
lower blood ethanol concentrations (BEC) as well as steeper absorption and elimination
slopes than those fed either saturated fatty acids (SF A) or cis fatty acids (CF A) diet. In
addition, TF A did not behave like SF A on blood ethanol clearance. Therefore, this study
was conducted to further examine the possible mechanisms of dietary fat related changes
on blood ethanol clearance in young male Sprague Dawley rats. It was found that TF A
enhanced blood ethanol clearance in comparison to SFA or CFA which cou]d not be
explained on the basis of differences in the hepatic alcohol dehydrogenase (ADH) activity
after either 2 or 6 weeks of dietary treatment. The excretion of ethanol in urine was
relatively higher in the TF A group than in the CF A group during the first 4 hours after
ethanol administration and may partially account for the differences in BEC between the
CF A and TF A groups. In addition, changes in the plasma camitines which changed
parallel with BEC contributed to higher BEC in the SF A and CF A groups than in the
TFA group.
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INTRODUCTION
Trans fatty acids (TFA), the geometrical isomers of the cis fatty acids (CFA), are
chiefly produced during the partial hydrogenation of vegetable oils (Emken 1984, Enig
1996). Such chemical hydrogenation is applied to manufacture margarines, shortenings,
salad oils, and cooking oils with improved flavor, increased shelf-life, and lowered cost
(Dutton 1979). TF A are also synthesized in the rumen of ruminant animals by microbial
biohydrogenation (Emken 1984, Sachan and Davis 1969). About 90 to 95% of dietary
TF A in the U. S. diet are provided by the partially hydrogenated vegetable oils and the
remaining 5 to 10% from ruminant fats (Emken 1984, Enig 1996). The principal TFA
produced by the chemical partial hydrogenation and microbial biohydrogenation are
elaidic acid and vaccenic acid, respectively (Kris-Etherton and Nicolosi 1995, Senti 1985,
Sommerfeld 1983). In the average American diet, the estimated intake ofTFA is 8.1 to
13.3 g per person per day, accounting for 3 to 4% of total energy intake, as assessed by
availability or disappearance data (Enig et al. 1990, Hunter and Applewhite 1991).
We have previously shown that feeding the TF A diet to rats for 2 weeks
significantly decreased blood ethanol concentrations (BEC) as compared to the feeding of
either SFA or CFA diets (Chapter 3). Based on the time-dependent changes in the BEC
curves, the TFA group had steeper absorption and elimination slopes and consequently a
higher blood ethanol clearance than the SFA or CFA groups. In addition, TF A and SFA
did not behave alike regarding blood ethanol clearance. The mechanisms responsible for
these changes were not clear. Thus, the objectives of this study were to explore the
possible mechanisms behind the TFA-mediated acceleration of blood ethanol clearance.
The changes in hepatic alcohol dehydrogenase (ADH) activity, mitochondrial carnitine
89

palmitoyl trans ferase-I (CPT-I) activity, camitine concentrations, and urinary ethanol
excretion were determined in rats fed SFA, CF A, or TF A diet for either 2 or 6 weeks.

MATERIALS AND METHODS

Animals and diets. The experimental protocol was approved by the University of
Tennessee Committee on Humane Care and Use of Laboratory Animals. The details for
the use of animals and preparation of experimental diets are described in the materials
and methods section of Chapter 3. Briefly, 18 male Sprague-Dawley rats were randomly
assigned to 3 dietary groups for 6 weeks of dietary treatment in Experiment 1. Twentyfour rats with similar characteristics were fed CFA or TF A diets for 2 weeks in
Experiment 2. All animals were allowed free access to food and water. When urine
samples were collected, the rats were placed in the individual metabolic cages for 24
hours. Food consumption was recorded daily and body weight was monitored weekly for
each animal.
Rats were fed modified AIN 76 diets enriched with 10% (w/w) SFA, CFA, or TFA
in Experiments 1 and 2 (Tables 3-1 and 3-3 in Chapter 3). Various edible fats, oils and
one fatty acid were mixed to generate the diets of comparable fatty acid content (Tables
3-2 and 3-4 in Chapter 3). The composition of dietary fatty acids was analyzed in a

Hewlet-Packard Model 5890 series II chromatograph equipped with a flame ionization
detector and a DB23 fused silica capillary column (0.25 mm I.D. x 30 m x 0.25 µ film,
J & W Scientific, Folsom, CA). All diets were prepared weekly and stored at -20 °C.

Fresh food was provided daily to the animals.

Sampling. In Experiment 1, the animals were restrained for 3 to 5 minutes in a folded
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towel or a plastic cone (DeCapicone) for tail vein blood sampling. Tail vein blood (500
µl) was collected for carnitine determination before and after 2, 4, and 6 weeks of dietary
treatment. Twenty-four-hour urine samples were collected in a urine collector containing
1 mL of 0.2 moVL HCl before and after 2, 4, and 6 weeks of dietary treatment for
camitine determination. At the end of the study period, blood samples were collected by
cardiac puncture under Metaphane anesthesia. Following the blood collection, brain,
heart, liver (perfused), skeletal muscle, and small intestine were removed, frozen in liquid
nitrogen, and stored at -80°C until assayed for carnitine. A portion ofliver was also
processed at the same day for the ADH and CPT-I assays.
In Experiment 2, urine samples were collected at 2, 4, 6, 8, and 24 hours after
giving ethanol and analyzed for urinary ethanol concentrations (UEC). Blood and urine
samples for ethanol concentration determinations were collected at a 2-day interval to
avoid the possible stress effect on the biochemical markers. At the end of the study, half
of the rats of each dietary group were given an oral dose of ethanol (3 g/kg body weight)
2 hours prior to killing. Then, animals were anesthetized by Metaphane and blood
samples were collected by cardiac puncture. After blood collection, the liver was
perfused, removed, and processed immediately for ADH determination in 100,000 x g
supernatant fractions. In Experiments 1 and 2, the diets were not taken away from the
rats to preserve normal ethanol oxidation and maximal ADH activity (Lumeng et al.
1979).

Preparation of tissue homogenate. Pieces of frozen tissue cut from similar sites were
weighed and homogenized with cold saline in a teflon/glass homogenizer yielding a
weight by volume (w/v) homogenate. For the carnitine assay, the w/v ratio of brain and
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heart was 1:9; liver, 1:6; muscle, 1:15; and small intestine, 1:4. These homogenates were
prepared at Oto 5°C and stored at -80°C until ready for assay.

Preparation of enzyme. In Experiment 1, the CPT-I activity was assayed in the intact
hepatic mitochondria. The activity of ADH was assayed in the 100,000 x g supernatant
fraction of the liver. Liver tissue was first minced by cutting with scissors in cold 0.25
mol/L sucrose and then homogenized using a teflon/glass homogenizer. The homogenate
was then centrifuged at 600 x g for 10 minutes at 4 ° C. The supernatant containing the
mitochondria was transferred to another centrifuge tube and then centrifuged at 12,000 x
g for 10 minutes at 4 °C. The 12,000 x g pellet was then resuspended in 0.25 moVL
sucrose and centrifuged again at 12,000 x g for 10 minutes at 4 °C. The pellet was
resuspended as before and used for determination of CPT-I. The 12,000 x g supernatant
was centrifuged at 100,000 x g for 1 hour at 4 °C in an ultracentrifuge. The 100,000 x g
supernatant was used for ADH analysis. Protein concentration was determinated by the
Biuret method (Layne 1957).
In Experiment 2, the liver was first minced by cutting with scissors in cold 150
mmol/L KCl in 10 mmol/L phosphate buffer (pH 7.4). The liver was then homogenized
in 3 volumes ofKCl-phosphate buffer (pH 7.4) by 4 strokes in a teflon/glass
homogenizer. The homogenate was centrifuged at 600 x g for 10 minutes at 4 °C. The
600 x g supernatant was transferred to another centrifuge tube and centrifuged at 10,000 x
g for 10 minutes at 4 °C. The 10,000 x g supernatant was centrifuged at 100,000 x g for 1
hour at 4 °C in an ultracentrifuge. The 100,000 x g supernatant was used for ADH
analysis. Protein concentration was determinated by the method of Bradford (1976). The
activities of ADH in the stomach and small intestine were not determined because of the
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difficulties in preparing the homogenates and cytosolic fractions from these tissues.
Determination of UEC. The modified enzymatic method of Bernt and Gutmann
(1974) was used for the determination of ethanol concentrations in the urine samples.
Briefly, urine samples (100 µL) were diluted (2 to 30 times) or undiluted and kept on ice
until assayed. A total of 2.5 mL of reaction mixture containing 71 mmol/L
pyrophosphate buffer (pH 8.7), 71 mmol/L semicarbazide, 20 mmol/L glycine, 0.96
mmol/L NAD+, and ADH was prepared for each test sample. Ethanol standards were
prepared by diluting the working standard, 0 to 100 µL, with cold saline. A 0.1 mL
aliquot of supernatant from each centrifuged standard or sample was mixed with the
reaction mixture and then incubated for 25 minutes in a 37°C water bath. After cooling
to room temperature, the absorbance of each sample was determined by a
spectrophotometer at 340 nm. The UEC was expressed as mg ethanol/mg creatinine, mg
ethanol/mL urine, or mg total ethanol/collection period of time.
Determination ofADH activity. The modified method of Bergmeyer et al. ( 1974) was
used to measure the activity of ADH. Each reaction was performed in a total volume of 3
mL at 3 7 °C. The reaction mixture included 55 mmol/L pyrophosphate buffer (pH 7.4),
20 mmol/L ethanol, 2 mmol/L NAD+, 1.1 mmol/L reduced glutathione, 55 mmol/L
semicarbazide, 1.6 mmol/L glycine, and liver homogenate. The reaction mixture lacking
ethanol was pre-incubated for 3 minutes at 37°C in a temperature controlled Beckman
model 34 spectrophotometer. The reaction was initiated by adding ethanol and change in
absorbance at 340 nm was recorded for 5 minutes. Each sample was read against a blank
with distilled water replacing ethanol. The activity of ADH was expressed as nmol
NADH per minute per mg protein.
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Determination of CPT-1 activity. CPT-I activity was estimated by the method of
Bremer (1981). The mitochondrial suspension was adjusted to 10 mg protein/mL. Each
assay mixture containing 82 mol/L sucrose, 70 mol/L KCl, 1 mol/L EGTA, 70 mol/L
imidazole, 1 µg antimycin A, 2 mg BSA, 0.5 mol/L L-carnitine (0.4 mCi/mmol of L[methyl-3H] carnitine), 40 µmoVL palmitoyl CoA, and liver mitochondria in a total
volume of 0.5 mL. For determination of malonyl CoA inhibition, the concentrations of
malonyl CoA were 0, 10, 25, and 50 µmoVL. For estimation of the apparent Km of
palmitoyl CoA, concentrations were 10, 50, 100, and 200 µmoVL and for the Km of
carnitine, concentrations were 0.1, 0.5, 1, and 2 mmol/L. The CPT-I activity was
expressed as nmol/min per mg protein.
Determination of carnitine. Plasma, urine, and tissue carnitine concentrations were
determined by a radioisotopic method by Cederblad and Lindstedt (1972) as modified by
Sachan et al. (1984). Total carnitine (TC) in plasma, urine, and tissue was determined by
adding up measured free carnitine (NEC or nonesterified carnitine), acid soluble
acylcarnitine (ASAC or short-chain carnitine), and acid insoluble acylcarnitine (AIAC or
long-chain carnitine).
Cami tine standards were prepared by making O to 24 nmol/µL of carnitine
concentrations. For each test sample, 20 to 100 µL of plasma, urine, and tissue
homogenate was added to 200 µL of0.6 mol/L perchloric acid (PCA) contained in a test
tube. Enough distilled water was added to make a desired final volume of 400 µL. All
vortexed standards and samples were centrifuged at 1500 x g for 10 minutes at 4 °C.
The 1500 x g supernatant was immediately separated from the pellet. Aliquots of 150 µL
and 100 µL of PCA-supernatant were transferred to phenol red tubes for NEC and ASAC
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determinations, respectively. The supernatant liquids were completely drained off from
the tubes containing the pellets. The pellets were used for AIAC determination.
The PCA-supematant of each NEC tube was mixed with about 50 µL of 1 mol/L
KHC0 3 and then placed on ice for 30 minutes. PCA-supematant of each ASAC tube was
hydrolyzed by adding 100 µL of 0.5 moVL KOH, incubated in a shaking water bath at
37°C for 30 minutes, neutralized with 25 µL PCA-MOPS-II solution, and then placed on
ice for 30 minutes. The pellet of each AIAC tube was washed twice with 200 µL of 0.6
mol/L PCA and inverted to drain. A drop of phenol red indicator was added to the AIAC
tube. The pellet was then hydrolyzed by adding 200 µL of 0.5 moVL KOH, incubated in
a water bath at 65°C for 60 minutes, neutralized with 50 µL PCA-MOPS-I solution, and
placed on ice for 30 minutes.
The NEC, ASAC, and AIAC tubes were centrifuged at 1500 x g for 10 minutes at
4 °C. A 100 µL aliquot of each of the three fractions was transferred to a microcentrifuge
tube and 400 µL ofreagent mixture, including 1 mol/L MOPS, 0.1 moVL EGTA, 0.1

moVL N'1iS 4 0 6 , 0.1 mol/L 14C-acetyl CoA solution (1 4C-acetyl CoA and acetyl-CoA, 2: 1
v/v), and distilled water was added. Camitine acetyltransferase (CAT, 20 µL, 1 unit)
was then added. Each tube was capped, gently mixed by tapping, and placed in a shaking

incubator water bath at 37°C for 30 minutes. At the end of the incubation period, 200 µL
of incubation mixture was transferred onto a mini column filled with anion exchange
resin. The column was then rinsed down with 2 aliquots of 500 µL distilled water into a
scintillation vial. Five mL of scintillation fluid was added to each scintillation vial and
the vial was capped and mixed by swirling . The radioactivity of all vials was determined
in a Beckman LS-3801 scintillation counter. Inverse slope of standards was applied to
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determine the µmol camitine per L plasma, µmol camitine per 24-hour urine, or µmol
camitine per g of tissue.

Determination of creatinine. Creatinine assays in urine were performed by the Jaffe
reaction according to the methods ofTaussky (1954) as modified by Henry (1967).
Three mL of a dilute urine sample was mixed with 2 mL of alkaline-picrate solution (0.04
moVL picric acid and 0.75 moVL NaOH, 1:1, v/v). A series of standard were made using
7.5 to 45 µg of creatinine. After standing at room temperature for 20 minutes, the
absorbance was measured at 520 nm against a water blank. The creatinine levels were
expressed as µg creatinine/mL urine.

Statistics. All data were expressed as the group means ± SEM. The statistical
significance was evaluated by student's t test when there were 2 dietary FA groups.
ANOV A was used to detect the statistical significance among 3 dietary FA groups and
Duncan's multiple range test was used for multiple comparisons. The level of statistical
significance was set at P < 0.05. All statistical analyses were performed using SAS for
Unix system (version 6, SAS Institute, Cary, NC).

RESULTS

ADH and CPT-1 activities. In Experiment 1, hepatic ADH and mitochondrial CPT-I
activities were not significantly different among the 3 dietary groups after 6 weeks of
dietary treatment, although there was a trend that the TFA group had lower activities of
ADH and CPT-I than the SFA and C FA groups (Table 4-1). In Experiment 2, hepatic
ADH activity was not significantly different between the 2 dietary groups after 2 weeks
of feeding (Table 4-2).
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TABLE 4-1

Activities of hepatic alcohol dehydrogenase (ADH) and mitochondrial carnitine
palmitoyl trans/erase (CPT-1) in rats fed saturated, cis, or trans
fatty acids diet for 6 weeks from Experiment 1 1•2
Dietary group
Parameter
SFA
Hepatic ADH
(nmol/min/mg)
Mitochondrial CPT-1
(nmol/min/mg)

CFA

TFA

11.9 ± 1.4a

12.0 ± 1.4a

11.3 ± 1.2a

4.4 ± 0.3a

4.9 ± 0.3a

4.2 ± 0.3a

1

Values are group means± SEM (n = 6) and those with the same superscripts in a row
are not significantly different at P < 0.05.
2
Abbreviations used: SF A, saturated fatty acids; CFA, cis fatty acids; TF A, trans fatty
acid; ADH, alcohol dehydrogenase; CPT-I, camitine palmitoyl transferase-I.

Urinary ethanol concentrations (UEC). The UEC are expressed in 3 units: mg
ethanol/mg creatinine, mg ethanol/mL urine, or mg ethanol/collection period (Figure 41). There was no significant difference in the UEC between the 2 dietary groups

regardless the units of expression. The numerical UEC values are presented in Appendix

I, Tables 1-4 to 1-7.
Plasma, urinary, and tissue carnitine. In Experiment 1, plasma concentrations of
ASAC and AIAC were significantly higher (P < 0.05 and P < 0.01, respectively) in the
SF A and CF A groups than the TF A group after 2 weeks of dietary treatment (Figure 42B ). However, there was no significant difference for NEC and TC concentrations

among the 3 dietary groups. Similar trends of plasma carnitine concentrations were
found after 4 and 6 weeks of feeding. However, significant differences were observed in
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TABLE 4-2

Activity of hepatic alcohol dehydrogenase (ADH) in rats fed cis or trans fatty acids
diet for 2 weeks from Experiment 2 1•2
Dietary group
Parameter
CFA

TFA

Hepatic ADH activity (nmol/min/mg)
no EtOHa

20.3 ± 0.7a

19.8 ± 1.9a

with EtOHa

16.9 ± 1.3a

19.9 ± 1.2a

Combined

18.6 ± 0.8a

19.9 ± I.la

1

Values are group means± SEM (n=12), except for those with or without ethanol
treatment (n = 6), and those with the same superscripts in a row are not significantly
different at P < 0.05.
2
Abbreviations used: CF A, cis fatty acids; TF A, trans fatty acid; ADH, alcohol
dehydrogenase; EtOH, ethanol.
a With EtOH, animals received an oral dose (3 g/kg body weight) of ethanol (13%, v/v)
2 hours before being killed; no EtOH, animals received no ethanol before being killed.

AIAC after 4 weeks (P < 0.04) (Figure 4-2C) and ASAC after 6 weeks (P < 0.02)

(Figure 4-2D). There was no difference in urine camitine concentrations at any of the
collection periods (Figure 4-3). It appeared that both plasma and urinary camitine
concentrations were increased with the age of the rats (Figures 4-2 and 4-3). The plasma
and urinary camitine concentrations are presented in Appendix II, Tables 11-1 and 11-2.
The plasma camitine concentrations in rats after 2 weeks of dietary treatment from
Experiment 2 are presented in Table 4-3. Although the different fractions of camitine
concentrations were lower in the TFA group than in the CF A group, the differences were
not statistically significant.
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FIGURE 4-3 Urinary excretion camitine (µmol/day) in rats fed saturated, cis, or trans
fatty acids diet for O (A), 2 (B), 4 (C), and 6 (D) weeks from Experiment 1. SFA =
saturated fatty acids, CF A = cis fatty acids, TF A = trans fatty acid, NEC = non-esterified
camitine, ASAC = acid-soluble acyl camitine, AIAC = acid-insoluble acyl camitine, TC
= total camitine. All values are the group means± SEM (n = 6). Different letters
indicate significant differences by ANOVA and Duncan's tests at P < 0.05.
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TABLE4-3
Plasma carnitine concentrations (µmoVL) in rats fed cis or trans fatty acids diet
for 2 weeks from Experiment 2 1•2
Dietary group
CFA

TFA

24.6 ± 1.2a

23.5 ± 1. 7a

ASAC

7.8 ± o.r

7.7±1.la

AIAC

l.7±0.3a

1.3 ± 0.6a

TC

34.2 ± 1.2a

32.7 ± 2.4a

NEC

20.6 ± 1.4a

19.6 ± 0.7a

ASAC

11.2 ± 1.oa

8.6 ± 1.2a

AIAC

1.8 ± o.sa

1.7 ± 0.4a

33.6 ± 1.2a

29.9 ± 1.2a

22.6 ± l.la

21.6 ± 1.oa

ASAC

9.5 ± 0.8a

8.3 ± 0.8a

AIAC

1.8 ± 0.3a

1.6 ± 0.4a

33.9 ± 0.8a

31.3 ± 1.4a

No EtOHa:
NEC

TC
Combined:
NEC

TC
1

Values are group means± SEM (n = 12), except for those with or without ethanol
treatment (n = 6), and those with the same superscript letters in a row are not significantly
different at P < 0.05.
2
Abbreviations used: CF A, cis fatty acids; TFA, trans fatty acid; NEC, nonesterified
camitine; ASAC, acid-soluble acylcamitine; AIAC, acid-insoluble acylcamitine; TC,
total camitine.
a With ethanol, animals received an oral dose (3 g/kg body weight) of ethanol (13%,
v/v) 2 hours before being killed; no ethanol, animals received no ethanol before being
killed.
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The distributions of the various fractions of camitine in the brain, heart, liver, and
small intestine were affected by dietary fats in Experiment 1 (Table 4-4). In the brain
samples, the NEC and AIAC concentrations were significantly higher in the SFA group
(P < 0.03 and P < 0.0001, respectively), while the ASAC concentrations were

significantly lower in SFA group than the TFA group (P < 0.02). There was no
significant change between the CFA and TFA groups. In the heart samples, the SFA
group also had significantly higher NEC concentrations than the CFA and TFA groups (P

< 0.0001); however, the concentrations of other camitine fractions was not significantly
different among the 3 dietary groups. The TF A group had significantly higher liver
ASAC levels than the CF A group (P < 0.0009) and significantly lower liver AIAC levels
than the other 2 groups (P < 0.05). No statistical difference was found in the muscle
camitine concentrations. In the small intestine samples, the NEC levels were
significantly higher in the SFA group than in the CFA and TFA groups (P < 0.0001),
while the AIAC levels were higher in the CFA group than in the TFA group (P < 0.03).

DISCUSSION
In the previous study as described in Chapter 3, rats fed the TFA diet for 2 weeks
had consistently lower blood ethanol concentrations (BEC) compared to those fed the
SFA or CFA diets after an acute ethanol administration (3 g/kg body weight). The
changes in BEC modulated by dietary fatty acids may arise from changes in ethanol
metabolism. However, it was also possible that CF A and TF A differently altered the
speed of ethanol transport or the movement of ethanol in the digestive tract rather than its
metabolism after absorption .. Therefore, in the present study, the activities of ADH and
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TABLE 4-4

Tissue carnitine concentrations (nmoVg) in rats fed saturated, cis, or trans
fatty acids diet for 6 weeks from Experiment 1 1' 2
Dietary group
CPA

TPA

77.7 ± 5.7a

66.2 ± 3.9ab

59.0 ± 2.5b

ASAC

6.7 ± 1.2b

12.8 ± 1.4a

15.8 ± 2.8a

AIAC

13.2±1.la

6.0 ± 0.5b

7.6 ± l.Ob

TC

97.6±6.la

85.1 ± 4.5a

82.3 ± 2.9a

NEC

727.2 ± 25.9a

594.6 ± 24.6b

534.8 ± 21.4b

ASAC

280.9 ± 30.6a

323.4 ± 20.4a

316.5±21.3a

AIAC

11.9 ± 3.2a

11.1 ± 2.1 a

11.6 ± 2.9a

986.8 ± 36.2a

929.1 ± 29.8a

862.9 ± 20.1 a

148.3 ± 12.9a

146.8 ± 3.6a

125.1 ± 7.5a

SPA

Brain:
NEC

Heart:

TC
Liver:
NEC
ASAC

7.5 ± 1.7b

9.1 ± 0.8b

19.3 ± 2.7a

AIAC

3.8 ± o.sab

5.0±0.la

3.5 ± 0.5b

159.6 ± 13.8a

161.0 ± 4.0a

147.9± 10.2a

NEC

474.1 ± 20.2a

423.9 ± 41.4a

391.5 ± 27.6a

ASAC

192.2 ± 17.6a

177.9 ± 18.8a

188.4± 17.8a

AIAC

44.2 ± 6.9a

38.0 ± 7.2a

29.0 ± I.Sa

710.5 ± 29.8a

639.9 ± 50.9a

609.0 ± 24.0a

TC
Skeletal muscle:

TC

Continued
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TABLE 4-4 (Continued)
Tissue carnitine concentrations (nmoVg) in rats fed saturated, cis, or trans
fatty acids diet for 6 weeks from Experiment 1 1' 2
Dietary group
SFA

CFA

TFA

Small intestine:
NEC
ASAC
AIAC
TC

122.7 ± 2.9a

113.3 ± 2.0b

101.6 ± 2.3c

69.0 ± 6.4a

64.7 ± 4.0a

69.4 ± 2.9a

8.0 ± 0.5a

5.4 ± 0.6b

7.0 ± 0.7ab

185.9 ± 5.1 ab

198.8 ± 8.5a

176.4 ± 1.3b

1

Values are group means± SEM (n = 6) and those with the same superscripts in a row
are not significantly different at P < 0.05.
2
Abbreviations used: SF A, saturated fatty acids; CFA, cis fatty acids; TF A, trans fatty
acid; NEC, nonesterified camitine; ASAC, acid-soluble acylcamitine; AIAC, acidinsoluble acylcamitine; TC, total camitine.

CPT-I as well as the concentrations of camitine were determined to provide a mechanistic
explanations for the differences in BEC.
In general, ethanol is almost completely metabolized by oxidative metabolism (Li
1977). Under physiological conditions, ADH is the major enzyme catalyzing the
oxidation of ethanol to acetaldehyde in the liver (Lieber 1994). The changes in ethanol
metabolism parallel alterations in enzyme activity. For example, Sachan and Mynatt
(1993) showed in rats that a lysine-deficient wheat gluten diet delayed ethanol
metabolism and produced higher BEC than did a casein-based diet because of decreased
hepatic ADH activity. In Experiment 1, the hepatic ADH activity was slightly but not
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significantly lower in the TFA group than in the SFA and CF A groups after 6 weeks of
feeding (Table 4-1). However, it is important to remember that the ADH activity was
measured after 6 weeks of dietary treatment and the ethanol clearance was not different
among the 3 dietary groups after 4 weeks of feeding. In Experiment 2, the activity of
liver ADH was not statistically different after 2 weeks of feeding (Table 4-2). Analogous
results were reported by Cha and Sachan (1994) that hepatic ADH activities were
identical between the SFA and USFA groups. Therefore, the changes in BEC could not
be explained by the changes in hepatic ADH activity. Other metabolisms of ethanol such
as the extrahepatic ADH activities and non-ADH dependent ethanol oxidation may
explain the changes in BEC.
The presence of ADH activity in the gastrointestinal tract is well established.
Mistilis and Garske (1969) have clearly showed that the activity of ADH in the stomach
and small intestine significantly increased with administration of single or repeated doses
of alcohol and the effect lasted up to 72 hours. Carter and Isselbacher ( 1971) reported
that, in male rats, the ADH specific activity of the gastric slices (0.48 µmo I/hour/mg
protein) was about 3 times higher than in the liver slices (0.11 µmol/hour/mg protein),
while that of the small intestinal slices (0.15 µmo I/hour/mg protein) was comparable to
that of the liver slices. In 1985, Julkunen et al. (1985a) demonstrated that the BEC was
lower in rats after intragastric compared to intravenous ethanol administration, which
suggested the incomplete bioavailability of orally ingested alcohol and the existence of
first-pass metabolism of ethanol. Julkunen's group (1985b) again reported that the AUC
of BEC was significantly lower after intragastric administration than after administration
via intraduodenal, intravenous, and intraportal routes and thus the stomach was most
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likely the site of first-pass metabolism of ethanol. The metabolism of ethanol in the
digestive tract will cause a decline in systemic bioavailability of ethanol (first-pass
metabolism) and may explain some of the differences in BEC observed with various
diets. The determination of ADH activities in the small intestine and stomach was
intended in Experiment 2. However, the assay was not performed due to the difficulties
in preparing the homogenates and subcellular fractions.
The rate of gastric emptying is one of the factors that influence the absorption and
first-pass metabolism of ethanol (Kricka and Clark 1979, Seitz and Oneta 1998). A
delayed gastric emptying rate leads to prolonged exposure of alcohol to gastric ADH and
results in an increased gastric metabolism of alcohol. Delayed gastric emptying would
also stall the delivery of ethanol to the small intestine. A smaller rate of ethanol
absorption from the small intestine could optimize hepatic metabolism of alcohol and
could contribute to an increased hepatic first-pass metabolism of ethanol (Pedrosa et al.
1996). Delayed gastric emptying has been shown in the fed versus fasted state which was
associated with an increased first-pass metabolism (Di Padova et al. 1987). No food was
taken away from the animals before they were killed in the present study so as to preserve
maximal ADH activity (Lumeng et al. 1979). Therefore, the BEC may have been indeed
modulated by metabolism in the stomachs and possibly in the small intestines of the TFA
group more than the SFA or CF A group.
The microsomal ethanol oxidizing system (MEOS) is induced following chronic
and/or highly concentrated alcohol intake. The ethanol-inducible cytochrome P450 2El
(CYP2El) is a major component of the MEOS (Lieber 1994). Studies have shown that
the level of CYP2E 1 was modulated by the quantity and degree of saturation of dietary
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lipids without administration of ethanol (Yoo et al. 1990;1991;1992). Microsomes from
rats fed a diet containing 20 wt% com oil or an amount of linoleic acid equivalent to the
20% com oil diet showed 2- to 3-fold increases in the level of CYP2El protein and its
catalytic activity over those from the rats fed the fat-free diet (Yoo et al. 1990; 1991;
1992). Furthermore, at moderate fat levels (5 and 20 wt%), rats fed com oil and
menhaden oil diets produced significantly higher (P < 0.05) CYP2E 1 activity than those
fed lard and olive oil diets (Yoo et al. 1991). In the intragastric feeding rat model
(chronic ethanol treatment), the extent of CYP2El was also dependent on the type of
dietary fat (Nanji et al. 1994b;1994c, Takashi et al. 1992). Rats fed com oil and ethanol
had 2- to 6-fold higher levels of CYP2El protein and enzyme activity compared with
animals fed saturated fat and ethanol (Nanji et al. 1994b, Takashi et al. 1992). The
CYP2El protein level in rats fed fish oil and ethanol was even higher (P < 0.01) than that
in rats fed com oil and ethanol (Nanji et al. 1994c). However, chronic ethanol ingestion
is not required for induction of CYP2E 1; significant increases in this enzyme can be
observed after a single dose of ethanol (Koop 1992). Therefore, although the present
study was designed to study the acute ethanol treatment, CYP2E 1 might be induced by
the administration of a single dose of ethanol after 2 weeks of dietary treatment. Whether
the dietary fat compositions in the present study can influence CYP2E 1 is unknown and
needs to be investigated.
The excretion of ethanol from the urine must be considered as another possible
factor which may affect the BEC. Thus, the time-dependent changes in UEC were
determined in Experiment 2. There was no difference in the UEC between the 2 dietary
groups (Figure 4-1). However, as the slopes between UEC (mg/mL) at 2 and 4 hours
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were calculated by the simple linear regression, the TFA group had a steeper slope ( 17%
higher) than the CFA group (-0.63 and -0.52, respectively) (Figure 4-lB). Therefore, the
urinary excretion of ethanol was involved in the dietary fatty acids related changes in the
BEC; it was faster in the TF A group than in the CF A group.
It has been shown that dietary camitine raised BEC in a dose-dependent manner
following both acute and chronic treatment of ethanol in rats (Berger and Sachan
1986;1991, Sachan 1992, Sachan and Berger 1987). Camitine also delayed ethanol
oxidation and thus expanded the half-life of ethanol in broilers (Smith et al. 1994). In the
isolated rat hepatocytes, the rate of ethanol oxidation was reduced by acetylcamitine and
L-camitine as compared to that without camitine (Cha and Sachan 1995). All these
results clearly indicated that camitine retarded ethanol metabolism. Furthermore, the
BEC was positively related to plasma NEC and TC of rats fed the SF A and USF A diets
as reported by Cha and Sachan (1994). In Experiment 1 of the present study, the TFA
group had significantly lower concentrations of plasma ASAC (P < 0.05) and AIAC (P <
0.01) than the SFA and CFA groups after 2 weeks of dietary treatment (Figure 4-2B).
Plasma AIAC concentrations remained significantly lower (P < 0.04) in the trans FA
group than in the SFA group after 4 weeks of feeding (Figure 4-2C). After 6 weeks of
feeding, plasma ASAC concentration was significantly lower (P < 0.02) in the TF A
group than in the SFA group (Figure 4-2D). In Experiment 2, plasma camitine
concentrations were lower in the TF A group than in the CF A group (Table 4-3), which
was consistent with the earlier results. Therefore, faster rate of ethanol metabolism in the
TF A group and relatively slower rates of ethanol metabolism in the SFA and CF A groups
may be mediated at least in part through camitine.
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In addition to the liver, the measured tissue carnitine concentrations were within
the reported range of tissue carnitine concentrations in rats (B0hmer and M0lstad 1980).
The low camitine concentrations of the liver might be because the liver was perfused;
therefore, the liver carnitine content was not contaminated with plasma camitine. The
liver carnitine content might also be diluted by extra perfused solution (saline) retained in
the liver. Data of tissue camitine concentrations (Table 4-4) indicate that the changes in
camitine created by dietary fats were not consistent. Except for the liver and skeletal
muscle, the NEC concentrations were significantly elevated with the increased degree of
saturation of dietary fats. The ASAC concentrations in the brain decreased with
increased degree of saturation of dietary fats. However, in the liver, the ASAC
concentrations was affected by the geometry of dietary fatty acids; the concentrations of
ASAC were significantly higher in the TF A group than in the SFA and CF A groups (P <
0.001). The AIAC concentrations were significantly increased in the brain (P < 0.0001)

of rats fed the SFA diet but were significantly lowered in the liver (P < 0.05) and small
intestine (P < 0.03) ofrats fed the TFA diet. Only the TC concentrations of the small
intestine were significantly modulated by the dietary lipids; it was higher in the SFA
group than in the TFA group (P < 0.05). The relation of the changes in tissue camitine
distributions to ethanol metabolism is not clear. Since the liver is the primary organ of
ethanol metabolism, the changes in hepatic carnitine may influence ethanol metabolism.
However, the liver carnitine profile was opposite of that seen in plasma, especially with
regard to the ASAC concentrations. The ASAC concentrations in the liver or plasma
may not be equated with acetyl carnitine even though acetyl carnitine is part of ASAC.
Therefore, determination of acetyl carnitine is one of the logical ways to assess the role of
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endogenous acetyl camitine and relate it to ethanol metabolism.
CPT-I, the outer form of camitine palmitoyltransferase, is regarded as a key
enzyme regulating hepatic and extrahepatic mitochondrial FA oxidation (Saggerson 1986,
Schulz 1991). The activity of hepatic CPT-I has been shown to be inhibited by both
short-term and prolonged ethanol feeding in animal studies (Castro 1991, Guzman and
Geelen 1988, Guzman et al. 1987). Consequently, CPT-I could play a critical role in the
ethanol-induced inhibition of hepatic FA oxidation leading to triglyceride accumulation
in the liver (Guzman et al. 1987). The CPT-I activity has been reported to be modulated
by the dietary lipids. Feeding olive, safflower, and menhaden oils to rats resulted in
higher CPT-I activities in the liver (Power et al. 1994), heart, and skeletal muscle (Power
and Newsholme 1997) than feeding hydrogenated coconut oil. In the present study,
hepatic CPT-I activity was not affected by the TFA diet (Table 4-1) which is in
agreement with the results of other studies. Ide et al. (1987) reported that short- and longterm TF A (elaidic acid) feeding had only a marginal effect on the activities of liver
mitochondrial fatty acid oxidation enzymes, including camitine acyltransferase, in
different strains ofrats. In primary rat hepatocyte cultures, brassidic acid (trans C22:l)
had no effect on CPT-1 activities compared to erucic (cis C22:l) or oleic acids
(Christiansen et al. 1985). Feeding conjugated linoleic acid, a positional and geometric
isomer of conjugated dienoic derivatives of linoleic acid, had no effect on CPT-I activity
in the liver of mice (Park et al. 1997). It has been noted that freezing/thawing of
mitochondria inactivated CPT-I but not CPT-II, the camitine palmitoyltransferase present
in the inner mitochondrial membrane (McGarry and Brown 1997). In Experiment 1, the
mitochondria were prepared freshly (not frozen) for CPT-I assay and thus the
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measurement should be representative of the CPT-I activity.
In summary, the hepatic ADH activity was not significantly affected by the
dietary fatty acids after 2 or 6 weeks of dietary treatment. Therefore, the dietary fatty
acids related changes in BEC must be explained by other mechanisms like MEOS and by
the extrahepatic ADH activity. The TF A group appeared to eliminate more ethanol per
mL of urine than the CF A group during the first 4 hours after ethanol administration and
may partially be the reason for the differences in BEC. Further, the parallel changes in
the BEC and plasma camitines may also contributed to higher BEC in rats fed the SF A
and CFA diets compared to those fed the TF A diet.
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CHAPTERV
EFFECTS OF SATURATED, CIS, AND TRANS FATTY ACIDS ON
INTESTINAL UPTAKE AND METABOLISM OF
ETHANOL IN RATS

ABSTRACT
The rats fed trans fatty acid (TF A) for 2 weeks maintained lower blood ethanol
than those fed saturated fatty acids (SF A) or cis fatty acids (CFA) which may have been
due to differences in the absorption of ethanol from the gastrointestinal tract. This
experiments was designed to determine the differences in ethanol uptake and metabolism
in the small intestines of 18 male Sprague-Dawley rats fed dietary SFA, CFA, or TF A.
The uptake and/or metabolism of ethanol was measured in everted intestinal sacs.
Ethanol transport expressed as the ratio of serosal to mucosa! ethanol concentrations and
the in vitro absorption rate of ethanol was not significantly affected by dietary fatty acids.
However, when the amount of ethanol metabolized to CO 2 during the transport process
was taken into account, uptake and metabolism of ethanol by the proximal segments of
the small intestine were significantly higher in the rats fed the TF A and CF A than in
those fed SF A. Because ethanol oxidation was not significantly different between the
CF A and TF A group, some other mechanism must be responsible for the differences in
BEC of animals fed CF A and TF A. Nonetheless, it is recognized that ethanol
metabolism in extrahepatic tissues can not be ignored due to the effects of SFA and
unsaturated fatty acids on ethanol pharmacokinetics.
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INTRODUCTION
The manipulation of dietary fatty acids alters the fatty acid composition of the
intestinal membranes and thus influences the absorption of ingested nutrients (Thomson
and Rajotte 1983, Thomson et al. 1986). Sugano et al. (1984) found that the cholesterol
absorption rate was markedly reduced in the enterocytes of rats fed trans fat than in those
fed cis fat. Manteca et al. ( 1994) have shown an increased intestinal uptake of cholesterol
in rats fed a diet supplemented with elaidic acid. However, Thomson et al. (1994)
determined that feeding TF A to rats for 2 weeks had no influence on the jejunal or ileal
uptake of glucose, fatty acids (lauric, stearic, oleic, linoleic, and linolenic acids), and
cholesterol. In addition, it was noticed that SFA, compared to polyunsaturated fatty acids
(PUFA) prevented the acute ethanol-induced inhibition of the jejunal and ileal uptake of
hexoses and lipids in rats (Thomson et al. 1991 ). These reports and the slower rate of
ethanol absorption in rats fed the TF A diet observed earlier (Chapter 3), added strength to
the hypothesis that ethanol transport and/or metabolism may be modulated at the small
intestinal level in these animals. A search of the literature revealed that there is no data
on the response of the small intestine to TF A feeding regarding ethanol uptake and
metabolism in rats. Thus, the objective of this study was to determine the uptake and
metabolism of ethanol in the small intestine of rats fed SFA, CFA, or TFA diets for 2
weeks using the in vitro everted intestinal sacs.

MATERIALS AND METHODS
Animals. The experimental protocol was approved by the University of Tennessee
Committee on Humane Care and Use of Laboratory Animals. Male Sprague-Dawley rats
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of approximately 4 weeks of age were purchased from Harlan Sprague Dawley Inc.
(Indianapolis, IN). Each rat was individually housed in a stainless steel wire bottom cage
in a temperature controlled room (23 ± 2 °C) with a 12-hour light-dark cycle. After 1
week of acclimation with Purina Rodent chow diet (Ralston, Purina Co., St. Louis, MO),
rats were randomly assigned to different groups for 2 weeks of dietary treatment. All
animals were allowed free access to food and water. When urine samples were collected,
the rats were placed in the individual metabolic cages for 24 hours. Food consumption
was recorded daily and body weight was monitored weekly for each animal.
Diet. Rats were fed modified AIN76 diets enriched with 10% (w/w) SFA, CFA, or TFA
(Table 5-1). Various edible fats and oils and one fatty acid were mixed to generate the
diets of comparable fatty acid composition. The fat sources of the SFA and CFA diets
consisted of butter, com oil, and olive oil. Margarine, free elaidic acid, and butter were
used as the fat sources of the TF A diet. The dietary fats were adjusted to have a similar
level of total poly-unsaturated fatty acids (PUF A). Table 5-2 presents the fatty acid
compositions of the different diets as determined in a Hew let-Packard (Model 5890 series
II) chromatograph equipped with a flame ionization detector and a DB23 fused silica
capillary column (0.25 mm I.D. x 30 m x 0.25 µ film, J & W Scientific, Folsom, CA).

All diets were prepared weekly and stored at -20 °C. The fresh diets were given every
morning and leftovers were discarded.
Experimental design. The 18 rats were randomly assigned to one of the 3 diets (n =
6): SF A, CF A, or TF A and fed the respective diets for 2 weeks. The food was withheld
overnight prior to their being killed by cervical dislocation. The small intestine was
processed immediately to determine the uptake and metabolism of ethanol by the everted
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TABLE 5-1

Composition of the experimental diets 1
Diet
Ingredient

SFA

CPA

TFA

g/kg
200

200

200

3

3

3

Com starch

150

150

150

Sucrose

450

450

450

Cellulose

50

50

50

Vitamin mix

10

10

10

Mineral mix

35

35

35

Comoie

58

52

Olive oila

5

37

47.1

14

Casein
DL-Methionine

Buttera
Margarine3a

110.73
12

Elaidic acida
Choline bitartrate

1.27

2

2

1

2

Abbreviations used: SFA, saturated fatty acids; CFA, cis fatty acids; TFA, trans fatty
acid.
2
Butter: 113g of butter contains 92g of fat; therefore, there is about 81 % fat in butter.
3
Margarine: 113 g of margarine contains 91 g of fat; therefore, there is about 80% fat in
marganne.
a Differences presented in fat sources are due to their compositions of fatty acids which
are balanced between the three experimental diets.
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TABLE 5-2

Fatty acid composition of the experimental diets (mole%/· 2
Dietary group
SPA

CPA

TFA

ClO:O

0.8

0.2

0.0

C12:0

1.2

0.4

0.0

C14:0

4.3

1.3

0.2

C16:0

19.5

14.0

12.2

C16:1

0.6

0.5

0.1

C18:0

7.3

4.0

7.4

29.3

44.5

26.1

0.1

0.1

19.2

C18:2 (n-6)

34.5

33.1

33.1

C18:3 (n-3)

0.8

0.9

0.7

~SPA

34.0

20.6

20.6

~MUFA

30.4

45.4

45.5

~PUPA

35.6

34.0

33.9

1.0

1.7

1.7

Fatty acid

cisC18:1 (n-9)
trans C18:1 (n-9)

PIS
S/M/P

1/2.2/1.7

1/0.911

1

1/2.2/1.7

Diets were analyzed for fatty acid compositions in a Hewlet-Packard Model 5890
series II gas chromatograph equipped with a flame ionization detector and a DB23 fused
silica capillary column (0.25 mm I.D. x 30 m x 0.25 µ film, J & W Scientific, Folsom,
CA).
2
Abbreviations used: SFA, saturated fatty acids; CF A, cis fatty acids; TF A, trans fatty
acid; MUF A, mono-unsaturated fatty acids; PUFA, poly-unsaturated fatty acids; ~ SFA,
total saturated fatty acids; ~ MUF A, total mono-unsaturated fatty acids; ~ PUFA, total
poly-unsaturated fatty acids; PIS, PUFA:SFA ratio; S/M/P, SFA:MUFA:PUFA ratio.
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sacs of small intestine.

Preparation of everted intestine segments. The everted intestinal sac was prepared
according to the procedure described by Wilson and Wiseman (1954). After the animal
was killed by cervical dislocation, the abdomen was opened and the entire small intestine
was washed out with cold saline. The whole small intestine was removed by cutting
across the beginning of duodenum and the end of ileum. The mesentery was manually
stripped from the intestine and the intestine was rinsed gently with 10 to 20 mL of cold
saline. To evert the entire gut, one end of the entire intestinal segment was tied with
cotton thread. A plastic rod was then used to push the tied end of the gut into the gut
lumen until it appeared at the opening of the intestinal segment. The eversion was
completed by rolling the whole intestinal segment on the rod. The everted intestine was
then slipped off the rod, cut into 4 (2 proximal and 2 distal) segments, and placed in cold
saline at room temperature in a flat porcelain dish.

Determination of ethanol uptake by everted intestinal sacs. Two proximal and 2
distal small intestinal sacs, approximately 6 cm in length, were prepared from each
animal. Using a blunt needle, 1 mL of oxygenated Krebs-Ringer bicarbonate (KRB)
buffer containing 0.3% glucose (serosal medium) was injected into the intestinal segment
with one end tied. The open end of the intestinal segment was then closed off with a
ligature. The everted sacs were then placed in a 25 mL Erlenmeyer flask containing 5 mL
KRB buffer with 0.3% glucose and l- 14C ethanol (specific activity, 10932 cpm/mmol) or
unlabeled ethanol (mucosa! medium). The flask and its content were flushed with a
mixture of 0 2:C02 (95:5), sealed with rubber stopper, and incubated at 37°C for 20
minutes in a Dubnoff metabolic shaking incubator at 96 cycles/minute. At the end of the
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incubation period, the sacs were removed and the serosal medium was drained into a test
tube. The radioactivities of 14C from serosal media, mucosa! media, and intestinal sac
homogenates were determined in a Beckman LS-3801 liquid scintillation counter. The
concentrations of ethanol of the mucosa! or serosal medium were also assayed by the
modified enzymatic method of Bernt and Gutmann (1974) as described in the materials
and methods section of Chapter 3. The ratio of 14C radioactivities or the ethanol
concentrations in the serosal and mucosal media were used as indices of uptake function.
Determination of 14 C02 in mucosa/ media. Determination of 14C02 content in
mucosal medium was carried out in 25 mL Warburg flasks. Two mL of mucosal medium
was used for the determination of CO2 derived from ethanol. The center well contained
0.2 mL of 100% ethanolamine and the side arm contained 0.2 mL of 60% perchloric acid
(PCA). The flask was sealed with a rubber stopper. Any possible ongoing ethanol
oxidation was stopped by tipping PCA from the side arm into the mucosal medium. The
flask and its contents were then incubated for 60 minutes at 37°C in a Dubnoffmetabolic
shaking water bath to allow CO2 absorption into the ethanolamine. After the incubation,
the flask was allowed to equilibrate in chilled ice water for 30 minutes. Ethanolamine
was transferred from center well to a scintillation vial. Residual ethanolamine was
washed 3 times with scintillation fluid (200 µL). After adding 4 mL of scintillation fluid
to the vial, the radioactivity was counted in a Beckman LS 3801 liquid scintillation
counter.
Statistics. All data were expressed as the group means± SEM. The statistical
significance was evaluated by ANOVA among 3 dietary groups and Duncan's multiple
range test was used for multiple comparisons. All statistical analyses were performed
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using SAS for Unix system (version 6, SAS Institute, Cary, NC) and the significance
level was set at P < 0.05.

RESULTS

Weight gain and food intake. There were no differences in the weight gain and food
intake among the 3 dietary groups (Table 5-3).
Ethanol uptake and/or metabolism by everted intestinal sacs. The effect of different
dietary fatty acids on the intestinal uptake and/or metabolism of ethanol carried out in the
everted intestinal sacs model is presented in Tables 5-4 to 5-7. Two methods were
applied to measure the ethanol concentrations: 14C radioactivity counting and the
enzymatic method. At first, ethanol transport across everted intestinal sacs was expressed

TABLE 5-3

Body weight and food intake in rats fed saturated, cis or trans fatty acids diets
for 2 weeks 1' 2
Dietary group
Parameter
SFA

CFA

TFA

187.8 ± 6.4a

186.6 ± 5.7a

186.7 ± 6.la

Weight gain (g)

65.2 ± 3.0a

64.2 ± 7.3a

70.7 ± 5.4a

Food intake (g)

219.8 ± 7.0a

212.7 ± 10.7a

220.1 ± 4.6a

Initial body weight (g)

1

Values are group means± SEM (n = 6) and those with the same superscripts in a row
are not significantly different at P < 0.05.
2
Abbreviations used: SFA, saturated fatty acids; CFA, cis fatty acids; TF A, trans fatty
acid.
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TABLE 5-4
Ethanol transport across everted intestinal sacs as determined by the specific activity of J-1 4 C-ethanol in rats
fed saturated, cis or trans fatty acids diet for 2 weeks 1' 2
Dietary group
Segment

Medium

TFA

CFA

SFA

µmol ethanol/mg tissue/20 minutes
Proximal

I'--'

N

Serosal

3.53 ± 0.25

5.48 ± 0.52

5.01 ± 0.72

Mucosa}

22.16 ± 1.81

34.10 ± 1.73

35.04 ± 1.90

Serosal/mucosal

0.16 ± O.Ola

0.16 ± O.Ola

0.14 ± 0.02a

Serosal

2.75 ± 0.52

5.02 ± 1.33

4.89 ± 0.78

Mucosal

18.53 ± 2.69

36.06 ± 6.57

31.15 ± 4.28

I'--'

Distal

Proximal and distal

Serosal/mucosal

0.15 ± O.Ola

0.14 ± 0.02a

0.15 ± O.Ola

Serosal

3.14 ± 0.30

5.25 ± 0.69

4.95 ± 0.51

Mucosa}

20.34 ± 1.64

35.08 ± 3.25

33.10±2.31

Serosal/mucosal
1

0.15 ± O.Ola

0.15 ± O.Ola

0.15 ± O.Ola

Values are mean± SEM (n = 3, 2 proximal and 2 distal segments from each rat) and those bearing the same superscript letters in a row
are not significantly different at P < 0.05. Substrate used was l- 14C-ethanol. Concentrations were determined by specific activity of
ethanol (10932 cpm/mmol).
2
Abbreviations used: SFA, saturated fatty acids; CFA, cis fatty acids; TF A, trans fatty acid.

TABLE 5-5
Ethanol transport across everted intestinal sacs as determined by enzymatic ethanol assay in 3 rats
fed saturated, cis or trans fatty acids diet for 2 weeks 1' 2
Dietary group
Segment

Medium
SFA

CFA

TFA

µmol ethanol/mg tissue/20 min
Proximal

I-'

N
N

Distal

Proximal and distal

Serosal

2.75 ± 0.42

4.32 ± 0.56

3.44 ± 0.52

Mucosa!

16.68 ± 2.08

24.47 ± 2.00

23.48 ± 1.58

Serosal/mucosal

0.16 ± O.Ola

0.17±0.0la

0.15 ± 0.02a

Serosal

2.11 ± 0.63

3.83 ± 1.24

3.64 ± 0.62

Mucosa!

12.50 ± 2.35

25.83 ± 5.90

21.91±3.31

Serosal/mucosal

0.16 ± 0.02a

0.15 ± 0.02a

0.16±0.0la

Serosal

2.43 ± 0.37

4.07 ± 0.65

3.54 ± 0.38

Mucosal

14.59 ± 1.62

25.15 ± 2.98

22.69 ± 1.76

Serosal/mucosal
1

0.16 ± O.Ola

0.16±0.0la

0.15±0.01 3

Values are mean± SEM (n = 3, 2 proximal and 2 distal segments from each rat) and those bearing the same superscript letters in a row
are not significantly different at P < 0.05. Substrate used was l- 14 C-ethanol. Ethanol concentrations were determined by enzymatic
method.
2
Abbreviations used: SFA, saturated fatty acids; CFA, cis fatty acids; TFA, trans fatty acid.

TABLE 5-6
Ethanol transport across everted intestinal sacs as determined by enzymatic ethanol assay in 6 rats
fed saturated, cis or trans fatty acids diet for 2 weeks 1' 2
Dietary group
Segment

Medium
SFA

CFA

TFA

µmol ethanol/mg tissue/20 min
Proximal

......
N

Serosal

4.00 ± 0.43

4.89 ± 0.35

4.16 ± 0.44

Mucosa!

21.12±1.79

27.13 ± 1.38

27.66 ± 2.25

Serosal/mucosal

0.18 ± 0.01 a

0.18 ± 0.01 3

0.15±0.01 3

Serosal

4.01 ± 0.68

4.68 ± 0.69

4.68 ± 0.65

Mucosa!

20.55 ± 3.02

31.16±5.05

24.58 ± 2.00

Serosal/mucosal

0.18±0.01 3

0.16 ± 0.02 3

0.18 ± 0.01 3

Serosal

4.00 ± 0.38

4.79 ± 0.38

4.42 ± 0.39

Mucosa!

20.85 ± 1.72

29.14 ± 2.59

26.12 ± 1.50

0.18±0.01 3

0.17±0.01 3

0.17 ± 0.01 3

w

Distal

Proximal and distal

Serosal/mucosal
1

Values are mean± SEM (n = 6, 2 proximal and 2 distal segments from each rat) and those bearing the same superscript letters in a row
are not significantly different at P < 0 .05. Half of the intestinal sacs were incubated with l - 14C-ethanol and the other half in nonradioactive
ethanol. Ethanol concentrations were determined by enzymatic method.
2
Abbreviations used: SFA, saturated fatty acids; Cis FA, cis fatty acids; Trans FA, trans fatty acid.

TABLE 5-7
Ethanol uptake and metabolism by everted intestinal sacs in rat fed saturated, cis or trans fatty acids diet for 2 weeks 1' 2
Dietary group
Segment

Ethanol equivalent in
SFA

CFA

TFA

µmol ethanol/mg tissue/20 min
Proximal

Serosal medium

3.53 ± 0.25

5.48 ± 0.52

5.01 ± 0.72

Intestinal sac

0.32 ± 0.08

0.38 ± 0.08

0.34 ± 0.06

CO2

1.05 ± 0.07

1.41 ± 0.10

1.32 ± 0.14

Total

4.90 ± 0.29b

7.27 ± 0.50a

6.68 ± 0.80a

Serosal medium

2.75 ± 0.52

5.02 ± 1.33

4.89 ± 0.78

Intestinal sac

0.44 ± 0.09

0.40 ± 0.10

0.42 ± 0.11

CO 2

0.70 ± 0.09

1.49 ± 0.37

0.95 ± 0.19

Total

3.89 ± 0.59a

6.91 ± 1.62a

6.26 ± 0.82a

Serosal medium

3.14 ± 0.30

5.25 ± 0.69

4.95 ± 0.51

Intestinal sac

0.38 ± 0.06

0.39 ± 0.06

0.38 ± 0.06

CO2

0.87 ± 0.08

1.45 ± 0.18

1.14 ± 0.12

Total

4.39 ± 0.35b

7.09 ± 0.81 a

6.47 ± 0.55a

~

N

.,I:::,.

Distal

Proximal and distal

1

Values are mean± SEM (n = 3, 2 proximal and 2 distal segments from each rat) and those bearing the same superscript letters in a row
are not significantly different at P < 0.05.
2
Abbreviations used: SF A, saturated fatty acids; CFA, cis fatty acids; TF A, trans fatty acid.

as the ratio of the ethanol concentrations inside and outside the sacs. The ratios were not
different in any of the segments or in the proximal plus distal segments as determined by
either method (Tables 5-4 and 5-5). The ethanol concentrations determined by the
enzymatic method (Table 5-5) were generally lower than those measured by radioactive
counting (Table 5-4), but the ratios of ethanol concentrations were similar between the 2
methods. Therefore, the intestinal segments from 3 rats were incubated with l- 14 C
ethanol and those of the remaining 3 rats were incubated with unlabeled ethanol in each
dietary group. The ratios of ethanol concentrations assayed by the enzymatic method
were then calculated for 6 rats from each dietary fatty acid group. The index of ethanol
absorption was also similar among the 3 groups (Table 5-6).
The ethanol uptake and metabolism was also expressed as the sum of ethanol
concentrations in the serosal medium and the intestinal sac plus the amount of ethanol
metabolized to CO 2 (µmole ethanol/mg tissue within 20 minutes of incubation) (Table 57). Both the CF A and TF A groups had significantly higher ethanol concentrations
than the SFA group in proximal (P < 0.01) and proximal plus distal segments (P < 0.02).
No difference was found in the distal segments among the 3 dietary groups.

DISCUSSION

Generally, ethanol can be absorbed into the body through the whole GI tract from
the mouth to the rectum, but the main sites for ethanol absorption are the duodenum and
jejunum (Butt 1989). Everted sacs ofrat small intestine were used to understand the
mechanism of dietary fatty acid-mediated differences in blood ethanol clearance. The
everted intestinal sac technique was developed by Wilson and Wiseman (1954) in which
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only the mucosa is directly in contact with oxygenated incubation medium, while the
serosal fluid is isolated inside the closed sac and thus can be sampled independently from
the mucosal medium. Consequently, the ratio of the substrate concentration in the serosal
medium (inside the sac) to the concentration of the substrate in the mucosa! medium
(outside) is used as an indicator of transport function.
In the present study, the ethanol concentrations were determined by the specific
activity of the 14C and by the enzymatic method. The results indicated that ethanol
concentrations were comparable between the 2 methods (Table 5-4 and 5-5). The
ethanol transport across the everted intestinal sacs, determined by either method, was not
affected by dietary fatty acids (Table 5-4 to 5-6).
Because a significant amount of the substrate may be retained and/or metabolized
in the tissue, the disappearance of a solute from the mucosa! fluid does not necessarily
constitute absorption in the everted intestinal sacs model (Foulkes 1996). It is well
established that ethanol is absorbed from the digestive tract and metabolized by ADH at
this site (Boleda et al. 1989, Carter and Isselbacher 1971). Therefore, the absorption of
ethanol was expressed as the sum of ethanol concentrations in serosal and intestinal sac
plus the amount of ethanol metabolized to CO2 (Table 5-7). Ethanol uptake and
metabolism of the CF A and TF A groups was significantly higher than that of the SF A
group in the proximal (P < 0.01) and proximal plus distal segments (P < 0.03).
Therefore, it appeared that the degree of saturation and not the geometry of the double
bond affected the uptake and metabolism of ethanol in the everted intestinal sacs model.
The ethanol absorption, however, can be affected by other factors such as blood flow and
gastric emptying. These factors cannot be imitated in the everted intestinal sac model. In
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addition, with a simplified system like the everted intestinal sac, extrapolation back to the

in vivo situation introduces considerable uncertainty. As a result, other approaches may
be needed to study the effects of dietary fatty acids on ethanol absorption.
In summary, the everted sacs of the small intestine were able to convert l- 14Cethanol to 14C02 • The uptake and metabolism of ethanol was higher in the CF A and TF A
groups than in the SFA group in this model. Because there was no difference in
the ethanol oxidation and uptake between the CF A and TF A groups, these data do not
explain the differences in BEC. Therefore, additional studies are needed to understand
the mechanism responsible for dietary fatty acid mediated differences in BEC of the rats.
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CHAPTER VI
EFFECTS OF SATURATED, CIS, AND TRANS FATTY ACIDS ON
TISSUE, PLASMA, AND MICROSOMAL FATTY ACID
COMPOSITION IN RA TS

ABSTRACT
The effect of feeding dietary saturated fatty acids (SF A), cis fatty acids (CF A),
and trans fatty acid (TF A) on tissue fatty acid composition were determined in male
Sprague-Dawley rats. In general, the fatty acid profiles of various tissues were highly
reflective of the fatty acid content of the diets. In Experiment 1, the phospholipids (PL)
fraction of the liver and small intestine of rats fed the TF A diet for 6 weeks had a higher
percentage of linoleic acid and lower percentages of palmitic, stearic, and arachidonic
acids than those fed the SF A and CF A diets. In Experiment 2, after 2 weeks of dietary
treatment, elaidic acid was present in the plasma and liver microsomes of the TF A group
only. Compared with rats fed the CFA diet, the fatty acid composition in the liver
microsomes of rats fed the TF A diet was characterized by a) a significant decrease in
palmitic, stearic, and oleic acids and an increase in linoleic acid, and b) an elevated
percentage of total MUF A and a reduced proportion of total SF A regardless of the lipid
fractions. These fatty acid changes were similar to those in plasma. The fatty acid
composition data supports the suggestion that TFA and perhaps elaidic acid in particular,
interfered with the conversion of linoleic acid to arachidonic acid, which has been shown
to protect liver from alcohol injury.
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INTRODUCTION
Trans fatty acids (TF A), formed during the biological and industrial
hydrogenation of unsaturated fats, are found in ruminant fats, margarines, shortenings,
and commercial bakeries (Emken 1984, Sachan and Davis 1969). A primary TF A
produced by the chemically partial hydrogenation of vegetable oils is elaidic acid (KrisEtherton and Nicolosi 1995). It has been suggested that TFA resemble SFA in their
metabolic action (Beare-Rogers 1983, Dupont et al. 1991).
Dietary fatty acids have been shown to modify the fatty acid composition of cell
membranes, which in tum affects their stability, permeability, transport properties, and
other biological functions (Clandinin et al. 1991). It has been shown that exposure to
ethanol affected the composition and metabolism of fatty acids in the liver (French et al.
1970, Nanji et al. 1993). A common finding of these studies was that the levels of
polyunsaturated fatty acids (PUF A), especially arachidonic acid, were decreased in the
liver. The decreased concentrations of arachidonic acid were accompanied by an increase
in linoleic acid in some studies (Nanji et al. 1993). The increased linoleic acid and
decreased arachidonic acid concentrations were also observed in the tissues of animals
fed TFA (Atal et al. 1994, Ostlund-Lindqvist et al. 1985). It is not known if the tissue
fatty acid composition relates to blood ethanol concentrations. Therefore, the objective of
this study was to determine the relative effects of diets rich in saturated, cis or trans fatty
acids on the changes in tissue fatty acid compositions and relate it to blood ethanol
clearance.
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MATERIALS AND METHODS
Animals, diets, and experimental design. The experimental protocol was approved by
the University of Tennessee Committee on Humane Care and Use of Laboratory
Animals. The details of treating animals, preparing experimental diets, and experimental
design are described in the materials and methods section in Chapter 3.
Sampling. At the end of the 6-week study period of Experiment 1, adipose tissues
(epididymal, perirenal, and inguinal fat pads), liver (perfused), skeletal muscle, and small
intestine were removed, frozen in liquid nitrogen, and stored at -80°C until assayed for
fatty acid composition. In Experiment 2, at the end of the 2-week experimental period,
blood samples were collected by cardiac puncture. After blood collection, the liver was
removed and processed immediately for microsome preparation. Blood samples were
centrifuged at 1500 x g for 10 minutes at 4 °C and the plasma samples were frozen at 80°C until assayed for fatty acid profile.
Preparation of microsome from liver. In Experiment 2, the liver was first minced by
cutting with scissors in cold 150 mmol/L KCl in 10 mmol/L phosphate buffer (pH 7.4).
Each liver sample was then homogenized in 3 volumes ofKCl-phosphate buffer (pH 7.4)
by 4 strokes in a teflon/glass homogenizer. The homogenate was centrifuged at 600 x g
for 10 minutes at 4 °C. The 600 x g supernatant was transferred to another centrifuge
tube and centrifuged at 10,000 x g for 10 minutes at 4 °C. The 10,000 x g supernatant
was centrifuged at 100,000 x g for 1 hour at 4°C in an ultracentrifuge. The 100,000 x g
pellet (microsomes) was suspended in KCl-phosphate buffer (pH 7.4) and used for
determination of fatty acid composition. Protein concentration was determinated by the
method of Bradford (1976).
130

Determination offatty acid composition. Total lipids from all homogenized tissues
were extracted by the Bligh and Dyer (1959) procedure. The lipids from each tissue
homogenate (100 mg/mL) were extracted by a mixture of chloroform and methanol (1:2,
v/v). The lipids extracted into the chloroform phase were removed after a centrifuge at
900 x g for 3 minutes. The mixture of tissue homogenate and extraction reagent was reextracted with chloroform. The combined chloroform fractions were dried under a stream
of nitrogen and resuspended in a small volume of chloroform for thin-layer
chromatography (TLC) separation.
The phospholipids (PL) of liver, skeletal muscle, small intestine, and hepatic
microsomes were chromatographed on HP-K silica gel TLC plate (Whatman, Maidstone,
England) with a mixture of chloroform and methanol (8: 1, v/v) as a moving solvent. The
PL bands (at the origin) were scraped into screw-cap test tubes and suspended in toluene.
Each PL sample was then saponified with 0.5 mol/L of KOH in methanol at 86°C for 8
minutes and acidified with 0. 7 mol/L HCl in methanol. The fatty acids were twice
extracted with hexane, evaporated, and methylated with diazomethane.
Fatty acid methyl esters (FAME) were resuspended in hexane and analyzed using
a Hewlett-Packard Model 5890 series II gas chromatograph equipped with a flame
ionization detector and a DB23 fused silica capillary column (0.25 mm I. D. x 30 m x
0.25 µ film) (J & W Scientific, Folsom, CA). Separation of FAME was achieved by
temperature programming from 160 to 250°C per minute with hydrogen as the carrier
gas. The internal standard, pentadecanoic acid (Cl5:0) methyl ester (100 µg) was added
to each sample prior to the saponification process. Unknown FAME peaks were
identified by comparison of retention times with those of known standards and the
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individual FAME was quantified as area percentage compared with the internal standards.
The protocol of the fatty acid assay is present in Appendix III.

Statistics. All data were expressed as the group means ± SEM. The ANOV A and
Duncan's multiple range test as well as the student's t test were utilized in Experiments 1
and 2, respectively. The level of statistical significance was set at P < 0.05. All
statistical analyses were performed using SAS for Unix system (version 6, SAS Institute,
Cary, NC).

RESULTS

Tissue fatty acid compositions in Experiment 1. The fatty acid composition of
various tissues from Experiment 1 are shown in Tables 6-1 to 6-9. As expected, the fatty
acid composition of various tissues were modified according to the fatty acid content of
the diets. Significant percentages of elaidic acid, derived from the exogenous dietary
source, were found only in rats fed the TF A diet. Trace amounts of elaidic acid were
detected in some tissues and lipid fractions from rats fed the SFA and CF A diets.
Relative to the proportions distributed in the diets, more monounsaturated fatty acids
(MUF A) were present in the adipose fats isolated from rats fed the TF A diet due to the

increased percentages of palmitoleic and elaidic acids in the adipose tissues. Because of
the comparable fatty acid content of the CF A and TF A diets, the main comparisons of
tissue fatty acid composition were made between these 2 dietary groups.
Adipose tissue. The effects of dietary fats on the fatty acid composition of

epididymal, perirenal and inguinal adipose tissues are presented in Tables 6-1 to 6-3.
Compared to the CFA diet, the TF A diet resulted in significantly higher (P < 0.05)
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percentages of palmitoleic and elaidic acids and a significantly lower (P < 0.05)
proportions of oleic acid in the 3 different types of adipose tissue. The percentage of
arachidonic acid was significantly lower (P < 0.05) in the epididymal and inguinal fat
pads of the TFA group compared to the CFA group (Tables 6-1 and 6-3). Rats fed the
TFA diet had a significantly higher (P < 0.05) percentage of stearic acid and a
significantly lower (P < 0.05) percentage of palmitic acid in the epididymal fat pads than
those fed the CF A diet (Table 6-1 ). A significantly lower (P < 0.05) percentage of
linoleic acid was found in the perirenal adipose fat of the TF A group compared to that of
the CF A group (Table 6-2). The deposition of elaidic acid significantly increased the
percentage of total MUFA in the 3 types of adipose tissues.
Liver. The fatty acid composition of PL and NL of the liver are shown in Tables
6-4 and 6-5. In the PL fraction, the incorporation of elaidic acid was accompanied by a

significant reduction (P < 0.05) in the proportions of palmitic and stearic acids (Table 64). By contrast, in the NL fraction, the TF A group showed a significantly lower (P <

0.05) level of oleic acid (Table 6-5). Significantly higher (P < 0.05) percentages of
palmitoleic, oleic, elaidic, and linoleic acids and a significantly lower (P < 0.05)
percentage of arachidonic acid were found in the PL of rats fed the TFA versus the CFA
diet (Table 6-4). Rats fed the TFA diet had significantly higher (P < 0.05) proportions of
palmitoleic and elaidic acids and significantly lower (P < 0.05) proportions of oleic and
arachidonic acids than those fed the CFA diet in the NL fraction (Table 6-5). Reduced
total SFA and increased total MUFA proportions of the PL fraction were observed in the
TFA group compared to the CFA group (Table 6-4). The proportions of total SFA,
MUFA, and PUFA were not affected by the dietary fats in the NL fraction (Table 6-5).
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TABLE 6-1
Fatty acid composition of epididymal adipose tissue (mole%) in rats fed saturated,
cis, or trans fatty acids diet for 6 weeks from Experiment 1 1' 2
Dietary group
Fatty acid

SFA

CFA

TFA

ClO:O

0.6 ± O.la

0.2± o.ob

0.2 ± O.Ob

C12:0

11.6 ± 0.7a

0.3 ± O.lb

0.2 ± O.Ob

C14:0

8.5 ± O.la

1.5 ± O.Ob

1.4 ± O.Ob

Cl6:0

23.9 ± 0.3a

22.5 ± 0.3b

21.3 ± 0.4c

C16:1

6.1 ± 0.3a

4.2 ± 0.2c

4.9 ± 0.2b

Cl8:0

2.9 ± O.lb

3.7 ± 0.3b

4.7 ± 0.3a

24.6 ± 0.2c

41.5 ± 0.4a

30.2 ± 0.2b

0.2 ± o.ob

n.d.

12.4 ± 0.5a

Cl8:2 (n-6)

20.6 ± 0.5b

25.7 ± 0.2a

24.1 ± 0.8a

Cl8:3 (n-3)

o.5 ± o.ob

0.7 ± O.Ob

2.2 ± O.la

C20:4 (n-6)

0.3 ± 0.lab

0.4 ± o.oa

0.2 ± O.Ob

cisC18:1 (n-9)
trans C 18: 1 (n-9)

~SFA

47.5 ± 0.8a

28.1 ± 0.5b

27.9 ± 0.6b

~MUFA

30.8 ± 0.4c

45.7 ± 0.4b

47.5 ± 0.5a

~PUFA

21.5 ± 0.6b

26.8 ± 0.3a

26.6 ± 0.8a

18:2 (n-6)/20:4 (n-6)

79.7 ± 9.8b

74.3 ± 8.3b

143.6 ± 7.6a

1

Values are group means± SEM (n = 6) and those with the same superscripts in a row
are not significantly different at P < 0.05.
2
Abbreviations used: SFA, saturated fatty acids; CFA, cis fatty acids; TF A, trans fatty
acid; MUF A, mono-unsaturated fatty acids; PUF A, poly-unsaturated fatty acids; ~ SF A,
total saturated fatty acids; ~ MUF A, total mono-unsaturated fatty acids; ~ PUF A, total
poly-unsaturated fatty acids; n.d., not detectable.
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TABLE 6-2

Fatty acid composition ofperirenal adipose tissue (mole%) in rats fed saturated, cis,
or trans fatty acids diet for 6 weeks from Experiment 1 1' 2
Dietary group
Fatty acid

CFA

SFA

TFA

ClO:O

1.0±0.la

0.4 ± o.ob

0.5 ± O.lb

Cl2:0

13.4 ± 0.5a

0.2± o.ob

0.2 ± O.Ob

Cl4:0

9.3±0.la

1.7 ± O.lb

1.8 ± O.Ob

Cl6:0

26.4 ± 0.5a

25.4 ± 0.7a

25.2 ± 0.7a

Cl6:l

5.8 ± 0.3a

4.3 ± 0.2b

5.6± 0.3a

Cl8:0

3.5 ± 0.4a

3.6± 0.2a

3.5 ± O.la

23.5 ± 0.4c

40.7 ± 0.6a

29.3 ± 0.2b

0.2 ± O.Ob

0.2 ± O.lb

11.8 ± 0.3a

Cl8:2 (n-6)

16.3 ± 0.5c

22.7 ± 0.6a

20.2 ± 0.7b

Cl8:3 (n-3)

0.2 ± o.oc

0.4 ± o.ob

2.0± o.oa

C20:4 (n-6)

0.4 ± 0.3a

0.3 ± O.lb

0.2± O.Ob

~SFA

53.6 ± 0.5a

31.4 ± 0.9b

31.2 ± 0.7b

~MUFA

29.4 ± 0.3c

45.2 ± 0.4b

46.6 ± 0.4a

~PUFA

17.0 ± 0.4b

23.4 ± 0.6a

22.2 ± 0.7a

18:2 (n-6)/20:4 (n-6)

94.9 ± 17.7a

23.4 ± 0.6a

22.2 ± 0.7a

cisC18:l (n-9)
trans Cl8:l (n-9)

1

Values are group means± SEM (n = 6) and those with the same superscripts in a row
are not significantly different at P < 0.05.
2
Abbreviations used: SFA, saturated fatty acids; CF A, cis fatty acids; TFA, trans fatty
acid; MUF A, mono-unsaturated fatty acids; PUF A, poly-unsaturated fatty acids; ~ SFA,
total saturated fatty acids; ~ MUFA, total mono-unsaturated fatty acids; ~ PUF A, total
poly-unsaturated fatty acids.
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TABLE 6-3
Fatty acid composition of inguinal adipose tissue (mole%) in rats fed saturated, cis,
or trans fatty acids diet for 6 weeks from Experiment 1 1' 1
Dietary group
Fatty acid

CFA

SFA

TFA

CIO:O

1.0±0.la

0.5 ± O.lb

0.4±0.lb

C12:0

14.9 ± 0.3a

0.5 ± O.lb

0.4 ± O.Ob

C14:0

9.1 ± 0.2a

1.6±0.lb

1.7 ± O.Ob

C16:0

22.9 ± 0.5a

22.4 ± 0.3ab

21.4 ± 0.3b

C16:1

4.0 ± 0.3a

2.7 ± O.lb

3.7 ± 0.3a

C18:0

3.5 ± 0.2b

3.7 ± 0.1 ab

4.1 ± 0.2a

22.8 ± 0.3c

41.1 ± 0.4a

30.0 ± 0.3b

0.2 ± O.Ob

0.1 ± o.ob

11.8 ± 0.4a

C18:2 (n-6)

20.8 ± 0.7b

26.1 ± 0.5a

24.4 ± 0.6a

C18:3 (n-3)

0.4 ± o.oc

o.5 ± o.ob

2.0± o.oa

C20:4 (n-6)

0.3 ± O.lb

0.5 ± O.la

0.2± o.ob

~SFA

51.4 ± 0.8a

28.8 ± 0.4b

27.9 ± 0.3b

~MUFA

27.0 ± 0.2c

44.0 ± 0.4b

45.5 ± 0.7a

~PUFA

21.6 ± 0.7b

27.2 ± 0.4a

26.7 ± 0.6a

18:2 (n-6)/20:4 (n-6)

86.8 ± 12.2b

71.9 ± 15.lb

cisC18:1 (n-9)
trans Cl 8: 1 (n-9)

1

130.4 ± 7.la

Values are group means± SEM (n = 6) and those with the same superscripts in a row
are not significantly different at P < 0.05.
2
Abbreviations used: SF A, saturated fatty acids; CFA, cis fatty acids; TFA, trans fatty
acid; MUF A, mono-unsaturated fatty acids; PUFA, poly-unsaturated fatty acids; ~ SFA,
total saturated fatty acids; ~ MUF A, total mono-unsaturated fatty acids; ~ PUF A, total
poly-unsaturated fatty acids.
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TABLE 6-4
Fatty acid composition of liver phospholipids (mole%) in rats fed saturated, cis or
trans fatty acids diet for 6 weeks from Experiment 1 1' 2
Dietary group
Fatty acid
SPA

CPA

TFA

CIO:O

0.8 ± 0.2a

1.0 ± 0.7a

0.1 ± o.oa

C12:0

0.7 ± O.la

0.7 ± O.la

0.6± o.oa

C14:0

0.9 ± O.la

0.4± O.Ob

0.4 ± O.Ob

C16:0

21.6 ± 0.3a

20.9 ± 0.4a

19.2 ± 0.6b

C16:1

1.7±0.2a

1.0±0.lb

1.6 ± 0.2a

C18:0

22.7 ± 0.4a

21.9 ± 0.4a

16.l±0.4b

cis C18:1 (n-9)

4.6 ± O.lc

6.8 ± O.lb

7.8 ± 0.2a

trans C18:1 (n-9)

0.2 ± O.lb

0.2 ± O.lb

8.1 ± 0.2a

C18:2 (n-6)

16.7 ± 0.4b

16.l±0.2b

20.2 ± 0.3a

C18:3 (n-3)

n.d.

n.d.

0.10 ± 0.0

C20:4 (n-6)

29.9 ± 0.4a

30.8 ± 0.4a

25.6 ± 0.4b

~SPA

46.7 ± 0.3a

44.8 ± 0.6b

36.4 ± 0.4c

~MUFA

6.5 ± 0.4c

8.1 ± 0.2b

17.5 ± 0.2a

~PUFA

46.8 ± 0.4a

47.1 ± o.sa

46.0 ± 0.4a

o.6 ± o.ob

o.s ± a.ob

0.8 ± o.oa

18 :2 (n-6)/20:4 (n-6)
1

Values are group means± SEM (n = 6) and those with the same superscripts in a row
are not significantly different at P < 0.05.
2
Abbreviations used: SFA, saturated fatty acids; CF A, cis fatty acids; TFA, trans fatty
acid; MUF A, mono-unsaturated fatty acids; PUF A, poly-unsaturated fatty acids; ~ SF A,
total saturated fatty acids; ~ MUF A, total mono-unsaturated fatty acids; ~ PUF A, total
poly-unsaturated fatty acids; n.d., not detectable.
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TABLE 6-5

Fatty acid composition of liver neutral lipids (mole%) in rats fed saturated, cis, or
trans fatty acids diet for 6 weeks from Experiment 1 1' 2
Dietary group
Fatty acid

SFA

CFA

TFA

ClO:O

0.7 ± 0.2a

1.8 ± 0.7a

2.6 ± 1.oa

C12:0

2.5 ± O.la

2.1 ± 0.2b

2.0 ± O.lb

C14:0

4.5 ± 0.2a

1.5 ± O.Ob

1.5 ± O.Ob

C16:0

32.5 ± 0.6a

26.7 ± 0.4b

26.9 ± 0.6b

C16:1

6.1 ± 0.9a

3.0± 0.2b

5.0± 0.5a

C18:0

3.9 ± 0.2a

3.3 ± 0.2b

3.3 ± O.lb

25.2 ± 0.3b

35.3 ± 0.7a

26.5 ± 0.4b

0.3 ± 0.2b

n.d.

8.0 ± 0.5a

C18:2 (n-6)

20.5 ± 1.4a

22.4 ± 0.5a

20.5 ± 1.2a

C18:3 (n-3)

n.d.

n.d.

1.4 ± 0.1

C20:4 (n-6)

3.5 ± 0.3a

3.4 ± 0.3a

2.1 ± O.lb

~SFA

44.1 ± 0.8a

35.4±1.lb

36.2 ± 1.4b

~MUFA

31.6 ± 1.2b

38.4 ± 0.8a

39.5 ± 0.5a

~PUFA

24.4 ± 1.8a

26.3 ± 0.6a

24.3 ± 1.3a

6.0± 0.2b

6.9± 0.6b

9.8 ± 0.6a

cisC18:1 (n-9)
trans C18:1 (n-9)

18:2 (n-6)/20:4 (n-6)
1

Values are group means± SEM (n = 6) and those with the same superscripts in a row
are not significantly different at P < 0.05.
2
Abbreviations used: SFA, saturated fatty acids; CF A, cis fatty acids; TF A, trans fatty
acid; MUF A, mono-unsaturated fatty acids; PUF A, poly-unsaturated fatty acids; ~ SF A,
total saturated fatty acids; ~ MUFA, total mono-unsaturated fatty acids; ~ PUF A, total
poly-unsaturated fatty acids; n.d., not detectable.
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Skeletal muscle. The fatty acid composition of the skeletal muscle PL and NL
were summarized in Tables 6-6 and 6-7. In the PL fraction, the deposition of elaidic
acid significantly decreased the percentages of palmitic, stearic, oleic, and arachidonic
acids and significantly increased the level of linoleic acid (Table 6-6). In contrast, oleic
acid was significantly reduced and palmitoleic and linolenic acids were significantly
increased as the elaidic acid incorporated into the NL fraction (Table 6-7). In the PL
fraction, a lower percentage of total SFA and higher percentage of total MUF A were
found in rats fed the TF A diet than in those fed the CFA diet (Table 6-6). In the NL
fraction, feeding the TF A diet increased the proportion of total MUFA compared to
feeding of the CFA diet (Table 6-7).

Small intestine. Tables 6-8 and 6-9 present the fatty acid PL and NL content of
the small intestine. In the PL fraction, the incorporation of elaidic acid decreased the
proportions of palmitic, stearic, and oleic acids and increased the proportion of linoleic
acid (Table 6-8). In the NL fraction, the TFA group had significantly higher percentages
of elaidic and linolenic acids and significantly lower percentages of oleic and linoleic
acids than the CFA group (Table 6-9). Higher percentages of total MUFA and PUFA as
well as lower percentage of total SFA in the TF A group than in the CFA group was
observed in the PL fraction (Table 6-8), whereas there was no dietary fat effect on the
proportions of total SFA, MUFA, and PUFA in the NL fraction (Table 6-9).

Plasma FA composition in Experiment 2. The fatty acid compositions of plasma in
rats after 2 weeks of dietary treatment is shown in Table 6-10. In the total lipids of
plasma, rats received the TF A diet had significantly lower percentages of palmitic,
stearic, oleic, and docosahexaenoic acids than those fed the CF A diet (P < 0.05) (Table
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TABLE 6-6
Fatty acid composition of skeletal muscle phospholipids (mole%) in rats fed
saturated, cis, or trans fatty acids diet for 6 weeks from Experiment 1 1' 2
Dietary group
Fatty acid
SFA

CFA

TFA

ClO:O

n.d.

n.d.

n.d.

C12:0

n.d.

n.d.

n.d.

C14:0

0.7 ± 0.2a

0.3 ± o.2ab

0.1 ± O.lb

C16:0

22.7 ± 0.8a

22.9 ± 0.5a

20.8 ± 0.4b

C16:1

1.6 ± 0.9a

0.8 ± 0.2a

0.6± 0.2a

CI8:0

11.8±0.r

16.8 ± 0.3a

14.2±0.lb

5.2 ± 0.4b

7.5 ± 0.7a

5.5 ± 0.3b

n.d.

n.d.

5.0 ± 0.2

19.8 ± 0.5b

23.3 ± 0.5a

cisC18:1 (n-9)
trans C18: 1 (n-9)
CI8:2 (n-6)

22.6 ± 0.7a

C18:3 (n-3)

n.d.

n.d.

0.1 ± 0.1

C20:4 (n-6)

17.8 ± 1.oab

18.7 ± 0.8a

15.8 ± 0.6b

~SFA

41.2 ± 1.2a

40.1 ± 0.5a

35.1 ± 0.3b

6.9 ± 0.8b

8.3 ± 0.8b

11.1 ± 0.6a

51.7 ± 0.8a

51.5 ± 1.1 a

53.7 ± 0.4a

o.oc

1.5 ± O.la

~MUFA
~PUFA
18:2 (n-6)/20:4 (n-6)

1.3 ± O.lb

1

1.1 ±

Values are group means± SEM (n = 6) and those with the same superscripts in a row
are not significantly different at P < 0.05.
2
Abbreviations used: SFA, saturated fatty acids; CF A, cis fatty acids; TFA, trans fatty
acid; MUF A, mono-unsaturated fatty acids; PUF A, poly-unsaturated fatty acids; ~ SFA,
total saturated fatty acids; ~ MUF A, total mono-unsaturated fatty acids; ~ PUF A, total
poly-unsaturated fatty acids; n.d., not detectable.
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TABLE 6-7
Fatty acid composition of skeletal muscle neutral lipids (mole%) in rats fed
saturated, cis, or trans fatty acids diet for 6 weeks from Experiment 1 1' 2
Dietary group
Fatty acid
SFA

CFA

TFA

CIO:O

n.d.

n.d.

n.d.

CI2:0

3.7 ± 0.7

n.d.

n.d.

CI4:0

8.0 ± 0.5a

2.1 ± 0.2b

1.9 ± O.lb

CI6:0

28.3 ± 0.7a

24.9 ± 0.8b

23.0 ± 0.4b

CI6:1

4.7 ± 0.4a

3.1 ± O.lb

4.3 ± 0.2a

CI8:0

5.5 ± 0.4a

5.2 ± 0.3a

5.1 ± 0.2a

25.2 ± 0.5c

36.9 ± 0.8a

27.7 ± 0.4b

cisCI8:1 (n-9)
trans Cl 8: 1 (n-9)

n.d.

n.d.

10.5 ± 0.4
21.4 ± 0.6ab

CI8:2 (n-6)

20.6 ± 0.6b

23.1 ± 0.6a

CI8:3 (n-3)

0.4±0.lb

0.3 ± 0.1 b

1.8 ± O.la

C20:4 (n-6)

1.4 ± 0.2a

2.0± 0.3a

1.4 ± 0.2a

:E SFA

45.7 ± 0.5a

33.7 ± 1.4b

31.3 ± 1.1 b

:EMUFA

30.0 ± 0.3c

40.0 ± 0.8b

42.4 ± 0.9a

:E PUFA

24.3 ± 0.5a

26.2 ± 0.9a

26.2 ± 0.6a

18:2 (n-6)/20:4 (n-6)

15.7 ± 2.7a

12.8 ± 2.1 a

16.7 ± 2.la

1

Values are group means± SEM (n = 6) and those with the same superscripts in a row
are not significantly different at P < 0.05.
2
Abbreviations used: SFA, saturated fatty acids; CF A, cis fatty acids; TF A, trans fatty
acid; MUF A, mono-unsaturated fatty acids; PUF A, poly-unsaturated fatty acids; :E SFA,
total saturated fatty acids; :E MUF A, total mono-unsaturated fatty acids; :E PUF A, total
poly-unsaturated fatty acids; n.d., not detectable.
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TABLE 6-8
Fatty acid composition of small intestinal phospholipids (mole%) in rats fed
saturated, cis, or trans fatty acids diet for 6 weeks from Experiment 1 1' 2
Dietary group
Fatty acid
SFA

CFA

TFA

CIO:O

4.0 ± 1.5a

6.1 ± 2.la

3.1±1.la

C12:0

0.7 ± O.la

0.8 ± 0.1 a

0.6 ± O.la

C14:0

1.6 ± O.la

0.8 ± O.lb

0.7±0.lb

C16:0

17.1±0.3a

17.6 ± 0.8a

15.3 ± 0.4b

C16:1

0.4 ± O.la

0.5 ± o.oa

0.5 ± o.oa

C18:0

24.4 ± 0.7a

21.5 ± 0.5b

18.7 ± 0.4c

cisC18:1 (n-9)

7.3 ± 0.4c

11.6 ± 0.4a

10.3 ± 0.3b

trans C18:1 (n-9)

0.1 ± O.Ob

0.2± O.Ob

5.6 ± 0.3a

C18:2 (n-6)

23.0 ± 1.4ab

19.2 ± I.Ob

25.2 ± 1.4a

C18:3 (n-3)

n.d.

n.d.

0.3 ± 0.0

C20:4 (n-6)

17.0 ± 0.5a

17.2 ± 1.3a

14.8 ± 0.8a

~SFA

48.8 ± 1.oa

47.8 ± 1.4a

39.1 ± I.lb

~MUFA

8.3 ± o.sc

13.0 ± 0.5b

16.8 ± 0.3a

~PUFA

43.0 ± 1.oa

39.2 ± 1.2b

44.2 ± I.la

1.4 ± 0.1 ab

1.2 ± O.lb

1.7±0.2a

18:2 (n-6)/20:4 (n-6)
1

Values are group means± SEM (n = 6) and those with the same superscripts in a row
are not significantly different at P < 0.05.
2
Abbreviations used: SFA, saturated fatty acids; CF A, cis fatty acids; TF A, trans fatty
acid; MUF A, mono-unsaturated fatty acids; PUF A, poly-unsaturated fatty acids; ~ SFA,
total saturated fatty acids; ~ MUFA, total mono-unsaturated fatty acids; ~ PUFA, total
poly-unsaturated fatty acids; n.d., not detectable.

142

TABLE 6-9

Fatty acid composition of small intestinal neutral lipids (mole%) in rats fed
saturated, cis, or trans fatty acids diet for 6 weeks from Experiment 1 1' 2
Dietary group
Fatty acid
SFA

CFA

TFA

ClO:O

1.2 ± 0.9a

0.9 ± 0.4a

l.4±0.6a

Cl2:0

8.7 ± 1.oa

0.5 ± O.lb

0.5 ± O.lb

Cl4:0

9.1 ± 0.5a

1.6±0.lb

1.7±0.lb

Cl6:0

24.8 ± 0.8a

22.4 ± 0.5a

22.1 ± 1.3a

Cl6:l

3.9 ± 0.4a

3.0±0.la

4.0± 0.6a

Cl8:0

6.1 ± 0.9a

4.4±0.la

5.0± 0.6a

22.5 ± 1.5c

40.4 ± 0.5a

27.7 ± 1.2b

0.2± O.Ob

0.1 ± o.ob

12.0 ± 0.6a

Cl8:2 (n-6)

19.2 ± 0.3c

23.6 ± 0.4a

21.2 ± 0.8b

Cl8:3 (n-3)

o.3 ± o.ob

0.4 ± O.Ob

1.8 ± O.la

C20:4 (n-6)

2.8 ± I.la

1.6 ± 0.2a

1.6 ± 0.6a

~SFA

50.4 ± 1.oa

30.3 ± 0.5b

31.1±0.5b

~MUFA

27.0 ± 1.8b

43.9 ± 0.5a

43.9 ± 1.2a

~PUFA

22.7 ± 1.4a

25.9 ± 0.3a

25.0 ± 1,5a

18:2 (n-6)/20:4 (n-6)

10.9 ± 2.5a

16.6 ± 2.4a

19.0 ± 4.2a

cisC18:l (n-9)
trans C 18: 1 (n-9)

1

Values are group means± SEM (n = 6) and those with the same superscripts in a row
are not significantly different at P < 0.05.
2
Abbreviations used: SFA, saturated fatty acids; CF A, cis fatty acids; TFA, trans fatty
acid; MUFA, mono-unsaturated fatty acids; PUF A, poly-unsaturated fatty acids; ~ SFA,
total saturated fatty acids; ~ MUF A, total mono-unsaturated fatty acids; ~ PUF A, total
poly-unsaturated fatty acids.
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6-10). Feeding the TFA diet resulted in a significant increase in the percentage of linoleic
acid (P < 0.05) and no decrease in the percentage of arachidonic acid, compared with
feeding of the CF A diet (Table 6-10). A significant amount of elaidic acid was present in
the TFA group and a trace amount of elaidic acid was also found in the CF A group
(Table 6-10). The different dietary fats led to variations in the total content of the
different fatty acid classes. Compared with the CFA group, the TFA group had
significantly higher percentages of total MUF A and PUFA, accompanied by a
significantly lower percentage of total SFA (Table 6-10).
After an acute dose of ethanol, within the CFA group, the levels of myristic and
palmitoleic acids increased and those of oleic and linoleic acids decreased in the CFA
group (Table 6-11 ). Within the TF A group, a reduced percentage of linoleic and elevated
percentage of arachidonic acid were found after the administration of ethanol (Table 611 ).

Liver microsomal fatty acid composition in Experiment 2. The fatty acid composition
of microsomal PL and NL isolated from the livers of rats fed CF A or TF A diets for 2
weeks are summarized in Tables 6-12 to 6-15. The characteristic changes of the fatty
acid profile in plasma were also observed in the microsomes. In both the PL (Tables 612) and NL (Tables 6-14) fractions, the percentages of palmitic, stearic and oleic acids

were significantly lower in the TFA group that those in the CFA group (P < 0.05). The
significantly higher percentage of linoleic acid was accompanied by an invariable level of
arachidonic acid in the TF A group compared to the CF A group. Elaidic acid was only
found in rats fed the TF A diet. Overall, feeding of TF A led to a decreased percentage of
total SFA, an increased percentage of total MUFA, and an unaffected percentage of total

144

TABLE 6-10
Fatty acid composition ofplasma total lipids (mole%) in rats fed cis or trans fatty
acids diet for 2 weeks from Experiment 2 1' 2
Dietary group
Fatty acid
CFA

TFA

ClO:O

n.d.

n.d.

C12:0

n.d.

n.d.

C14:0

0.6± o.oa

0.6 ± o.oa

C16:0

24.8 ± 0.3a

21.8 ± 0.3b

C16:1

1.3 ± O.la

1.5 ± O.la

C18:0

17.3 ± 0.3a

12.7 ± 0.2b

cis C18:1 (n-9)

9.8 ± O.la

8.6± 0.2b

trans C18:1 (n-9)

0.2 ± O.Ob

7.7 ± O.la

C18:2 (n-6)

21.0 ± 0.6b

23.8 ± 0.6a

Cl 8:3 (n-3)

n.d.

n.d.

C20:4 (n-6)

20.6 ± 0.5a

19.4 ± 0.6a

C22:6 (n-3)

2.6 ± O.la

2.4 ± O.lb

~SFA

43.2 ± 0.4a

35.5 ± 0.4b

~MUFA

11.4 ± 0.2b

17.8 ± 0.2a

~PUFA

45.4 ± 0.3b

46.7 ± 0.4a

1.0±0.lb

1.3 ± O.la

18 :2 (n-6)/20:4 (n-6)
1

Values are group means± SEM (n = 12) and those bearing the same superscript
letters in a row are not significant different at P < 0.05.
2
Abbreviations used: CF A, cis fatty acids; TF A, trans fatty acid; MUF A, monounsaturated fatty acids; PUF A, poly-unsaturated fatty acids; ~ SFA, total saturated fatty
acids; ~ MUF A, total mono-unsaturated fatty acids; ~ PUF A, total poly-unsaturated fatty
acids; n.d., not detectable.
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TABLE 6-11
Fatty acid composition ofplasma total lipids (mole%) in rats fed cis or trans fatty
acids diet with or without ethanol administration before being killed
from Experiment 2 1' 2
Dietary group
CFA

Fatty acid

TFA

no EtOHa

with EtOHa

no EtOH

with EtOH

ClO:O

n.d.

n.d.

n.d.

n.d.

C12:0

n.d.

n.d.

n.d.

n.d.

C14:0

0.6± O.Ob

0.7 ± 0.0 3

o.6± o.ob

0.6± O.Ob

C16:0

24.2 ± 0.53

25.3 ± 0.1 3

22.0 ± 0.5b

21.6 ± 0.4b

C16:1

1.0 ± O.lb

1.5±0.1 3

1.3 ± 0.1 ab

1.7 ± 0.2 3

C18:0

17.1 ± 0.4 3

17.5 ± 0.4 3

12.5 ± 0.2b

13.0± 0.2b

cis C18:1 (n-9)

10.1±0.1 3

9.4 ± 0.2b

8.6± 0.2c

8.6± 0.2c

0.2 ± O.Ob

0.2± O.Ob

7.8±0.23

7.5 ± 0.2 3

C18:2 (n-6)

22.7 ± 0.3b

19.2 ± OS

25.2 ± 0.6 3

22.4 ± 0.9b

C18:3 (n-3)

0.1 ± 0.0

0.2 ± 0.1

C20:4 (n-6)

19.5±0.?3

21.8 ± 0.53

18.3 ± 0.8b

C22:6 (n-3)

2.7 ± 0.1 3

2.6 ± O.lab

2.4 ± O.lb

2.3 ± 0.1 ab

trans Cl 8: 1 (n-9)

n.d.

n.d.
20.6 ± 0.8 3

:E SFA

42.4 ± 0.53

43.9 ± 0.3a

35.4 ± 0.6b

35.5 ± 0.6b

~MUFA

11.6 ± 0.2b

11.3 ± 0.3b

17.6 ± 0.3a

18.0 ± 0.4a

~PUFA

46.2 ± 0.5ab

45.1 ± 0.2b

47.1 ±OS

46.7 ± 0.53

1.2 ± O.Ob

0.9 ±0.oc

1.4±0.1 3

1.1 ±0.lb

18:2 (n-6)/20:4 (n-6)
1

Values are group means± SEM (n = 6) and those bearing the same superscript letters in a
row are not significant different at P < 0.05.
2
Abbreviations used: CF A, cis fatty acids; TF A, trans fatty acid; EtOH, ethanol; MUFA,
mono-unsaturated fatty acids; PUF A, poly-unsaturated fatty acids; ~ SF A, total saturated fatty
acids; ~ MUF A, total mono-unsaturated fatty acids; ~ PUF A, total poly-unsaturated fatty
acids; n.d., not detectable.
a With ethanol, animals received an oral dose (3 g/kg body weight) of ethanol (13%, v/v) 2
hours before being killed; no ethanol, animals received no ethanol before being killed.
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TABLE 6-12
Fatty acid composition in hepatic microsomal phospholipids (mole%) in rats fed cis
or trans fatty acids diet for 2 weeks from Experiment 2 1' 2
Dietary group
Fatty acid
CPA

TFA

ClO:O

n.d.

n.d.

C12:0

n.d.

n.d.

C14:0

0.6 ± 0.1 a

0.5 ± 0.1 a

C16:0

22.3 ± 0.5a

19.3 ± 0.4b

C16:1

1.7±0.2a

2.0± 0.2a

C18:0

18.3 ± 0.4a

13.3 ± 0.2b

7.0 ± O.la

6.6 ± O.lb

n.d.

7.9 ± 0.3

C18:2 (n-6)

12.3 ± 0.3b

14.7 ± 0.5a

C18:3 (n-3)

n.d.

n.d.

C20:4 (n-6)

30.1 ± 0.4a

29.1 ± 0.5a

C22:6 (n-3)

4.9 ± 0.4a

4.0 ± 0.5a

41.7 ± 0.6a

33.3 ± 0.5b

~MUFA

8.8 ± 0.3b

16.5 ± 0.3a

~PUFA

49.5 ± 0.5a

50.2 ± 0.6

0.4 ± O.Ob

0.5 ± o.oa

cis C18:1 (n-9)
trans C 18: 1 (n-9)

~SPA

18:2 (n-6)/20:4 (n-6)
1

3

Values are means± SEM (n = 12) and those bearing the same superscript letters in a
row are not significant different at P < 0.05.
2
Abbreviations used: CF A, cis fatty acids; TF A, trans fatty acid; MUF A, monounsaturated fatty acids; PUP A, poly-unsaturated fatty acids; ~ SFA, total saturated fatty
acids; ~ MUP A, total mono-unsaturated fatty acids; ~ PUP A, total poly-unsaturated fatty
acids; n.d., not detectable.
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TABLE 6-13
Fatty acid composition of hepatic microsomal phospholipids (mole%) ill rats fed cis
or trans fatty acids diet with or without ethanol administration before being killed
from Experiment 2 1' 2
Dietary group
Fatty acid

CFA

TFA

no EtOHa

with EtOHa

no EtOH

with EtOH

ClO:O

n.d.

n.d.

n.d.

n.d.

Cl2:0

n.d.

n.d.

n.d.

n.d.

0.7±0.la

0.4 ± 0.1 a

0.6±0.la

o.r

19.1 ± 0.6c

19.6 ± 0.6bc

Cl4:0

0.6± o.oa

Cl6:0

21.5 ± o.rb

C16:l

1.4 ± 0.2a

1.9 ± 0.4a

1.7 ± 0.2a

2.4 ± 0.3a

Cl8:0

18.5 ± OS

18.1 ± 0.7a

13.3 ± 0.2b

13.2 ± 0.4b

7.1±0.3a

7.0 ± O.lab

6.5 ± O.lb

6.7 ± 0.2ab

n.d.

7.8 ± 0.4a

8.0 ± 0.4a

11.8 ± 0.4c

15.1 ± OS

14.4 ± 1.oab

cis C18:1 (n-9)
trans Cl8:l (n-9)
C18:2 (n-6)
C18:3 (n-3)

23.2 ±

n.d.
12.8 ± 0.5bc
n.d.

n.d.

n.d.

n.d.

C20:4 (n-6)

29.4 ± OS

30.7 ± 0.6a

28.7 ± 0.7a

29.4 ± 0.7a

C22:6 (n-3)

5.3±0.la

4.5 ± 0.9a

4.2 ± 0.6a

3.8 ± 0.8a

SFA

41.1 ± OS

42.3 ± 1.1 a

33.1 ± 0.6b

33.6 ± 0.8b

~MUFA

8.6 ± 0.4c

8.9 ± 0.4c

16.0 ± 0.4b

17.1 ±0.3a

~PUFA

50.8 ± OS

49.1 ± 0.9a

51.4 ± 0.8a

49.7 ± 0.8a

0.4 ± o.oc

0.5 ± o.oa

~

18:2 (n-6)/20:4 (n-6)

0.4 ± o.obc

0.5 ± o.oab

1

Values are means± SEM (n = 6) and those bearing the same superscript letters in a row are
not significant different at P < 0.05.
2
Abbreviations used: CFA, cis fatty acids; TFA, trans fatty acid; EtOH, ethanol; MUFA,
mono-unsaturated fatty acids; PUF A, poly-unsaturated fatty acids; ~ SF A, total saturated fatty

acids; ~ MUF A, total mono-unsaturated fatty acids;
acids; n.d., not detectable.

~

PUF A, total poly-unsaturated fatty

a With ethanol, animals received an oral dose (3 g/kg body weight) of ethanol (13%, v/v) 2
hours before being killed; no ethanol, animals received no ethanol before being killed.
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TABLE 6-14
Fatty acid composition in hepatic microsomal neutral lipids (mole%) in rats fed cis
or trans fatty acids diet for 2 weeks from Experiment 2 1' 2
Dietary group
Fatty acid
CFA

TFA

ClO:O

n.d.

n.d.

C12:0

1.4 ± 0.2a

1.2 ± O.la

C14:0

2.8 ± 0.2a

2.3 ± 0.2a

C16:0

27.5 ± 0.8a

25.0 ± 0.6b

C16:1

5.3 ± 0.6a

5.4 ± 0.5a

C18:0

7.5 ± 0.3a

6.2 ± 0.2b

25.7 ± 0.5a

19.7 ± 0.8b

n.d.

8.1 ± 0.3

C18:2 (n-6)

16.6 ± 0.7a

18.6 ± 0.8a

C18:3 (n-3)

n.d.

n.d.

C20:4 (n-6)

9.8 ± 0.8a

9.7 ± 0.7a

C22:6 (n-3)

1.8 ± 0.2a

1.4 ± 0.3a

~SFA

39.4 ± 0.8a

34.8 ± 0.7b

~MUFA

31.1±0.8b

33.3 ± 0.6a

~PUFA

29.5 ± 1.4a

31.9 ± I.la

1.8 ± 0.2a

2.0± O.la

cis C18:1 (n-9)
trans C 18: 1 (n-9)

18 :2 (n-6)/20:4 (n-6)
1

Values are means± SEM (n = 12) and those bearing the same superscript letters in a
row are not significant different at P < 0.05.
2
Abbreviations used: CF A, cis fatty acids; TF A, trans fatty acid; MUFA, monounsaturated fatty acids; PUF A, poly-unsaturated fatty acids; ~ SFA, total saturated fatty
acids; ~ MUF A, total mono-unsaturated fatty acids; ~ PUF A, total poly-unsaturated fatty
acids; n.d., not detectable.
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TABLE 6-15
Fatty acid composition of hepatic microsomal neutral lipids (mole%) in rats fed cis
or trans fatty acids diet with or without ethanol administration before being killed
from Experiment 2 1' 2
Dietary group
Fatty acid

ClO:O

CFA

TFA

no EtOHa

with EtOHa

no EtOH

with EtOH

n.d.

n.d.

n.d.

n.d.

Cl2:0

1.0 ± 0.2b

1.8 ± 0.2a

1.1 ± O.lb

1.4 ± 0.1 ab

Cl4:0

2.2±0.lc

3.4 ± 0.2a

1.9±0.lc

2.8 ± 0.2b

Cl6:0

26.9 ± l.2ab

28.2±1.la

24.1 ± 0.8b

25.9 ± 0.8ab

Cl6:l

4.1 ± 0.6a

6.4 ± 0.9a

4.6±0S

6.3 ± 0.9a

Cl8:0

8.0 ± OS

6.9± 0.3b

6.4 ± 0.2b

6.0 ± 0.3b

25.5 ± 0.9a

25.9 ± 0.6a

19.7 ± 0.6b

19.7 ± 0.4b

8.8 ± 0.2a

7.4 ± 0.5b

20.2 ± 0.6a

17.0 ± I.Ob

cis Cl 8: 1 (n-9)
trans Cl8:l (n-9)
Cl8:2 (n-6)
Cl8:3 (n-3)

n.d.
17.7 ± 1.oab

n.d.
15.5 ± 0.8b

n.d.

n.d.

n.d.

n.d.

C20:4 (n-6)

10.9 ± 1.6a

8.7 ± 0.4a

10.4 ± 1.2a

9.4 ± 0.7a

C22:6 (n-3)

1.6 ± 0.3a

2.0 ± 0.4a

1.0 ± 0.4a

1.8 ± 0.2a

~SFA

38.2 ± 0.9ab

40.5 ± 1.2a

33.5 ± 0.8c

36.0 ± 0.9bc

~MUFA

29.7 ± 1.2b

32.4 ± OS

33.1 ± 0.9a

33.4 ± 0.7a

~PUFA

32.7 ± 1.8a

27.5 ± 1.5b

33.5 ± IS

30.6 ± l .4ab

1.8 ± O.Y

1.8 ± O.la

0.5 ± o.oa

0.5 ± o.oa

18:2 (n-6)/20:4 (n-6)
1

Values are mean± SEM (n = 6) and those bearing the same superscript letters in a row are
not significant different at P < 0.05.
2
Abbreviations used: CFA, cis fatty acids; TFA, trans fatty acid; EtOH, ethanol; MUFA,
mono-unsaturated fatty acids; PUFA, poly-unsaturated fatty acids; ~ SF A, total saturated fatty
acids; ~ MUF A, total mono-unsaturated fatty acids; ~ PUF A, total poly-unsaturated fatty
acids; n.d., not detectable.
a With ethanol, animals received an oral dose (3 g/kg body weight) of ethanol (13%, v/v) 2
hours before being killed; no ethanol, animals received no ethanol before being killed.
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PUF A compared to CF A feeding.
Administration of ethanol had only minor effects on the fatty acid profile of liver
microsomal PL and NL. In the PL fraction, the only change was an increase of the total
MUFA content in the TFA group after giving the acute ethanol dose (Table 6-13). In the
microsomal NL fraction of the CF A group, the ethanol administration resulted in a
significant increase in the levels of !auric and myristic acids and a significant decrease in
the levels of stearic acid (P < 0.05) (Table 6-15). The overall percentage ofMUFA was
increased and that of PUF A was decreased in the microsomal NL of rats fed CF A and
acute dose of ethanol. In the microsomal NL fraction of the TFA group, the percentage
of myristic acid was significantly increased (P < 0.05) and the percentages of elaidic and
linoleic acids were significantly decreased (P < 0.05) after the acute ethanol consumption

(Table 6-15). The overall fatty acid pattern ofrats fed TFA was not influenced by the
acute ethanol dose.

DISCUSSION
In order to evaluate the possible relevance of fatty acid changes to ethanol
metabolism, the fatty acid composition of the liver, small intestine (Experiment 1),
plasma, and liver microsome (Experiment 2) were determined. In Experiment 1, the fatty
acid profile was also analyzed in the adipose tissues and skeletal muscle for the
determination of TF A incorporation into these tissues. It is known that adipose tissues
and skeletal muscle have little relevance to ethanol metabolism. Therefore, the
discussion is focused on the fatty acid analysis of liver, small intestine, plasma, and liver
m1crosomes.
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In general, the extent of incorporation of TF A varied for different tissues and lipid
classes as expected. The results support a number of other studies showing that the fatty
acid composition of diverse classes of tissues mirrored the lipid content of the diet
(Decker and Mertz 1966, Hill et al. 1982, Moore et al. 1980, Ostlund-Lindqvist et al.
1985, Sgoutas et al. 1973, Sugano et al. 1984, Wood 1979, Wood et al. 1977). Due to the
low content of elaidic acid in the diet (19 mole%) of the present study, the measured
elaidic acid content in the studied tissues and lipid classes was much lower than that
reported in the previous studies, where elaidic acid made up 25 to 50% of the TFA diets.
It should be noted that elaidic acid was readily incorporated into the plasma and

microsome over a 2-week feeding period (Experiment 2) as compared to other studies
that fed TFA for 4 to 16 weeks (Blomstrand et al. 1985, Kirstein et al. 1983, Mahfouz et
al. 1984, Moore et al. 1980, Morgado et al. 1998, Sgoutas et al. 1973, Sugano et al.
1984).
Elaidic acid variously influenced the distribution of other fatty acids depending on
the tissue and lipid fraction studied. It has been shown that the pattern of incorporation of
elaidic acid resembled that of SFA in the PL and that of the of CF A isomer (oleic acid) in
the NL (Atal et al. 1994). This incorporation pattern was observed in the PL of liver and
hepatic microsome, and the NL of liver and small intestine. However, in the PL of small
intestine and the NL of liver microsome, feeding of TFA to rats resulted in decreased
palmitic, stearic, and oleic acids as compared to feeding of CFA, suggesting that elaidic
acid replaced both SFA and MUFA in these lipid fractions. Differences in the deposition
and incorporation of TFA into tissue lipids in animals fed the same dietary fats may
involve selective mechanisms. PUF A are incorporated exclusively into the 2-position of
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membrane PL, while SFA are incorporated into the I-position. More than 90% of elaidic
acid and linoelaidic acid are incorporated into the I-position of rat liver PL in place of
SFA (Wolff and Entressangles 1994). However, it was found that elaidic acid was also
preferentially incorporated into the 2-position of PL (Wood 1979). Therefore, acyl
transferases that esterify fatty acids to the 1- and 2-position are sensitive to the
configuration of fatty acids and may contribute to the differences in TFA deposition.
The dietary lipids related effect on linoleic and arachidonic acids were also
observed in the present study. In Experiment 1, the PL of the liver (Table 6-4) in rats fed
the TF A diet had a higher content of linoleic acid and a lower content of arachidonic acid
than those found in rats fed the CF A diet. In Experiment 2, both the plasma and liver
microsomes of the TFA group had significantly more linoleic acid than the CF A group,
while arachidonic acid levels were not statistically different between the 2 dietary groups.
This change could not be attributed to different levels of these fatty acids in the diets
because the TF A diet contained less or the same content of linoleic acid than the CFA
diet and neither diet contained arachidonic acid. This observation indicates the potential
for inhibition by TF A in the conversion of linoleic acid to arachidonic acid. It has been
shown in the previous studies that trans isomers of oleic acid exert a competitive
inhibition on the activity of ~6-desaturase (De Schrijver and Privett 1982, Kurata and
Privett 1980, Lawson et al. 1983, Mahfouz et al. 1980; 1984). However, a-linolenic acid,
a more preferable substrate for ~6-desaturase than linoleic acid (Sugano and Ikeda 1996),
was higher in the TF A diet than in the CF A diet and thus might result in decreased
conversion of linoleic acid to arachidonic acid.
Exposure to ethanol also has been shown to increase the ratio of linoleate to
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arachidonate in the rat liver (French et al. 1970, Mendenhall et al. 1969, Nanji et al. 1993,
Salem et al. 1996). Moreover, the liver microsomal linoleic acid concentration was lower
in rats fed saturated fats and ethanol than that of animal fed com oil and ethanol (Nanji et
al. 1994a). The definite mechanism for the ethanol-related alteration in the
concentrations of linoleic and arachidonic acids is not clear. However, this phenomenon
may be in part explained by ethanol inhibition of ~6- and ~5-desaturases, which are
responsible for the conversion oflinoleic acid to arachidonic acid (Wang and Reitz 1983).
In addition, lipid peroxidation has been demonstrated to be initiated in the hepatic
endoplasmic reticulum in rats during the metabolism of ethanol (Reinke et al. 1987).
Arachidonic acid is a component of cell membranes and is susceptible to lipid
peroxidation (Szebeni and Eskelson 1989). In rats with continuous ethanol infusion,
reduced arachidonic acid in hepatic microsomal membrane was positively correlated with
raised CYP2El content (r = 0.69, P < 0.01) and increased conjugated dienes in the liver
microsome (r = 0.70, P < 0.05) (Nanji et al. 1993). The content ofliver microsomal
arachidonic acid was decreased in rats fed com oil and ethanol compared to those fed
only corn oil (Nanji et al 1994a). Therefore, it was suggested that ethanol-induced lipid
peroxidation in microsomes could play a role in the decrease of arachidonic acid (Nanji et
al. 1993). In Experiment 1, rats fed the TFA diet for 6 weeks had an increased linolenate
to arachidonate ratio in the liver PL compared to those fed the SFA and CFA diets (Table
6-4). The elevated ratios of linolenate to arachidonate was also observed in the plasma
and liver microsomes of rats fed the TFA diet for 2 weeks (Tables 6-10, 6-12, and 6-14).
The exact relevance of these changes in fatty acid composition with regard to altered
ethanol clearance is unknown. Because the microsomal ethanol oxidizing system
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(cytochrome P450) is a membrane bound enzyme system, the incorporation of TFA into
the microsomal PL of the P450 system may alter the activity of CYP2E 1 and thereby
change the ethanol metabolism. The lowered BEC in rats fed the TF A diet as shown in
Chapter 3 might be due to enhanced CYP2El activity. While the relationship between
the dietary and microsomal fatty acid patterns is evident from the data of fatty acid
analyses, the mechanism by which these changes are affecting blood ethanol clearance in
not understood.
In summary, the fatty acid composition of tissues were highly reflective of the
dietary fatty acid composition. The increased ratio of linoleate to arachidonate observed
in the plasma and liver microsomes of TFA-fed rats supports the inhibition of
desaturation and elongation of linoleic acid to arachidonic acid. This shift in the ratio of
linoleic acid to arachidonic acid has been shown to increase ethanol-induced liver disease
which may be accompanied by relatively faster rates of ethanol metabolism similar to that
seen in the TFA group.
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CHAPTER VII
CONCLUSIONS

The effects of dietary saturated fatty acids (SF A), cis fatty acids (CF A), and trans
fatty acid (TFA) on blood ethanol clearance were determined in 5-week-old male
Sprague-Dawley rats. Various fats, oils, and one fatty acids were blended to generate
diets of comparable fatty acid content.
Two experiments were conducted to establish the effects of the types of dietary
fatty acids on the blood ethanol concentrations (BEC). In Experiment 1, after 2 weeks of
feeding, the BEC of SF A and CF A groups were higher than those of TF A group.
However, these differences in BEC were not significant after 4 and 6 weeks of feeding
the diets. Experiment 2 confirmed the decrease in BEC caused by the TF A diets in rats
after 2 weeks of dietary treatment. Therefore, it is concluded that the TFA diet lowered
BEC compared to the SF A or CF A diets. In addition, liver triglycerides were
significantly decreased in the TF A group, which suggests that TF A may offer protection
against fatty liver.
Possible mechanisms of dietary fatty acids related changes on BEC were
examined in these animals. It was found that TFA enhanced blood ethanol clearance in
comparison to SF A or CF A without affecting the hepatic alcohol dehydrogenase (ADH)
activity after either 2 or 6 weeks of dietary treatment. The activity of carnitine palmitoyl
transferase-I (CPT-I) was not affected by the types of dietary fatty acids. The urinary
ethanol excretion (mg ethanol/mL urine) was higher in the TFA group than in the CFA
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group during the first 4-hour post-ethanol administration, which may have contributed to
the lower BEC in the TFA group. The concentrations of camitines changed parallel with
BEC among the dietary groups which are consistent with the fact that camitine attenuates
blood ethanol clearance.
The lower BEC maintained in the TF A group compared to the SF A and CFA
groups may have been due to differences in the absorption of ethanol from the
gastrointestinal tract. Therefore, the differences in ethanol uptake and metabolism in the
small intestines was determined in everted intestinal sacs. Ethanol transport expressed as
the ratio of serosal to mucosa! ethanol concentrations and the in vitro absorption rate of
ethanol was not significantly affected by dietary fatty acids. However, when the amount
of ethanol metabolized to CO 2 during the transport process was taken into account,
uptake and metabolism of ethanol by the proximal segments of the small intestine were
significantly higher in the rats fed the TF A and CFA diet than in those fed the SFA diet.
Because ethanol oxidation was not significantly different between CF A and TF A group,
ethanol transport and metabolism in the small intestine can not be a mechanism and some
other mechanism must be responsible for the differences in BEC between the CF A and
TF A groups. Nonetheless, it is recognized that ethanol metabolism in extrahepatic

tissues is important and must be reexamined in this context.
Analyses of fatty acid composition revealed that the fatty acid composition of
various tissues was highly reflective of the fatty acid content of the diets. Elaidic acid
was well incorporated into the adipose tissues, liver, skeletal muscle, small intestine,
plasma, and hepatic microsomes of the TF A group after 2 or 6 weeks of dietary
treatment. Compared with rats fed the CF A diet, the fatty acid composition in the
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plasma, liver NL, and liver microsomes of rats fed the TFA diet was characterized by a
significant decrease in palmitic, stearic, and oleic acids and an increase in linoleic acid.
The higher linoleate to arachidonate ratio in the TF A group compared to the CFA group
supports the suggestion that TF A, and elaidic acid in particular, may interfere with the
conversion of linoleic acid to arachidonic acid which has been shown to protect liver
from alcohol-induced injury.
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APPENDIXES

APPENDIX I
ETHANOL CONCENTRATIONS

TABLE 1-1

Blood ethanol concentrations (BEC, mmoVL) in rats fed saturated, cis, or trans fatty
acids diet for 2 weeks from Experiment 1 1' 2
Dietary group
Time (minutes)
CFA

SFA

TFA

15

8.97 ± 1.49a

8.12 ± 1.54a

2.83 ± 1.54b

30

15.27 ± 1.04a

14.97 ± 1.98a

5.92 ± 2.34b

60

19.25 ± 1.80a

19.83 ± 2.34a

12.30 ± 3.07b

90

21.88 ± 1.55a

21.91 ± 2.45a

13.26 ± 1.19b

120

23.91 ± 1. 76a

23.07 ± 2.26a

13.05 ± 1.70b

180

24.91 ± 2.12a

23.68 ± 2.16a

16.41 ± 4.03a

240

23.39 ± 1.91 a

21.13 ± l.lla

11.46 ± 3.91 b

300

16.45 ± 1.58a

14.33 ± 1.81 ab

7.55 ± 3.08b

360

13.55 ± 0.62a

12.70 ± 2.05a

7.70 ± 4.53a

1

Values are group means± SEM (n = 5) and those with the same superscripts in a row
are not significantly different at P < 0.05.
2
Abbreviations used: SFA, saturated fatty acids; CF A, cis fatty acids; TF A, trans fatty
acid.

184

TABLE 1-2

Blood ethanol concentrations (BEC, mmoVL) in rats fed saturated, cis, or trans fatty
acids diet for 4 weeks from Experiment 1 1' 2
Dietary group
Time (minutes)
SFA

CFA

TFA

15

9.03 ± 1.30a

10.54 ± 1.82a

11.19 ± 2. ooa

30

16.35 ± 1.25a

17. 91 ± 1.47a

14.83 ± 1.80a

60

21.51 ± 1.25a

23.63 ± 1.92a

18.25 ± 2.15a

90

25.27± 1.18a

27.09 ± 2.78a

21.13 ± 1.72a

120

31.49 ± 0.56a

29.94 ± 3.17a

25.19 ± 2.39a

180

27.43 ± 0.95a

26.29 ± 3.09a

23. 71 ± 2.68a

240

26.21 ± 1. 72a

24.12 ± 3.72a

24.23 ± 1.99a

300

20.95 ± 2.63a

18.14 ± 3.60a

21.06 ± 2.21a

360

16.71 ± 2.34a

14.82 ± 3.21 a

16.59 ± 1.69a

1

Values are group means± SEM (n = 6) and those with the same superscripts in a row
are not significantly different at P < 0.05.
2
Abbreviations used: SFA, saturated fatty acids; CFA, cis fatty acids; TF A, trans fatty
acid.
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TABLE 1-3

Blood ethanol concentrations (BEC, mmoVL) in rats fed saturated, cis, or trans fatty
acids diet for 6 weeks from Experiment 1 1' 2
Dietary group
Time (minutes)
SPA

CPA

TFA

15

14.63 ± 2.37a

14.75 ± 3.12a

16.92 ± 3.18a

30

21.14 ± 4.13a

20.71 ± 2.84a

25.17 ± 3.89a

60

26.18± 1.60a

31.75 ± 5.48a

38.54 ± 7.42a

90

39.66 ± 7.53a

35.82 ± 7.58a

45.25 ± 9.09a

120

46.62 ± 8.55a

39.06 ± 7.86a

36.15 ± 3.91 a

180

34.84 ± 2.63a

28.08 ± 1.40a

31.50 ± 2.49a

240

30.16 ± 3.14a

27.74 ± 2.69a

28.46 ± 1.92a

300

26.63 ± 2.64a

22.49 ± 2.58a

27.49 ± 2.55a

360

20.56 ± 2.92a

12.68 ± 2.34a

17.37 ± 1.69a

1

Values are group means± SEM (n = 5) and those with the same superscripts in a row
are not significantly different P < 0.05.
2
Abbreviations used: SFA, saturated fatty acids; CF A, cis fatty acids; TF A, trans fatty
acid.
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TABLE 1-4

Blood ethanol concentrations (BEC, mmoVL) in rats fed cis or trans/atty acids diet
for 2 weeks from Experiment 2 1•2
Dietary group
Time (minutes)
CPA

TFA

30

19.86 ± 1.69a

17.61±1.31a

60

22. 77 ± 2.13a

17.19 ± 1.40b

90

22.32 ± 2.34a

15.63 ± 1.59b

120

22.49 ± 2.40a

15.53 ± 1.69b

150

19.82 ± 2.56a

13.79 ± 1.73a

180

18.18 ± 2.69a

13.11 ± 2.04a

210

14.22 ± 2.55a

10.84 ± 1.99a

240

12.51±2.41a

8.12 ± 2.39b

270

9.92 ± 2.30a

7.93 ± 2.64a

300

6.76 ± 2.01 a

4.96 ± 1.73a

360

1.82 ± 0.80a

1.21 ± 0.53a

1

Values are means± SEM (n = 12) and those with the same superscript letters in a row
are not significant different at P < 0.05.
2
Abbreviations used: CFA, cis fatty acids; TF A, trans fatty acid.
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TABLE 1-5

Urinary ethanol concentrations (UEC, mg/mg creatinine) in rats fed cis or trans
fatty acids diet for 2 weeks from Experiment 2 1'2
Dietary group
Collection time (hour)
CPA

TFA

2

6.0± 1.5a

4.7 ± 0.7a

4

2.0± 0.6a

1.3 ± 0.5a

6

O.la
0.1 ± o.oa
0.0± o.oa

0.2± o.oa

8
24

0.3 ±

1

o.oa
0.0± o.oa
0.1 ±

Values are means± SEM (n = 12) and those with the same superscript letters in a row
are not significant different at P < 0.05. Creatinine was determined in the urine of the
given collection period and related to the mg of ethanol per mg of creatinine.
2
Abbreviations used: CF A, cis fatty acids; TFA, trans fatty acid.
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TABLE 1-6

Urinary ethanol concentrations (UEC, mglmL urine) in rats fed cis or trans fatty
acids diet for 2 weeks from Experiment 2 1' 2
Dietary group
Collection time (hour)
TFA

CFA
2

1.3 ± 0.2a (3.0± 0.4)

1.1 ± O.la (3.0± 0.3)

4

0.8 ± 0.2a (1.1 ± 0.2)

0.5 ± 0.1 a (1.3 ± 0.3)

6

0.2± O.la (0.6± 0.2)

8

o.oa
0.0± o.oa

o.oa (0.7 ± 0.1)
0.0 ± o.oa (0.5 ± 0.2)
0.0 ± o.oa (9.8 ± 0.9)

24

0.1 ±

(0.4± 0.2)
(8.2± 0.8)

1

0.1 ±

Values are means± SEM (n = 12) and those with the same superscript letters in a row
are not significant different at P < 0.05. Number in parenthesis refers to the mL of urine
in a particular collection period.
2
Abbreviations used: CF A, cis fatty acids; TFA, trans fatty acid.
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TABLE 1-7

Urinary ethanol concentrations (UEC, mg/collection period) in rats fed cis or trans
fatty acids diet for 2 weeks from Experiment 2 1' 2
Dietary group
Collection time (hour)
CFA

TFA

2

4.2 ± 0.9a

3.8 ± 0.8a

4

1.0 ± 0.3a

0.8 ± 0.4a

6

0.2 ± O.la

0.1 ± o.oa

8

0.1 ± o.oa

0.0± o.oa

24

0.4 ± o.oa

0.3 ± o.oa

1

Values are means± SEM (n = 12) and those with the same superscript letters in a row
are not significant different at P < 0.05.
2
Abbreviations used: CF A, cis fatty acids; TFA, trans fatty acid.
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APPENDIX II
CARNITINE CONCENTRATIONS

TABLE 11-1
Plasma carnitine concentrations (µmoVL) in rats fed saturated, cis, or trans fatty
acids diet for 0, 2, 4, and 6 weeks from Experiment 2 1' 2
Dietary group

SFA

CFA

TFA

0 week:

NEC

19.4±1.la

19.6 ± 2.la

17.3 ± 0.8a

ASAC

6.8 ± 0.7a

8.0± 0.9a

7.7± 0.6a

AIAC

1.3 ± 0.5a

0.7± 0.2a

1.0 ± 0.4a

27.5±1.la

28.3 ± 3.la

26.0 ± 1.oa

24.5 ± 2.la

24.5 ± 2.3a

21.2 ± 1.5a

ASAC

9.2 ± 1.4a

9.0± 0.8a

5.7± 0.7b

AIAC

2.5 ± 0.2a

2.3 ± 0.2a

1.4 ± O.lb

36.2 ± 3.2a

35.7±3.la

28.3 ± 1.8a

29.6 ± 4.03

29.7±3.1 3

26.0 ± 2.0a

ASAC

8.6 ± 0.6a

8.1 ± 1.4a

6.5 ± 0.4a

AIAC

2.4 ± 0.2a

1.8 ± 0.3ab

1.6 ± 0.2b

TC
2 weeks:

NEC

TC
4 weeks:

NEC

TC

40.5 ± 4.4a

39.6 ± 3.9a

Continued
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34.0±2.la

TABLE 11-1 (Continued)

Plasma carnitine concentrations (µmoVL) in rats fed saturated, cis, or trans fatty
acids diet for 0, 2, 4, and 6 weeks from Experiment 2 1' 2
Dietary group
CFA

SFA

TFA

6 weeks:
NEC

36.8 ± 4.4a

40.4 ± 3.6a

31.2 ± 1.4a

ASAC

14.4 ± 1.3a

11.3 ± 1.1 ab

8.7 ± 1.0b

AIAC

4.3 ± 0.4a

4.0± 0.3a

3.3 ± 0.2a

55.5 ± 5.3a

55.7 ± 4.7a

43.1 ± 1.la

TC
1

Values are means± SEM (n = 6) and those with the same superscript letters in a row
are not significantly different at P < 0.05.
2
Abbreviations used: SFA, saturated fatty acids; CF A, cis fatty acids; TF A, trans fatty
acid; NEC, nonesterified camitine; ASAC, acid-soluble acylcamitine; AIAC, acidinsoluble acylcamitine; TC, total camitine.
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TABLEil-2
Urinary excretion carnitine concentrations (µnoVday) in rats fed saturated, cis or trans
fatty acids diet for 0, 2, 4, and 6 weeks from Experiment 2 1' 2
Dietary group
CFA

SFA

TFA

0 week:
NEC

0.17 ± 0.03a

0.14±0.0la

0.14 ± 0.01 a

ASAC

0.19 ± 0.02a

0.19±0.0la

0.21 ± 0.02a

AIAC

0.03 ± o.ooa

0.02 ± o.ooa

0.02 ± o.ooa

TC

0.39 ± 0.05a

0.34 ± 0.01 a

0.36 ± 0.02a

NEC

0.16 ± 0.02a

0.17 ± 0.02a

0.16 ± 0.02a

ASAC

0.07 ± 0.01 a

0.09 ± o.ooa

0.09 ± O.Ola

AIAC

0.02 ± o.ooa

0.01 ± o.ooa

0.01 ± o.ooa

TC

0.25 ± 0.02a

0.27 ± 0.02a

0.27 ± 0.02a

NEC

0.23 ± 0.03a

0.23 ± 0.04a

0.20 ± 0.03a

ASAC

0.13±0.0la

0.16 ± 0.02a

0.15 ± 0.02a

AIAC

0.02 ± o.ooa

0.01 ± o.oob

0.01 ± o.oob

TC

0.38 ± 0. 04a

0.39 ± 0.06a

0.36 ± 0.04a

NEC

0.33 ± 0.06a

0.43 ± o.or

0.28 ± 0.04a

ASAC

0.14 ± 0.02a

0.14 ± 0.02a

0.15 ± 0.02a

AIAC

0.02 ± o.ooa

0.02 ± o.ooa

0.04 ± o.ooa

TC

0.49 ± o.or

0.59 ± 0.08a

0.46 ± 0.06a

2 weeks:

4 weeks:

6 weeks:

1

Values are means± SEM (n = 6) and those with the same superscript letters in a row are not
significantly different at P < 0.05.
2
Abbreviations used: SFA, saturated fatty acids; CFA, cis fatty acids; TFA, trans fatty acid;
NEC, nonesterified camitine; ASAC, acid-soluble acylcamitine; AIAC, acid-insoluble
acylcamitine; TC, total carnitine.
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APPENDIX III
FATTY ACID ANALYSIS

Part A. Extraction of fatty acids
1.

Homogenize the tissue sample of adipose tissue, liver, muscle, or small intestine
in cold saline to yield a concentration at 1 mg/mL using a glass homogenizer. For
plasma and microsome, 250 µLis used for fatty acid assay.

2.

Transfer 800 µL of homogenate into teflon coated 16 x 125 screw top tubes and
add 3 mL of chloroform:methanol (1 :2, v/v).

3.

Vortex and incubate the mixture for 30 minutes on ice in dark condition.

4.

Add 200 µL of saturated NaCl and 1 mL chloroform to each sample tube.

5.

Vortex and incubate the mixture for 15 minutes on ice in dark condition.

6.

Centrifuge at 900 x g for 3 minutes to separate the lipid and non-lipid phases.

7.

Remove chloroform layer (bottom layer) and transfer to 12 x 75 mm test tube.

8.

Extract the lipids one more time by adding 1 mL of chloroform and follow the
steps 5 to 7.

9.

Evaporate chloroform under nitrogen to dryness.

10.

Resuspend the lipid extraction in 50 µL of chloroform.

11.

Separate polar fraction (phospholipids) and non-polar fraction (triglyceride,
cholesterol, and free fatty acids) with thin layer chromatography (TLC) by
applying 25 µL of lipid extract to TLC silica gel 60 HP-TLC plate.

12.

Place TLC plate into a glass chamber containing chloroform:methanol (8:1, v/v)
and run TLC for about 15 minutes or until solvent reach the top line. Dry TLC
plate under hood.

Part B. Saponification, acidification, and methylation of fatty acids
13.

Phospholipid fraction is scraped from point of origin of plate using razor blade
and placed in a 16 x 125 mm screw top tube.

14.

Add 100 µL of C15:0 (1 mg/mL in iso-octane) as internal standard to the screw
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top tube.
15.

Add 250 µL of toluene and 500 µL of0.5 N KOH/MeOH for fatty acid
saponification. Make sure the caps are tightly fitted. Incubate the tube at 86 °C
water bath for 8 minutes.

16.

Cool the tube to room temperature.

17.

Add 1 mL of 0.7N HCVMeOH to the tube for fatty acid acidification.

18.

Add 2 mL of hexane to extract the fatty acids. Vortex well and centrifuge at 900
x g for 3 minutes.

19.

Transfer the top layer to a 12 x 75 mm tube.

20.

Repeat steps 17 to 19 and evaporate hexane to dryness under nitrogen gas.

21.

Resuspend lipids in 200 µL of hexane and transfer to a 2 mL vial. Evaporate
hexane to dryness under nitrogen gas.

22.

Repeat step 21.

23.

Under the hood, add 150 to 200 µL of ethereal diazomethane to the vial for fatty
acid methylation. Place the cap on the vial loosely immediately after adding
diazomethane and incubate for 10 minutes.

24.

Evaporate the vial to dryness under the hood.

25.

Add hexane to the vial to resuspend the methylated fatty acids. Cap the vial and
vortex well.
* Amount of hexane used for resuspension of methylated fatty acids:
For adipose tissue, 120 µL; liver.1 100 µL; microsome, 250 µL; muscle, 500 µL;
plasma, 100 µL; small intestine, 15 µL.

26.

Analyze fatty acids via gas chromatograph.
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